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Activation of Ras/mitogen-activated protein kinase (ERK MAPK) signalling 
controls the differentiation of mouse embryonic stem (ES) cells. An 
established modulator of the ERK MAPK pathway is the IRS-1 (Insulin 
Receptor Substrate 1) family adaptor protein Gab1 (Grb2-associated binder 
1). Gab1 is ubiquitously expressed and is activated by a wide range of cell 
surface receptors, mediating growth factor, cell-cell and cell-substratum 
interactions. The N-terminal region of Gab1 contains a pleckstrin homology 
(PH) domain required for membrane binding and a nuclear localisation 
sequence (NLS) that facilitates nuclear translocation. Undifferentiated mouse 
ES cells preferentially express high levels of a novel form of Gab1 (Gab1β) 
lacking the N-terminal region. Based on its novel structure and abundance, 
Gab1β may act in a dominant negative manner by binding and mislocalising 
downstream effectors. Alternatively, it may have a deregulated function 
unrestrained by the PH or NLS domains. Data presented here shows that 
Gab1β is tyrosine phosphorylated in response to the self-renewal factor 
Leukemia Inhibitory Factor (LIF) and/or Foetal Bovine Serum (FBS) 
stimulation. This then leads to the formation of complexes with Shp2 and the 
p85 subunit of PI3K. Experiments comparing the responses of wild-type and 
Gab1β knock-out ES cells indicate that Gab1β enhances ERK and potentially 
AKT phosphorylation in response to LIF. In contrast, Gab1β has a negative 
effect on ERK and AKT phosphorylation in response to IGF-1 (Insulin 
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Growth Factor 1). These results suggest that the contribution of Gab1β to 
signalling activity is receptor specific and may imply that the response of ES 
cells to ERK activation is context specific. By reintroducing fluorescently 
tagged Gab1 proteins into Gab1β knockout ES cells, I investigated the 
localisation of Gab1β in ES cells. Gab1β localised at the cell membrane as 
well as in a perinuclear body. I next investigated the potential role of Gab1β 
in the differentiation of ES cells into neural precursors. A monolayer 
differentiation protocol was used to differentiate Gab1β wild-type and 
knock-out cells into neural precursors. Furthermore, the effect of insulin on 
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CHAPTER 1: INTRODUCTION 
 
1.1 Embryonic Stem cells 
 
Multicellular organisms require the existence and precise control of stem 
cells, which maintain tissue homeostasis by replacing terminally, 
differentiated, aged or injured cells (Boiani and Scholer, 2005). Stem cells are  
cells that have the ability to divide for indefinite periods in the 
undifferentiated state but also retain the potential to give rise to specialised 
cells (Boiani and Scholer, 2005). In addition to somatic stem cell systems in 
the foetus and the adult, stem cells can also be obtained from inner cell mass 
(ICM) of peri- and early post-implantation-stage embryos. Such cells are 
called embryonic stem cells (ES cells) (Evans and Kaufman, 1981; Martin, 
1981). ES cells can be readily propagated in culture, unlike most somatic stem 
cells. As the in vitro counterpart of epiblast cells (Smith, 2001), ES cells have 
the capacity to differentiate into cells of all three germ layers (endoderm, 
mesoderm, ectoderm), a property referred to as pluripotency. This can be 
demonstrated by their injection into a mouse blastocyst, and their 
contribution to all the tissues of the developing mouse including colonisation 
of the germline (Bradley et al., 1992). Because pluripotency is a fundamental 
biological function in multicellular organisms, it is probably evolutionarily 
secured by numerous genetic backup systems and conserved among 
different types of stem cell (Boiani and Scholer, 2005). Another property of 
ES cells is their continuous self-renewal, which requires the unique 
transcriptional profile of the pluripotent state to be maintained (Chen and 
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Daley, 2008). Despite the considerable interest in the use and manipulation of 
ES cells, some of the factors that regulate their unique properties are still to 
be elucidated.  
 
1.2 Regulation of Embryonic Stem cell self-renewal and pluripotency 
 
In early experimental approaches to address the molecular mechanism of 
pluripotency, it was hypothesised that pluripotent cells express a unique set 
of factors that underlie their “stemness” (Chen and Daley, 2008). This is 
supported by a study, which set out to characterise the transcriptional profile 
of embryonic and adult stem cells (Ramalho-Santos et al., 2002). In the latter 
study, the authors demonstrated that self-renewing cells do share common 
genetic profiles, but that ES cells express a significantly higher number of 
genes. Understanding ES cell self-renewal and the factors that underlie these 
mechanisms is important for the future therapeutic use of ES cells. In 
addition to general pathways of signal transduction that operate in most cells 
types, several exogenous factors are known to modulate stem cell 
pluripotency and self-renewal (Boiani and Scholer, 2005). Therefore, ES cell 
self-renewal is directed by both intrinsic and extrinsic factors. The best-






1.2.1 Endogenous self-renewal signals 
 
Several key factors regulating ES cell self-renewal have been identified. They 
include the homeodomain transcription factors Oct4 and Nanog, as well as 
the HMG-box transcription factor Sox2. These three transcription factors 
have been shown to co-occupy the promoters of a large population of 
regulatory genes potentially involved in specialised circuits in human ES 
cells (Boyer et al., 2005). 
 
1.2.1.1  Oct4 
 
The murine Oct4 gene encodes a Class V POU transcription factor containing 
a POU-specific domain and a homeodomain (Okamoto et al., 1990; Rosner et 
al., 1990). The Oct4 protein is a member of the POU family of transcription 
factors that bind the octamer sequence ATGCAAAT and is expressed in early 
embryo cells and germ cells (Okamoto et al., 1990; Pesce and Scholer, 2001; 
Rosner et al., 1990). Oct4 is highly expressed in pluripotent ES cells, but is 
absent from all differentiated somatic cell types in vivo and in vitro (Niwa et 
al., 2002; Niwa et al., 2000; Rosner et al., 1990). Oct4 was recently shown to be 
involved in the maintenance of ES cell survival and antiapoptosis 
mechanisms (Guo et al., 2008). In this study, using a tetracycline-inducible ES 
cell line (ZHBtc4) and its parental control line (CGR8), Oct4 was 
demonstrated to be protect ES cells from apoptosis, induced by etoposide, 
UV or heat shock. Upon reduction of Oct4, the percentage of caspase-positive 
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cells, a measure of apoptotic cells, increased, in contrast to parental cells. 
Therefore, not only is Oct4 involved in the maintenance of ES cell self-
renewal and pluripotency, but in the survival of ES cells too. This suggests a 
more global role for Oct4 in ES cell biology.  The feature common to all cells 
expressing Oct4 in the early embryo is that they retain the capacity for 
differentiation along multiple lineages (Rosner et al., 1990). When Oct4 is 
deleted from ES cells, they transdifferentiate into trophectodermal cells, 
indicating that Oct4 is required for ES cells to maintain their pluripotent 
identity (Chambers and Smith, 2004; Niwa et al., 2000). Similarly, Oct4 -/- 
embryos die at peri-implantation stages because of the conversion of ICM 
into trophectoderm (Nichols et al., 1998). Interestingly, a PouV gene from 
Xenopus laevis, Xlpou91, has the capacity to maintain murine ES cells in the 
absence of Oct4 (Morrison and Brickman, 2006). This suggests that Oct4 may 
act as a conserved transcription factor in the maintenance of pluripotency in 
both mammals and amphibians. It is the amount of Oct4, however, that 
controls the fate of ES cells (Niwa et al., 2000). A less than 2-fold increase 
from the normal expression levels causes differentiation into ectoderm and 
mesoderm, whereas a reduction to less than 50% leads to de-differentiation 
into trophectoderm (Niwa et al., 2000; Okumura-Nakanishi et al., 2005). This 
reduction in Oct4 is coupled with the upregulation of Cdx2 (Caudal-related 
homeobox 2) and Eomes (Eomesodermin) (Niwa et al., 2000; Niwa et al., 
2005). Ectopic expression of Oct4 in immortalised murine cells results in their 
transformation (Gidekel et al., 2003). This suggests that the reactivation of a 
pluripotency factor such as Oct4 may contribute to tumourigenesis in 
somatic tissues (Hochedlinger et al., 2005). Furthermore, Oct4 expression is 
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downregulated in ES cells upon withdrawal of LIF (Chambers and Smith, 
2004; Nichols et al., 1998), which suggests that Oct4 may be a target of the 
LIF/Stat3 signalling cascade. However, when Oct4 expression in ES cells is 
maintained via a tetracycline-dependent transgene and LIF is withdrawn, the 
cells differentiate (Niwa et al., 2000). This suggests that other factors may be 
acting along with Oct4 in order to maintain pluripotency. Many ES cell-
expressed genes (e.g. the zinc-finger protein Zfp42/Rex-1) have Oct4 binding 
domains within their regulatory elements and so Oct4 can act directly to 
activate these target genes (Friel et al., 2005). It may also act by forming 
complexes with transcriptional co-factors. For example the Sry-related factor 
Sox2 is thought to cooperate with Oct4 in order to maintain self-renewal 




Sox2 is a member of the SRY-related HMG box gene family that encode 
transcription factors with a single HMG DNA-binding domain (Avilion et al., 
2003). Like Oct4, it is expressed in the ICM, epiblast and germ cells, but, 
unlike Oct4, it is also expressed in the multipotential cells of the 
extraembryonic ectoderm of the mouse embryo (Avilion et al., 2003). Sox2-
null mice have primary defects in the pluripotent epiblast and the null 
blastocysts are incapable of giving rise to pluripotent ES cells (Avilion et al., 
2003). Small increases in the level of Sox2 have been shown to trigger the 
differentiation of ES cells (Kopp et al., 2008). Although Sox2 homozygous 
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mutants have been shown to undergo early embryonic lethality (Avilion et 
al., 2003), it is thought that the requirement of ES cells for Sox2 is based on its 
indirect association with Oct4 on a pluripotency-associated gene enhancer 
containing Oct4 and Sox2 binding motifs. Sox2 and Oct4 have been shown to 
physically interact and to cooperatively regulate their own expression by 
binding to adjacent HMG and POU motifs within enhancers required for the 
transcription of each gene (Okumura-Nakanishi et al., 2005; Tomioka et al., 
2002). Furthermore, the expression of most pluripotency-asscociated genes, 
such as Fgf4 (Ambrosetti et al., 2000; Yuan et al., 1995), Utf1 (Nishimoto et al., 
1999), Fbx15 (Tokuzawa et al., 2003), Lefty1 (Nakatake et al., 2006) and 
Nanog (Kuroda et al., 2005; Rodda et al., 2005), is regulated by enhancers, 
which are highly active in undifferentiated ES cells, but not in differentiated 
cells.  New evidence has shown that, using an inducible Sox2-null ES cel line, 
Sox2 is indispensable for maintaining ES cell pluripotency, as Sox2 null cells 
differentiate into trophectoderm-like cells (Masui et al., 2007). Interestingly, 
however, by monitoring the levels of Oct4/Sox2 enhancer-dependent genes 
(such as Fgf4, Nanog, Lefty1 etc), it was shown that Sox2 is not required for 
the activation of the Oct4/Sox2 enhancers. These enhancers remained active 
even after the depletion of Sox2 protein.  The authors therefore suggested 
that Sox2 regulates the expression of Oct4 through the regulation of multiple 
transcription factors. Furthermore, in a study trying to identify the 
regulatory interactions between the fundamental regulators  (Oct4, Sox2 and 
Nanog), and additional transcription factors (such as Stat3, Klf4 and others), 
it was found that the three “master regulators” worked in conjunction with 
other transcription factors to control ES cell biology (Zhou et al., 2007). These 
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additional factors may act in a repressive or positive manner on the control 
of target genes. These data suggest that ES cells are governed by a complex 
regulatory network of many factors, whose repressive and enhancing actions 




Nanog was initially described as a novel divergent homeobox transcription 
factor which promotes ES self-renewal, pluripotency and epiblast formation 
(Chambers et al., 2003; Mitsui et al., 2003). Nanog-null embryos fail to form 
epiblasts, and are mostly composed of disorganised extraembryonic tissue 
(Chambers et al., 2003; Mitsui et al., 2003). Nanog is specifically expressed in 
ES cells but not in differentiated cells. Furthermore, Nanog has been shown 
to act independently of the LIF cascade (the cytokine required to maintain ES 
cell self-renewal in culture), as overexpression of Nanog leads to LIF-
independent self-renewal of ES cells (Chambers et al., 2003). Nanog has been 
shown to require dimerisation in order to exert its positive effects on the 
maintenance of self-renewal and pluripotency (Mullin et al., 2008; Wang et 
al., 2008). A Nanog monomer was shown to be unable to replace wild-type 
Nanog to sustain LIF-independent self-renewal of ES cells. How Nanog is 
able to sustain ES cells self-renewal independently of LIF is still unclear. 
Nanog was recently demonstrated to bind to NFκB, which then represses its 
pro-differentiative effects (Torres and Watt, 2008). The authors also 
demonstrated that Nanog does this in cooperation with Stat3, the 
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transcription factor activated by LIF, to maintain pluripotency. Once Nanog 
is downregulated, human and mouse ES cells undergo differentiation by 
showing morphological changes characteristic of differentiated cells, as well 
as a decrease in proliferation rate (Ivanova et al., 2006; Liu et al., 2008; 
Zaehres et al., 2005). In contrast, Nanog overexpressing cells show a marked 
increase in reprogramming activity after fusion with neural stem cells (Silva 
et al., 2006). A series of differentially expressed genes has been identified 
upon the downregulation of Nanog in ES cells (Liu et al., 2008). The general 
trend was that genes known to be involved in ES cell self-renewal and 
pluripotency, such as Utf1 and Klf4, were downregulated upon Nanog 
silencing. Similarly, genes known to be involved in ES cell differentiation, 
such as Lefty1, were upregulated during Nanog silencing. Interestingly, 
Nanog function requires the continued presence of Oct4. As described above, 
when ES cells that express Oct4 from the tetracycline-regulated locus have 
their Oct4 transgene repressed, ES cells differentiate along the trophectoderm 
lineage, an effect rescued by the transfection of Oct4 cDNA into the cells 
(Niwa et al., 2002). This however cannot be prevented by the transfection of 
Nanog cDNA (Chambers et al., 2003). Nanog and Oct4 have also been shown 
to interact with each other as well as with proteins from multiple repression 
complexes, such as the NuRD, Sin3A and Pml complexes (Liang et al., 2008). 
Furthermore, Zfp143, a selenocysteine tRNA gene transcription-activating 
factor, was recently shown to interact with Oct4 on a cis-regulatory element 
of Nanog, thereby activating Nanog transcription (Chen et al., 2008). This 
was also true for another zinc finger transcription factor, Zfp281, which was 
shown to physically interact with Oct4, Nanog and Sox2. Therefore, despite 
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the fact that Oct4 and Nanog may act independently, their signals must occur 
simultaneously in order to maintain pluripotency in the epiblast. This is sure 
to be dependent on various repressive and activating transcription factor 
networks, which act in concert to maintain ES cell self-renewal and 
pluripotency. More recently, however, Nanog was shown to be undetectable 
in around 20% of cells that express Oct4 (Chambers et al., 2007). Nanog null 
cells were shown to produce teratomas containing tissues representative of 
all three germ layers. Furthermore, Nanog null cells are fully capable of  
forming undifferentiated AP positive colonies. This observation lead to the 
discovery that the permanent loss of Nanog in ES cells does not mark 
commitment, but it merely predisposes them to towards the differentiation 
into germ cells (Chambers et al., 2007).  
 
1.2.2 Induced Pluripotent Stem cells 
 
The property of ES cells to self-renew indefinitely while maintaining 
pluripotency has lead to the expectation of their potential use in the 
treatment of various diseases as well as drug screening and genetic therapy. 
The use of human embryos, however, has shown to be ethically questionable 
and therefore the use of human ES cells has been hindered. A seminal study 
successfully demonstrated that the pluripotent state could be induced from a 
differentiated cell. Takahashi et al. demonstrated that ES-like cells can be 
generated from both mouse (Takahashi et al., 2007; Takahashi and 
Yamanaka, 2006) and human (Takahashi et al., 2007) fibroblasts by the 
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reprogramming of their Oct4, Sox2, Klf4 and cMyc genes. Such cells are now 
known as induced pluripotent stem (iPS) cells. The use of iPS cells not only 
bypasses the ethically challenging use of embryos, but the risk of immune 
rejection as well during the treatment of disease. iPS cells are comparable to 
ES cells, as they exhibit the growth and morphology of ES cells and express 
ES cells marker genes such as Nanog and ERas (Takahashi et al., 2007; 
Takahashi and Yamanaka, 2006). Furthermore, iPS cells stain positive for 
alkaline phosphatase and the ES cell-specific surface marker SSEA1, 
differentiate into all three germ layers in vitro and form teratomas when 
injected into immunodefficient mice (Takahashi and Yamanaka, 2006; Zhao 
and Daley, 2008).   
 
iPS cells are generated by the retroviral transduction of four defined factors: 
Oct4, Sox2, Klf4 and c-Myc. Klf4 (gut-enriched Kruppel-like factor) belongs 
to the Kruppel-like factor (Klf) family of evolutionarily conserved zinc finger 
transcription factors that regulate numerous biological processes such as 
proliferation, differentiation, development and apoptosis (Jiang et al., 2008; 
McConnell et al., 2007). Although Klf4 is not required for the maintenance of 
the undifferentiated state in ES cells, simultaneous depletion of Klf2, Klf4 
and Klf5 in ES cells leads to differentiation (Jiang et al., 2008). Klf4 has also 
been shown to repress p53 directly (Rowland et al., 2005), and p53 has been 
demonstrated to suppress Nanog during ES cell differentiation (Lin et al., 
2005). This suggests that Klf4, although not directly required for the 
maintenance of pluripotency, is still an important factor in a wide network of 




c-Myc is part of the Myc family of oncogenes encoding a basix helix-loop-
helix leucine zipper transcription factor (de Alboran et al., 2001), and 
contributes to many human tumours. Other members of the family include 
N-Myc, L-Myc, S-Myc and B-Myc (Adhikary and Eilers, 2005). Activated c-
Myc has been shown to be important in the progression of Burkitt’s 
lymphoma (Spencer and Groudine, 1991). Its expression has also been 
demonstrated to be elevated or deregulated in a variety of other human 
cancers, such as breast, prostate and gastrointestinal cancers.  (Nesbit et al., 
1999; Pelengaris and Khan, 2003; Schlagbauer-Wadl et al., 1999). c-Myc is 
expressed in the whole embryo and in adult tissues where cells have a high 
proliferative capacity. As well promoting cell growth and proliferation (de 
Alboran et al., 2001), c-Myc inhibits terminal differentiation of most cell types 
and sensitizes cells to apoptosis (Pelengaris and Khan, 2003). Interestingly, c-
Myc has been shown to suppress p21CIPI/WAF1 expression in colonic epithelial 
cells, as the re-expression of p21CIPI/WAF1 restores both cell cycle arrest as well 
as cellular differentiation in cells that express c-Myc (Adhikary and Eilers, 
2005; van de Wetering et al., 2002). This suggests that c-Myc may have a role 
in the maintenance of ES cell proliferation as well as an anti-differentiation 
factor. c-Myc null embryos die by embryonic day 10.5 with defects in 
growth, cadiac and neural development. c-Myc null ES cells are 
compromised in their differentiative and growth potential as well as their 
ability to give rise to tumours (Baudino et al., 2002). Furthermore, Myc has 
been shown to be a target of Stat3 in ES cells (Cartwright et al., 2005). This 
suggests that Myc activity is involved to the maintenance of self-renewal and 
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pluripotency. However, limited Myc expression in response to MAPK/Erk 
inhibition cannot be rescued by the addition of LIF (Ying et al., 2008). This 
suggests that increased levels of Myc are not required for ES cell 
propagation, although some requirement for basal Myc activity cannot be 
excluded.  
 
1.2.3 The LIF signal cascade 
 
When they were originally isolated, ES cells required co-culture with 
mitotically inactive fibroblasts in order to maintain self-renewal. Since then, 
however, it has been demonstrated that murine ES cells will self-renew 
indefinitely if grown in medium containing the differentiation inhibitor 
called Leukaemia Inhibitory Factor (LIF) (Smith et al., 1988; Williams et al., 
1988). LIF is a cytokine belonging to the IL-6 family and was initially 
characterised by its ability to induce differentiation of M1 leukaemia cells 
(Gearing et al., 1987; Tomida et al., 1984). It exerts its effect by binding to the 
LIF receptor (LIFR) – gp130 receptor heterodimer on the cell membrane and 
activating the transcription factor signal transducer and activator of 
transcription-3 (Stat3). The addition of LIF to ES cell cultures activates the 
LIFR-gp130 heterodimer. Stat3 then binds to phosphotyrosine residues on 
the dimeric receptor (Davis et al., 1993) and undergoes phosphorylation and 
dimerisation itself. Phosphorylated Stat3 dimers then translocate to the 
nucleus, where they regulate target genes (Boiani and Scholer, 2005; Niwa et 
al., 1998). Stat3 is the critical signalling target of LIF in allowing ES cell self-
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renewal. Inactivation of Stat3 function in LIF-maintained ES cells by 
overexpression of a Stat3 dominant negative mutant triggers their 
morphological differentiation in the presence of LIF (Boeuf et al., 1997; Niwa 
et al., 1998). Furthermore, expression of a conditionally active form of Stat3 in 
ES cells in the absence of LIF allows ES cells to retain their undifferentiated 
state (Matsuda et al., 1999), thereby directly identifying Stat3 as the key 
element in LIF-mediated maintenance of ES cell self-renewal. LIF however, 
does not act alone as in the absence of serum it fails to block neural 
differentiation and to maintain pluripotency (Ying et al., 2003a). This serum 
factor is likely to be Bone Morphogenetic Protein 4 (BMP4). 
 
1.2.4 Bone Morphogenetic Proteins 
 
Bone Morphogenetic Proteins (BMPs) are members of the TGF-β 
(Transforming Growth Factor β) superfamily of secreted polypeptides (Shi 
and Massague, 2003). BMPs have been shown to participate in the activation 
of many key cellular responses during growth and differentiation (Feng and 
Derynck, 2005; Varga and Wrana, 2005). BMP proteins were originally 
isolated as critical components of bone protein extracts directing cartilage 
and bone formation (Wozney et al., 1988). More recently, Ying et al (Ying et 
al., 2003) demonstrated that ES cells required LIF in conjunction with BMP4 
in the absence of serum, in order to block neural differentiation and to 
maintain pluripotency. The authors demonstrated the success of serum-free 
self-renewal in LIF plus BMP by isolating stable transfectants, by single cell 
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cloning as well as by deriving de novo ES cells in these conditions. BMP 
proteins signal through cell surface complexes of “type I” and “type II” 
receptors, which are structurally similar transmembrane serine/threonine 
kinases. The binding of BMP proteins to the receptor complex results in the 
phosphorylation of Smad proteins, which are ligand-induced transcription 
regulators of BMP responses (Feng and Derynck, 2005; Murakami et al., 2003; 
Shi and Massague, 2003). BMP mediates its positive effects on ES cell self-
renewal through activation of members of the Id (inhibitor of differentiation) 
gene family via the Smad pathway and not through potentiating gp130/Stat3 
signalling (Hollnagel et al., 1999; Ying et al., 2003). Id proteins, inhibitors for 
basic helix-loop-helix transcription factors, have been shown to be involved 
in various cell fate decisions, including neural differentiation (Ruzinova and 
Benezra, 2003). Their constitutive expression bypasses BMP or FBS 
requirement for the maintenance of ES cell self-renewal (Ying et al., 2003a). 
Under these conditions, and in the absence of LIF, Id transfected ES cells do 
not differentiate into neural-like cells. This suggests that Id expression 
specifically blocks neural lineage commitment.   
 
1.2.5 Balancing LIF/Stat3 and BMP/Id signalling 
 
In summary, LIF and BMP act together in order to maintain ES cell self-
renewal, despite there being no evidence of common targets between their 
downstream transducers, Stat3 and Id, as yet. Nevertheless, the fact that 
overexpression of BMP, even in the presence of LIF, leads to differentiation 
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into non-neural fates, indicates that a balance between Stat3 and Smad 
signalling determines the choice between self-renewal and differentiation 
(reviewed in Temple, 2003). Although this synergism may be independently 
regulated, it may involve the coassembly of Stat3 and Smad with the 
transcriptional coactivators CREB-binding protein (CPB)/p300 in order to 
regulate binding to appropriate signalling sites. It has been demonstrated 
that this complex, bridged by p300 and induced upon LIF and BMP 
stimulation of neural progenitors, is involved in the cooperative signalling of 
LIF and BMP2 (Nakashima et al., 1999; Rao, 2004; Varga and Wrana, 2005). 
This complex may be active in ES cells, thereby inducing ES cell-specific 
target genes (Ying et al., 2003).  
 
Evidence for independent regulation of ES cell self-renewal by LIF and BMP 
is provided by two studies concentrating on potential targets of these two 
effectors. Firstly, using chromatin immunoprecipitation (ChIP), Cartwright et 
al. (Cartwright et al., 2005) have demonstrated  that Myc, a helix-loop-
helix/leucine zipper transcription factor, is a direct target gene of Stat3 in ES 
cells. The authors also demonstrated that sustained levels of Myc, using a 
constitutively expressed form of Myc, promoted self-renewal in the absence 
of LIF by blocking differentiation. Secondly, in a study identifying factors 
that are produced by mouse embryonic fibroblast cells required for the 
maintenance of pluripotency of ES cells, Qi et al. (Qi et al., 2004) 
demonstrated that BMP4 inhibits the mitogen activated protein kinase 
(MAPK) Erk (extracellular signal-related kinase) which is involved in ES cell 
differentiation (Burdon et al., 1999). Therefore, the fact that the LIF/ Stat3 
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cascade has been shown to activate Phosphoinositide 3-kinase (PI3K) (Paling 
et al., 2004), a pro-pluripotency effector, and BMP has been demonstrated to 
inhibit the pro-differentiative effectors, Erk1 and Erk2, is indicative of a 
system where LIF and BMP, rather than having the same targets, act 
cooperatively towards the maintenance of self-renewal.  
 
1.2.6 The Ras/mitogen-activated protein kinase 
 
Signal transduction via the gp130/LIF pathway induces the activation of the 
mitogen activated protein kinases (MAPK) Erk1 and Erk2 (extracellular 
signal-related kinase), in addition to Stat3. This activation results from the 
association of gp130 with the protein tyrosine phosphatase Shp2 (Fukada et 
al., 1996). The function of Shp2 in ES cell self-renewal is still unclear. Studies 
have shown that ES cells expressing a granulocyte colony stimulating factor 
(G-CSF)-gp130 chimeric receptor bearing a mutation at the Shp2 binding 
tyrosine residue (Y757), required lower levels of gp130 stimulation for the 
maintenance of pluripotency and demonstrated increased gp130-stimulated 
levels of activated Stat3 compared to ES cells bearing a wild type chimeric 
receptor (Burdon et al., 1999). This suggests that Shp2 participation is 
required in the LIF cascade in order to balance ES cell self-renewal and 
differentiation (Chan et al., 2003). Additionally, the MEK inhibitor PD098059-
treatment of ES cells leads to an increase in self-renewal (Burdon et al., 1999), 
which is indicative of Erk having a pro-differentiative effect. This study, in 
combination with the observation that lack of normal Shp2 function increases 
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an ES cell’s tendency to remain uncommitted and undifferentiated (Qu et al., 
1997; Qu and Feng, 1998), indicates that the balance between Stat3 activation, 
which promotes ES cell self-renewal, and Erk inhibition by BMP (Qi et al., 
2004), determine stem cell fate (Chan et al., 2003). More recently, however, 
FGF4 (Fibroblast Growth Factor 4) has been shown to act as an autoinductive 
stimulus that pushes ES cells towards lineage specification by activating Erk 
(Kunath et al., 2007). The authors suggest that the FGF4/Erk signal does not 
specify lineage but renders ES cells responsive to differentiative signals. This 
was confirmed by the observation that FGF4 null ES cells or ES cells deficient 
in downstream MAPK/Erk activation, exhibit a decreased ability to commit 
to any specific lineage, or indeed differentiate.  
 
1.2.7 PI3-Kinase/Akt Signal cascade 
 
Phosphoinositide 3-kinase (PI3K) generates phosphorylated 
phosphoinositides (phosphatidylinositol (3,4)-bipshosphate and 
phosphatidylinositol (3,4,5)-tripshosphate) at the cell membrane, which serve 
as crucial second messengers for a wide range of biological functions 
including mitogenesis, survival, differentiation, and cytoskeletal organisation 
(Gross et al., 2005; Hallmann et al., 2003). PI3Ks are regulated and activated 
by growth factors usually via receptor tyrosine kinases. Members of the IA 
family of PI3Ks, comprising a regulatory subunit (typically 85 or 55 kDa) and 
a 110 kDa catalytic subunit are known to be activated via the 
gp130/LIF/Stat3 pathway (Lehr et al., 2004; Vanhaesebroeck et al., 2001; 
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Vanhaesebroeck and Waterfield, 1999). Phosphorylated phosphoinositides 
transmit the signals through downstream effectors including Akt, a PH 
(pleckstrin homology) domain-containing serine/threonine kinase 
implicated in the regulation of cell cycle progression, cell death, adhesion, 
migration, metabolism and tumourigenesis (Brazil et al., 2004; Takahashi et 
al., 2005; Watanabe et al., 2006). A previous study has demonstrated that LIF 
induces the PI3K-dependent phosphorylation of Akt, and that expression of 
a dominant negative form of the p85 subunit of PI3K leads to a reduction of 
self-renewal (Paling et al., 2004). This is indicative of PI3K having a direct 
positive effect on the maintenance of ES cell self-renewal and that PI3K is a 
target of the LIF/Stat3 pathway. Inhibition of PI3K using chemical inhibitors, 
has also been shown to increase Erk phopsphorylation in response to LIF 
(Paling et al., 2004).  Furthermore, a more recent study using a myristoylated, 
constitutively active form of Akt expressed in ES cells, demonstrated that 
constitutive expression of Akt allows ES cells to self-renew with 
undifferentiated characteristics, even in the absence of LIF (Watanabe et al., 
2006). The authors also demonstrated that Akt signalling is able to maintain 
the undifferentiated state independently of the Stat3 and Erk signalling 
pathways. Nevertheless, Williams et al (Williams et al., 2000) have shown 
that PDK1 (3-phosphoinositide-dependent protein kinase 1; upstream 
activator of Akt) knockout mouse ES cells are viable, which indicates that the 
activation of PI3K signalling via PDK is not essential for ES cell self-renewal. 
Deletion of Akt1 in PTEN -/- ES cells has been shown to decrease the PTEN-
induced tumorigenesis (Stiles et al., 2002). PTEN is a tumour suppressor 
gene, whose deleted or mutated expression is associated with various human 
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cancers (Li et al., 1997). The deletion of PTEN leads to increased PIP3 and 
AKT expression (Franke et al., 1997; Sun et al., 1999). The further deletion of 
Akt1 in PTEN -/- ES cells partially rescues the increased uncontrolled cell 
growth. These data suggest that Akt1 may take part in PTEN-controlled 
tumorigenesis.  
 
1.2.8 Balancing internal and external signalling for efficient self-renewal 
 
ES cells are thought to represent the in vitro counterparts of in vivo epiblast 
cells. They are pluripotent and able to self renew indefinitely, but whether 
they depend on the same signals as pluripotent epiblast cells in order to 
maintain these characteristics, is still of great interest. The cues that are 
required to maintain this pluripotent state are still unclear, despite the fact 
that ES cells can routinely be propagated by adding LIF and BMP. The 
addition of these cytokines however is an attempt to mimic the environment 
in which these cells would find themselves in vivo. During normal 
development however, LIF is not required for the maintenance of the ICM in 
mouse epiblasts. Embryos lacking LIF, LIFR (LIF receptor) or gp130 develop 
normally, at least until mid-gestation. LIF null mice are viable into 
adulthood, although homozygous females are sterile due to a failure of the 
uterus to support implantation (Nichols et al., 2001; Stewart et al., 1992). A 
recent study has demonstrated the minimal signalling requirements for self-
renewal. Ying et al. (Ying et al., 2008) have shown that the addition of LIF 
and BMP to ES cell culture medium can be dispensed with, when the Erk and 
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GSK3β signalling pathways are inhibited. Replacing LIF and BMP with 
inhibitors against Erk (PD0325901) and GSK3β (CHIR99021), allowed ES cells 
to be expanded, as well as to maintain the appropriate levels of ES cell-
associated signal transducers such as Oct4, Nanog and Rex1. This 
maintenance of ES cell propagation was not dependent upon Stat3. 
Furthermore, whilst their pluripotency was maintained, multilineage 
commitment was also demonstrated. The authors suggested that ES cells 
represent a basal state of cellular existence and that they intrinsically 
maintain their pluripotent status until the correct inducing signal presents 
itself, such as FGF4. This suggests that ES cells are only capable of 
maintaining their self-renewal and pluripotency, as long as they are not 
placed in an environment that induces them to differentiate. This is 
representative of what happens in vivo, where pluripotent cells of the ICM of 
the epiblast maintain their ES cell status only until the right differentiative 
signals arise and instruct them to commit to a certain lineage.  
 
1.3 Gab adaptor proteins and their role in signalling 
 
The PI3 kinase (PI3K) and the Ras/mitogen-activated protein kinase (Erk 
MAPK) pathways are key regulators of cell proliferation and survival and 
are known to influence the fate of mouse embryonic stem (ES) cells. An 
established modulator of both these pathways is the IRS-1 (Insulin Receptor 
Substrate 1) family adaptor protein Gab1 (Grb2-associated binder 1). 
Scaffolding adaptor proteins contribute to the specification and/or 
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amplification of signal transduction pathways (Pawson and Scott, 1997). 
Although adaptors themselves do not contain any enzymatic or other direct 
effector function they contain modular domains that allow them to mediate 
multiple protein-protein and protein-lipid interactions (Schlessinger, 2000). 
Adaptor proteins are typically composed of interaction domains and binding 
motifs, and link cell-surface receptors to intracellular targets, which in turn 
regulate specific downstream signalling pathways (Koch et al., 1991).  
Adaptor proteins couple receptors to their proximal targets, and they also 
direct the flow of information in the intracellular networks that control 
cellular responses (Pawson, 2007).  
 
The Gab (Grb2-associated binding) proteins belong to a family of 
multifunctional docking proteins that play a central role in the integration of 
Receptor Tyrosine Kinases (RTKs). They are closely related to insulin 
receptor substrates, which function as binding partners of intracellular 
signalling proteins in response to receptor stimulation in order to bring them 
into close proximity to their targets (Jordan et al., 2003). Gab proteins are 
tyrosine phosphorylated in response to various growth factors, such as EGF, 
HGF and insulin, and serve as docking proteins that recruit a number of 
downstream signalling proteins (Itoh et al., 2000; Lehr et al., 2004; Rodrigues 
et al., 2000). Gab1 is ubiquitously expressed and is activated by a wide range 
of cell surface receptors, mediating growth factor, cell-cell and cell-




All Gab proteins are characterised by similar overall structural organisation 
and share 40-50% sequence similarity. The mammalian genes (Gab1, Gab2, 
Gab3) are homologous to the Drosophila melanogaster DOS (Daughter of 
Sevenless) gene, as well as to the C.elegans Soc1 (Suppressor-of-Clear) gene 
(reviewed in Gu and Neel, 2003). The molecular weights of the mammalian 
homologues Gab1, Gab2 and Gab3 are 100-120kDa, 97-100kDa and 90kDa 
respectively. Gab1 and Gab2 are expressed ubiquitously, but are most highly 
expressed in the brain, kidney, lung, heart, testis and ovary. Gab3 null mice 
develop normally, despite the protein’s widespread expression pattern. It is, 
however, predominantly expressed in lymphoid (Nishida and Hirano, 2003) 
and haematopoietic (Seiffert et al., 2003; Wolf et al., 2002) tissues. This is 
indicative of a role in macrophage cell development and differentiation. 
  
Gab2 was originally cloned from haematopoietic cells and was shown to be 
an important effector of cytokine receptor activation in association with Shp2 
(Gu et al., 1998). Gab2 overexpression has been shown to potentiate Neu-
evoked breast carcinogenesis in mice, an effect mediated by the 
hyperactivation of the Shp2-Erk pathway (Bentires-Alj et al., 2006). Gab2, 
along with Gab1 has also been demonstrated to mediate EGF-stimulated Erk 
activation and cell migration in breast carcinoma cells (Meng et al., 2005). 
The increased proliferation observed during mammary tumorigenesis in 
response to EGF stimulation has been linked to overexpression of Gab2 in 
human mammary epithelial cells (Brummer et al., 2006). This altered 
response to EGF is mediated by Gab2 potentiating Akt and Erk activation. 
Increased Gab2 expression has also been observed in malignant cancer cells 
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(Lee et al., 2007). This suggests that Gab2 may be a tumour-related adaptor 
protein because of its potentiating effect on Erk signalling in response to 
growth factor activation.  Gab2 has also been shown to be an essential, cell-
autonomous signalling molecule in FcγR- (a high affinity IgG receptor) 
mediated signal transduction during phagocytosis in macrophages (Gu et al., 
2003). A central function of Gab2 in the phagocytic machinery is to activate 
PI3K by binding its p85 subunit and recruiting it to its substrate lipids, 
thereby generating more PIP3 lipids at the phagocytic cup. This potentiation 
of PI3K signalling via Gab2 has also been shown in mast cells. Biochemical 
assays have shown that PI3K signalling downstream from the FcεR1 (a high 
affinity IgE receptor) receptor, is defective in Gab2 null mast cells (Gu et al., 
2001). Consequently, Gab2 null mice, though viable, are defected in their 
allergic response. In the same study, Gab2 expression increased dramatically 
during embryonic neural differentiation. Furthermore, Gab2 has been shown 
to mediate macrophage differentiation, mediated by enhanced MAPK 
signalling. In addition to these central roles in immune responses as well as 
tumourigenesis, Gab2 suppression has been shown to reduce bFGF (basic 
Fibroblast Growth Factor) – mediated Akt activity during RA- (retinoic acid) 








1.3.1 Gab1: Structure, Recruitment and Function 
 
Gab1 was originally isolated from a cDNA expression library derived from a 
glial tumour, and was found to be most similar to IRS-1 (Insulin Receptor 
Substrate 1), a major substrate of the insulin receptor (Holgado-Madruga et 
al., 1996). The Gab1 gene is localised to chromosome 4q31.1 in human and 
8C3 in mouse (Sarmay et al., 2006). As a scaffold protein upstream of RTK 
(Receptor Tyrosine Kinase) signal transduction, it has multiple tyrosine 
phosphorylation sites to dock downstream signalling proteins. Furthermore, 
it is a membrane-linked docking protein (MLDP) as it is localised in the lipid 
component of plasma membranes and contains a pleckstrin homology (PH) 
domain (Gotoh, 2008). Gab1 couples receptors to the cell membrane, but also 
amplifies the downstream signals emanating from the receptors themselves. 
What allows Gab1 to relay such complex signals from receptors is its 
structure. Its ability to bind to a variety of receptors and proteins allows 
Gab1 to dynamically regulate signalling, and to act as more than just a relay 
for signalling.  
 
1.3.1.1 Gab1 Structure 
 
The notable regions of the Gab1 protein that are important for its function 
are: the N-terminal PH (Pleckstrin Homology) domain, the N-terminal NLS 
(Nuclear Localisation Signal), a central series of proline-rich sequences, the 
MBD (Met Binding Domain) and multiple phosphotyrosine binding sites 
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(Figure 1.1). The PH domain recognises membrane components, most 
notably phosphoinositides, thus targeting Gab1 to the membrane, at points 




Figure 1.1: Structure of the Gab1 protein. The Gab1 protein contains five basic domains that 
are important for its function as an adaptor protein. The PH (Pleckstrin Homology) domain 
acts as a lipid membrane-binding domain which brings Gab1 close to the membrane. The 
NLS (Nuclear Localisation Sequence) allows Gab1 to move in and out of the nucleus. 
Proline-rich sequences provide binding sites for SH3 domain-containing proteins. The MBD 
(Met Binding Domain) is a fragment responsible for the binding of phosphorylated Met 
receptor and is located within the proline-rich domain. The phosphotyrosine binding sites, 
once phosphorylated upon stimulation, act as docking sites to mediate interactions with SH2 
domain-containing proteins such as Shp2 and the p85 subunit of PI3K. There are 16 
phosphotyrosine binding sites in total.   
 
The PH domain has been shown to be critical for EGF-induced activation of 
Erk and PI3K in epithelial cells (Itoh et al., 2000). It has also been shown to be 
required for its tyrosine phosphorylation and association with Shp2 after 
insulin stimulation (Rocchi et al., 1998). Furthermore, a PH domain deletion 
mutant of Gab1 was defective in EGFR signalling (Rodrigues et al., 2000) 
whilst it also fails to support tubulogenesis in MDCK cells (Maroun et al., 
1999a). The NLS is a short amino acid sequence, which is found within the 
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PH domain.  It is recognised by cytosolic nuclear receptors, and then acts to 
retain or to direct Gab1 into the cell nucleus. An NLS has been classically 
defined as a short primary amino acid sequence motif, consisting mainly of 
charged lysines or arginines, that is both necessary and sufficient for 
transport of the protein to the nucleus (Terry et al., 2007). 
 
The three proline-rich domains consist of PxxP motifs (proline-rich 
sequences), which are signature binding sites for SH3 (Src homology 3) 
domain-containing proteins (Feng et al., 1994), such as the adaptor protein 
Grb2 (Holgado-Madruga et al., 1996). Grb2 (growth factor receptor-bound 
protein 2) provides scaffold for the indirect binding of Gab1 to 
phosphorylated receptors. Grb2 has been demonstrated to be important in 
the differentiation of endodermal cells and formation of the epiblast (Cheng 
et al., 1998). The MBD is responsible for the direct binding of Gab1 to the 
tyrosyl phosphorylated c-Met receptor (Gu and Neel, 2003; Sachs et al., 2000). 
Gab1 can also, however, bind to the c-Met receptor indirectly thorough Grb2 
(Schaeper et al., 2000). The c-Met receptor is a tyrosine kinase receptor, and 
its activation by HGF (Hepatocte Growth Factor) stimulates a variety of 
cellular responses including cell motility (Stoker et al., 1987), growth (Maina 
et al., 1997) and branching tubulogenesis (Rosario and Birchmeier, 2003). 
Interestingly, the development of the embryo requires the direct and indirect 
binding of Gab1 to the c-Met receptor for different processes. For example, 
by analysing knockin mice with mutations in either the Grb2 or Met binding 
sites of Gab1, either mode of binding has been shown to be sufficient for Met-
dependent muscle precursor cell migration, whereas both modes are 
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required for placenta development, liver growth and palatal shelf closure 
(Schaeper et al., 2007). Upon the stimulation by growth factors or cytokines, 
Gab1 undergoes phosphorylation. These tyrosine phosphorylation sites 
provide docking sites for other downstream effectors of the signalling 
cascade to the RTK. The 16 phosphotyrosine sites located on this protein 
(Rocchi et al., 1998) allow for a diverse range of downstream effects. These 
phosphotyrosine sites, with the aid of the previously described domains 
within Gab1, provides docking sites for the recruitment and activation of 
downstream effectors. 
 
1.3.1.2  Recruitment of Gab1 and downstream effectors to the RTK 
 
Gab1 is tyrosine phosphorylated in response to various growth factors, 
cytokines and chemicals activating RTKs, such as: EGF (epidermal growth 
factor) (Holgado-Madruga et al., 1996; Kameda et al., 2001b; Montagner et al., 
2005), PDGF (Platelet Derived Growth Factor) (Kallin et al., 2004), HGF 
(Hepatocyte Growth Factor) (Hoffmann et al., 2005), Interleukin-6 (Podar et 
al., 2004), LIF (Takahashi-Tezuka et al., 1998) and hydrogen peroxide 
(Holgado-Madruga and Wong, 2003). The interactions that Gab1 elicits with 
RTKs occur both indirectly via the Grb2 adaptor protein and directly through 
the proline-rich MBD in Gab1. The direct interaction entails Gab1 acting as a 
substrate for the RTK c-Met, activated by the mesenchymally-derived HGF 
(Hepatocyte Growth Factor), where it is involved in the c-Met-specific cell 
dissociation and branching morphogenesis (Lock et al., 2002; Maroun et al., 
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2003; Montesano et al., 1991; Sachs et al., 2000; Schaeper et al., 2000). This 
interaction is very specific and the c-Met receptor is the only receptor to 
which Gab1 has been shown to bind to directly. The adaptor protein Grb2 
however, may act as a bridge between Gab1 and activated RTKs.  
 
1.3.1.2.1 The Gab1-Grb2 interaction 
 
Signalling by protein-tyrosine kinases involves a regulated series of protein-
protein interactions mediated by modules such as SH2 and SH3 domains 
(Pawson and Scott, 1997). As mentioned before, SH2 domains recognise 
phosphotyrosines (Anderson et al., 1990; Songyang et al., 1993), whilst SH3 
domains recognise proline-rich motifs (Feng et al., 1994). An example of an 
SH2-domain containing protein is the adaptor protein Grb2 (Cheng et al., 
1998). Grb2 has no catalytic domain, but recognises the proline-rich motifs of 
Gab1, therefore allowing Gab1 to be recruited to a RTK (Buday, 1999; de Mol 
et al., 2004; Kallin et al., 2004).  Once a RTK is activated by a ligand, Grb2 
binds to specific phosphotyrosines of the RTK (such as the EGF receptor) and 
then associates with Gab1 constitutively via its SH3 domains. The interaction 
between Grb2 and Gab1 is essential for the ability of Gab1 to convey the 
message to downstream signalling effectors. For example, a mutation in the 
Grb2 binding site of Gab1 inhibits with the association between Gab1 and the 
EGF receptor (Lock et al., 2000). Furthermore,  Gab1 fails to be tyrosine 
phosphorylated in response to EGF in fibroblasts isolated from mice 
expressing a null mutant of Grb2, which demonstrates the importance of 
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Grb2 for the efficient tyrosine phosphorylation of Gab1 (Saxton et al., 2001). 
The direct or indirect interaction between Gab1 and a RTK elicits the 
recruitment and activation of various downstream effectors, the most notable 
ones being Shp2, PI3K, PLCγ and CrkII (Sun et al., 2005). Grb2 null ES cells 
proliferate normally but are unable to differentiate into the endodermal 
lineage (Cheng et al., 1998).     
 
1.3.1.2.2 The Gab1-Shp2 interaction 
 
Shp2 (SH2 domain-containing protein tyrosine phosphatase 2) is a 
ubiquitously-expressed protein tyrosine phosphatase containing SH2 (Src 
homolog 2) domains, and takes part in the regulation of various biological 
functions in response to growth factors, cytokines and hormones  (Dance et 
al., 2008). For example, signal transduction via the gp130/LIF pathway 
induces the activation of the mitogen activated protein kinases (MAPK) Erk1 
and Erk2 (extracellular signal-related kinase), which results from the 
association of gp130 with Shp2 (Bradley et al., 1992). Shp2 null mice die 
between days 8.5 and 10.5 in gestation with multiple defects in the patterning 
of axial mesodermal tissues and posterior development during gastrulation 
(Qu and Feng, 1998; Raabe et al., 1996; Sun et al., 1993). Furthermore, an 
activation mutation of Shp2 causes Noonan syndrome, an autosomal 
dominant disorder characterised  by dysmorphic facial features, 
proportionate short stature and heart disease (Tartaglia et al., 2001). This 
gain-of-function mutation is also associated with sporadic juvenile 
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myelomonocytic leukaemia, myelodysplasic syndrome, acute lymphoblastic 
leukaemia and acute myelogenous leukaemia (Bentires-Alj et al., 2004; Loh et 
al., 2005; Tartaglia et al., 2004; Tartaglia et al., 2003; Wang et al., 2006). The 
general consensus is that the oncogenic potential of Shp2 is largely due to the 
resulting enhanced MAPK activation (Edouard et al., 2007). Shp2 has also 
been shown to be important for the β4-mediated induction of anchorage-
independent growth of epithelial and carcinoma cells (Bertotti et al., 2006).  It 
is also involved in haematopoiesis (Qu et al., 1997), focal adhesion (Herrera 
Abreu et al., 2006), as well as ES cell differentiation to mesoderm and 
haemangioblasts (Chan et al., 2003). Shp2-mutant ES cells, being more 
sensitive to LIF, are more efficient in producing secondary embryoid bodies 
(EBs) compared to wild type ES cells (Qu and Feng, 1998). The pro-
differentiative effect of Shp2, is supported by the demonstration that 
expression of a dominant-negative form of Shp2 leads to a decrease in the 
differentiation of ES cells (Burdon et al., 1999). Furthermore, inhibition of Erk 
activation by chemical inhibitors, enhances ES cell self- renewal (Burdon et 
al., 1999). Shp2 has been shown to be important in  many biological 
processes, a trait that probably derives itself from its ability to promote 
MAPK stimulation in response to diverse agonists (Dance et al., 2008).    
 
Shp2 has two SH2 domains in the amino-terminal region (N-SH2, C-SH2), a 
protein tyrosine phosphatase (PTP) domain and a C-terminal hydrophilic tail 
containing phosphotyrosines sites (‘C’ tail) (Dance et al., 2008). The latter 
contains two tyrosyl phosphorylation sites, which are differentially 
phosphorylated by receptor and non-receptor protein tyrosine kinases (Neel 
 
 31 
et al., 2003). Shp2 shows low basal activity, principally due to  an auto-
inhibition mechanism controlled by its own N-SH2 and PTP domains  
(Cunnick et al., 2002; Dance et al., 2008). The subsequent activation of Erk 
activation by LIF (Nakaoka et al., 2003; Takahashi-Tezuka et al., 1998) or EGF 
(Cai et al., 2002; Cunnick et al., 2001; Meng et al., 2005) for example, requires 
the association between Shp2 and Gab1.   
 
There are two Shp2 binding sites located in the C-terminal of Gab1 (Tyr-627, 
Tyr-659) (Cunnick et al., 2001; Rocchi et al., 1998). It has been suggested that 
the association between Shp2 and Gab1 acts to locate Shp2 to the plasma 
membrane in order to activate an upstream signalling step (such as 
activation of Src or Ras GTPase), as a Gab1-Shp2 fusion protein was shown to 
lead to growth factor-independent Erk activation (Cunnick et al., 2001; 
Cunnick et al., 2002). In the same studies, Gab1 has been shown to activate 
Shp2 by targeting it to the membrane in a PH domain-dependent manner in 
response to EGF, thereby activating Erk. The association between Gab1 and 
Shp2 has been demonstrated to be critical in promoting Ras/MAPK 
signalling to enhance epidermal cell proliferation and oppose differentiation 
(Cai et al., 2002; Montagner et al., 2005; Yamasaki et al., 2003). In another 
report, by mutating the phosphotyrosine 627 binding site in Gab1, Holgado-
Madruga & Wong demonstrated that this complex is essential for cell growth 
and transformation, as mutated cells exhibited an increase in stress fiber 
cytoskeletal organisation, and a decrease in cell proliferation and anchorage-
independent growth (Holgado-Madruga and Wong, 2004). The association 
between Shp2 and Gab1 has also been shown to be important for the 
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maturation of focal adhesions mediated by the cytokine IL-1β (Interleukin 
1β) (Herrera Abreu et al., 2006). Additionally, the Gab1-Shp2 complex has 
been demonstrated to regulate the phosphorylation and activity of eNOS 
(endothelial NO synthase), an enzyme involved in the response of 
endothelial cells to fluid sheer stress (Dixit et al., 2005). In the embryo, the 
association between Gab1 and Shp2 in response to EGF is required for Met 
receptor-directed placental development and muscle progenitor cell 
migration to the limbs (Schaeper et al., 2007). This was demonstrated by 
generating knockin mice that carried a point mutation in the Shp2 binding 
site of Gab1.  
 
1.3.1.2.3 The Gab1-PI3K interaction 
 
Another well-defined Gab1 partner is the p85 subunit of PI3K (Holgado-
Madruga et al., 1997; Laffargue et al., 1999).  This complex has been 
established through experiments mutating either the p85 subunit or the 
Gab1-p85 phosphotyrosine site on Gab1 itself (Holgado-Madruga et al., 
1997). These experiments demonstrate that Gab1 is important in the 
recruitment and activation of PI3K, as well as the downstream effector Akt, 
and the subsequent effects of this activation. In the embryo, recruitment of 
PI3K to the c-Met receptor by Gab1 has been shown to be important for EGF 
receptor-mediated embryonic eyelid closure and keratinocyte migration 
(Schaeper et al., 2007). Gab1 has been shown to associate with PI3K in 
response to various signals such as: fluid sheer stress in endothelial cells (Jin 
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et al., 2005), NGF (nerve growth factor) (Holgado-Madruga et al., 1997), 
lysophosphatidic acid (Laffargue et al., 1999), FGF (fibroblast growth factor) 
(Lamothe et al., 2004), EGF (epidermal growth factor) (Mattoon et al., 2004; 
Rodrigues et al., 2000), VEGF (vascular endothelial growth factor) (Dance et 
al., 2006), HGF (hepatocyte growth factor) (Maroun et al., 1999a) and 
members of the GDNF (glial cell line-derived neurotrophic factor) family of 
ligands (De, V et al., 2005; Maeda et al., 2004). Using a GST fusion protein of 
the Gab1 PH domain, Rodrigues et al. demonstrated that the Gab1 PH 
domain bound most strongly to PtdIns(3,4,5)P3 (phosphatidylinositol 3,4,5-
triphosphates), membrane lipids, in response to PDGF (platelet-derived 
growth factor) (Rodrigues et al., 2000). This paper demonstrated firstly, that 
the PH domain of Gab1 is directed to the membrane via PI3K activity. This is 
also true in the case of the activation of the c-Met receptor by HGF, whereby 
the inhibition of PI3K by a chemical inhibitor abrogates the PH domain-
dependent Gab1 subcellular localisation (Maroun et al., 1999a). Secondly and 
most importantly, Rodrigues et al. demonstrated that Gab1 may participate 
in a positive feedback loop with respect to PI3K activation, to enhance 
signalling through the RTK. Blocking the PH domain-mediated translocation 
of Gab1 to the plasma membrane using Wortmanin, also inhibited the MAPK 
pathway, which in this instance is not thought to be downstream of PI3K. 
Therefore, PI3K acts in two ways: it mediates EGFR signalling downstream 
of Gab1 but it is also required for the downstream signalling emanating from 
Gab1. In order to relate PI3K and Erk activation via Gab1, Lehr et al (Lehr et 
al., 2004) observed that insulin induction of CHO (chinese hamster ovarian) 
cells overexpressing Gab1, resulted in a substantial elevation of Gab1-
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associated PI(3)K binding activity. However, in the presence of activated 
Erk1/2, no significant change in PI(3)K binding/activity was detectable in 
response to insulin treatment. This is indicative of Gab1 having a modulating 
role within these major signalling pathways.   
 
1.3.1.3 Gab1: Biological Function 
 
The importance of this molecule is emphasised by the observation that Gab1 
null mice die in utero and display developmental defects in trophoblast 
differentiation and disruption of liver size, migration of myogenic precursor 
cells (due to altered c-Met receptor signalling) (Sachs et al., 2000), as well as 
disruptions of the heart (Nakaoka et al., 2007), placenta and skin (Itoh et al., 
2000). Many defects, are due to disrupted c-Met receptor downstream 
signalling. The lack of direct or indirect binding of Gab1 to the receptor has 
grave effects. Interestingly, the development of the embryo requires both the 
direct and indirect binding of Gab1 to the c-Met receptor for different 
processes. For example, either mode of binding is sufficient for Met-
dependent muscle precursor cell migration, whereas both modes are 
required for placenta development, liver growth and palatal shelf closure 
(Schaeper et al., 2007).  Gab1 has also been shown to have a role in several 
cellular processes, such as: cell survival (Holgado-Madruga et al., 1997; 
Holgado-Madruga and Wong, 2003), proliferation and survival of myeloma 
cells (Podar et al., 2004), cytoskeletal reorganisation and chemotaxis (Kallin et 
al., 2004), glucose tolerance and hepatic insulin action (Bard-Chapeau et al., 
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2005), flow sheer stress (Jin et al., 2005), development of migratory muscle 
progenitor cells (Vasyutina et al., 2005), epithelial morphogenesis (Maroun et 
al., 1999a; Maroun et al., 1999b), growth and regeneration of pancreatic cells 
(Hoffmann et al., 2005), mesangial cell morphogenesis (Kolatsi-Joannou et al., 
1995), cell cycle transition, cell proliferation and transformation (Kostenko et 
al., 2006; Mood et al., 2006), cardiomyocyte elongation (Nakaoka et al., 2003). 
Gab1 was also demonstrated to localise at adherens junctions and undergo 
tyrosine phosphorylation in response to cell-cell adhesion in an E-cadherin-
dependent manner in cultured epithelial cells (Shinohara et al., 2001). 
Furthermore, Gab1 is expressed in the marginal zone of B cells, where, in 
association with Shp2, it negatively regulates their differentiation in response 
to TI-2 (thymus independent 2 responses) (Sarmay et al., 2006).  
 
1.3.2 Gab1 Variants 
 
The Pleckstrin Homology (PH) domain is a region that shares homology with 
an internal repeat of pleckstrin, a major substrate of protein kinase C in 
platelets (Lemmon et al., 1996; Rebecchi and Scarlata, 1998). PH domains are 
believed to mediate intermolecular interactions, primarily protein-
phospholipid interactions (Kameda et al., 2001a). Rocchi et al (Rocchi et al., 
1998) demonstrated that the PH domain plays a critical role in the tyrosine 
phosphorylation of Gab1, as well as its subsequent association with Shp2 
after insulin stimulation. Recently, Kameda et al (Kameda et al., 2001a) 
demonstrated the expression of a novel 87 kDa Gab1 lacking its PH domain 
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during the neoplastic progression of carcinogen-transformed SHE (Syrian 
Hamster Embryo) cells. The authors showed that this short form of Gab1 
undergoes an EGF-dependent association with Shp2, as the long form would 
normally, thereby demonstrating that the lack of a PH domain does not 
significantly affect the protein’s ability to convey signalling. In addition to 
this, it was demonstrated that the expression of the short form of Gab1 was 
associated with an increase in growth-factor-dependent colony formation in 
soft agar.  
 
One of the most significant observations Kameda et al. (Kameda et al., 2001a) 
made, was the fact that the long form of Gab1 was localised sub-cellularly at 
cell membranes, whilst the short one was expressed diffusely in the cell 
cytoplasm. This observation was attributed to the N terminal of Gab1 
containing the PH domain. These differences in localisation between the two 
forms of Gab1 are not surprising, as it has been shown that the PH domain is 
essential for the targeting of Gab1 to the proxmimity of the cellular 
membrane at sites of cell-cell contact, this localisation being dependent on 
PI(3)K activity (Maroun et al., 1999a; Maroun et al., 2000). Furthermore, the 
long form of Gab1 has been shown to be involved in the nuclear 
translocation of ERK (Osawa et al., 2004). The authors demonstrated that the 
NLS contained within the PH domain of Gab1 is involved in the nuclear 
translocation of Erk, which then activates the downstream effector Egr1 
(early growth response factor 1) in response to re-endothelialisation. As Erk 
does not possess a Nuclear Localisation Signal (NLS), but Gab1 does, the 
authors proposed that Erk interacts with Gab1 via the latter’s MBD domain. 
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However, the PH domain of Gab2 has been shown to be redundant for its 
localisation and tyrosine phosphorylation in response to IL3 (interleukin 3) 





















1.4 Gab1β: an ES cell-associated signal transducer 
 
Unexpectedly, mouse ES cells preferentially express a novel form of Gab1 
called Gab1β (Burdon T, unpublished). Gab1α and β expression levels were 
compared in protein lysates obtained from ES cells, embryonal carcinoma 
(EC) cells, mouse embryonic fibroblasts (MEF) and pooled tissues from a 
whole mid-gestation embryo (Figure 1.2).  
 
 
Figure 1.2: Western blot showing that ES cells express a novel 95KDa variant of the adaptor 
protein Gab1 called Gab1β. Protein lysates obtained from ES (ES cells), EC (Embryonic 
Carcinoma cells), MEF (Mouse Embryonic Fibrobalsts) and 11dpc (11dpc whole mouse 
embryo) were analysed on a Western blot probed with a Gab1-specific antibody, which 
recognises both Gab1α and Gab1β (Burdon T., unpublished). 
 
The common form of Gab1, Gab1α, was expressed in all four protein lysate 
samples, whilst the ES and EC cell lysates contained predominantly a shorter 
form, Gab1β. This suggests that the expression of the smaller, novel Gab1β is 
downregulated upon the differentiation of ES cells. The Western blot in 
Figure 1.2 was probed with an antibody raised against an epitope common to 
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both isoforms. The novel isoform of Gab1 protein, called Gab1β, is readily 
detected in the mouse testes, at levels comparable to those of ES cells. In 
addition, it is also detected, albeit at lower levels, in the heart, muscle, 
stomach epithelium, lung and most strikingly in the pancreas, areas of the 
kidney and the dentate gyrus of the brain. Gab1β null mice are healthy and 
fertile and show no signs of abnormal development (Burdon T., 
unpublished). Structurally, Gab1β lacks the N-terminal PH domain and NLS 
but retains the majority of protein-protein interaction motifs (Figure 1.3), 
whilst the Gab1β protein contains a novel 50 nucleotide sequence at the 5’ 
end (Burdon T, unpublished). An alignment of mouse Gab1α and Gab1β 
protein sequences can be seen in Figure 1.4.   
 
 
Figure 1.3: Structure of the two Gab1 isoforms, Gab1α and Gab1β. The two proteins differ 
only in that Gab1β lacks part of the N-terminal of the protein, including the PH domain, 






mGab1a          MSGGEVVCSGWLRKSPPEKKLKRYAWKRRWFVLRSGRLTGDPDVLEYYKNDHAKKPIRII 60 
mGab1beta       ------------------------------------------------------------ 
                 :...  .:.   .:..... .  : .       :.  :....  .  ... :...     
mGab1a          DLNLCQQVDAGLTFNKKEFENSYIFDINTIDRIFYLVADSEEDMNKWVRCICDICGFNPT 120 
mGab1beta       -------------------------------------------MNKWVRCICDICGFNPT 4 
                . . ... .:. : .... ..:   . .: .      :.:... ..   . .. ..**** 
mGab1a          EEDPVKPLTGSSQAPVDSPFAISTAPASSQMEASSVALPPPYQVISLPPHPDTLGLQDDP 180 
mGab1beta       EEDPVKPLTGSSQAPVDSPFAISTAPASSQMEASSVALPPPYQVISLPPHPDTLGLQDDP 64 
                ************************************************************ 
mGab1a          QDYLLLINCQSKKPEPNRTLFDSAKPTFSETDCNDNVPSHQTPASSQSKHGMNGFFQQQM 240 
mGab1beta       QDYLLLINCQSKKPEPNRTLFDSAKPTFSETDCNDNVPSHQTPASSQSKHGMNGFFQQQM 124 
                ************************************************************ 
mGab1a          MYDCPPSRLTSVSGESSLYNLPRSYSHDVLPKESPSSTEADGELYTFNTPSGTAGVETQM 300 
mGab1beta       MYDCPPSRLTSVSGESSLYNLPRSYSHDVLPKESPSSTEADGELYTFNTPSGTAGVETQM 184 
                ************************************************************ 
mGab1a          RHVSISYDIPPTPGNTYQIPRTFPESTLGQSSKLDTIPDIPPPRPPKPHPTHDRSPVETC 360 
mGab1beta       RHVSISYDIPPTPGNTYQIPRTFPESTLGQSSKLDTIPDIPPPRPPKPHPTHDRSPVETC 244 
                ************************************************************ 
mGab1a          GVPRTASDTDSSYCIPPPAGMTPSRSNTISTVDLNKLRKDASSQDCYDIPRTFPSDRSSS 420 
mGab1beta       GVPRTASDTDSSYCIPPPAGMTPSRSNTISTVDLNKLRKDASSQDCYDIPRTFPSDRSSS 304 
                ************************************************************ 
mGab1a          LEGFHSQYKIKSVLTAGGVSGEELDENYVPMNPNSPPRQHSGSFTEPIQEPNYVPMTPGT 480 
mGab1beta       LEGFHSQYKIKSVLTAGGVSGEELDENYVPMNPNSPPRQHSGSFTEPIQEPNYVPMTPGT 364 
                ************************************************************ 
mGab1a          FDFSSFGMQVPPPAHMGFRSSPKTPPRRPVPVADCEPPPVDRNLKPDRKVKPAPLDIKPL 540 
mGab1beta       FDFSSFGMQVPPPAHMGFRSSPKTPPRRPVPVADCEPPPVDRNLKPDRKVKPAPLDIKPL 424 
                ************************************************************ 
mGab1a          SEWEELQAPVRSPITRSFARDSSRFPMSPRPDSVHSTTSSSDSHDSEENYVPMNPNLSGE 600 
mGab1beta       SEWEELQAPVRSPITRSFARDSSRFPMSPRPDSVHSTTSSSDSHDSEENYVPMNPNLSGE 484 
                ************************************************************ 
mGab1a          DPNLFASNSLDGGSSPMNKPKGDKQVEYLDLDLDSGKSTPPRKQKSSGSGSSMADERVDY 660 
mGab1beta       DPNLFASNSLDGGSSPMNKPKGDKQVEYLDLDLDSGKSTPPRKQKSSGSGSSMADERVDY 544 
                ************************************************************ 
mGab1a          VVVDQQKTLALKSTREAWTDGRQSTESETPTKNVK 695 
mGab1beta       VVVDQQKTLALKSTREAWTDGRQSTESETPTKNVK 579 
                *********************************** 
 
Figure 1.4: Alignment of mouse Gab1α and Gab1β protein sequences. Gab1β lacks the PH 
domain (red), as well the NLS (grey) contained within it. The proline rich regions (PxxP) to 
which Grb2 binds are coloured in blue. The Met Binding Sequence is coloured in green. 




Interestingly, these two different isoforms arise from alternative transcripts 
rather than splice variants, due to separate start sites (Figure 1.5). Gab1β 
protein lacks the N terminal PHD and NLS due to the lack of an ATG start 
until after the PH domain in the mRNA sequence, and therefore the latter is 
not translated into protein (Burdon T., unpublished). What regulates the 
generation of these alternative transcripts is unclear. It is possible that the 
transcription factors that regulate ES cells may also be involved in the 
upregulation of Gab1β protein transcription rather than that of Gab1α. 
Alternatively, different epigenetic effects such as methylation may also be 
involved in silencing one or the other in specific cell types. For example, 




Figure 1.5: Generation of alternative Gab1 transcripts. Gab1β transcription initiates at a 
different promoter site. Gab1β lacks the N terminal domains of Gab1α because of the 





1.5 Project aim and objectives 
 
Gab1β is a highly abundant and novel ES cell-associated protein. Gaining 
insight into its potential role, will allow the broadening of our understanding 
of the complex network of genes that regulate ES cell biology. In order to 
gain more knowledge of this novel signal transducer, the effect of the lack of 
a PH domain on the ability of Gab1β to act as an adaptor protein was 
investigated. Since the PH domain plays a critical role in membrane binding 
the function of the protein may be expected to differ. It is possible that Gab1β 
might act in a dominant negative manner, by binding and mislocalising 
downstream effectors that Gab1α proteins complex with. This would firstly 
alter what signalling Gab1β participates in and where. Alternatively, Gab1β 
might have a deregulated function and localisation, unrestrained by the 
PHD. Therefore, how Gab1β participates in Gab1-dependent signalling was 
investigated. 
 
The role of an NLS is to allow a protein to enter/exit from the nucleus of a 
cell, and clearly determines the intracellular localisation of a protein. This 
along with the PH domain have been shown to influence the localisation of 
Gab1α and therefore its function. The PH domain, affects what signalling 
pathways the protein participates in as well as the anchoring of the protein to 
RTKs and the membrane, and the other, the NLS, is involved in the protein’s 
intracellular localisation as well as its interaction with downstream effectors, 
such as Erk (Osawa et al., 2004). Therefore, the lack of these two crucial 
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localisation determination domains may affect the areas of the cell that 
Gab1β finds itself in. This in turn may have an effect on the signalling 
capacity of Gab1β. The localisation of the novel Gab1β isoform was therefore 
investigated in ES cells.  
 
The abundance of a protein in ES cells does not necessarily indicate a role in 
the maintenance of the cells’ “stemness”. Therefore, although highly 
expressed, Gab1β may not be involved in the regulation of self-renewal or 
pluripotency, the two defining characteristics of ES cells. It may indeed be 
involved in the transition of ES cells into differentiation. The neural path of 
differentiation is the default route that ES cells will follow once the 
exogenous factors that maintain them are removed. Gab1β may be part of 
this default differentiation pathway. Furthermore, Gab1β expression has 
been detected in the dentate gyrus of the brain (Burdon T., unpublished), an 
area of the brain where neural stem cells are thought to reside in (Gage et al., 
1995). The effect of Gab1β on the differentiation of ES cells into the neural 








CHAPTER 2: MATERIALS & METHODS 
 
2.1 Molecular Biology Methods 
 
2.1.1 DNA manipulation and modification 
 
2.1.1.1 Restriction Enzyme Digest 
A standard 50µl restriction digest normally contained 5µl of the appropriate 
10x buffer, 12µl DNA (100-200 ng), 29µl distilled H2O and 4µl enzyme. The 
optimum incubation time for most enzymes was 2 hours at 37°C, and the 
appropriate incubation temperature was used for enzymes with different 
optimum temperature conditions. For digestions with larger or smaller 
amounts of DNA, this standard digest was scaled up or down as required. 
Enzymes were predominantly purchased from New England Biolabs, Roche 
and Promega. 
 
2.1.1.2 Alkaline Phosphatase Digest 
This was performed using shrimp alkaline phosphatase (Promega). 10µl of 
10x alkaline phosphatase buffer was added to the DNA solution. The 
solution was then vortexed and then spun for a couple of seconds. The 
solution was split into two eppendorf tubes and 1/10 volume of alkaline 
phosphatase enzyme was added to one, whilst the other was used as an 
undigested control. The solutions were then left at 37°C for 1 hour and then 





Ligations of cohesive ends were performed using T4 DNA Ligase (New 
England Biolabs) which is supplied with a 10x T4 DNA Ligase buffer. A 
typical 20µl reaction contained: 2µl 10xligase buffer, 1µl ligase, ~50ng 
linearised vector DNA, 5-100ng insert DNA, and then up to 20µl with 
nuclease-free water. A typical insert:vector ration was 3:1 and the following 
equation was used to calculate the correct amount of insert to be used, as this 
depended on the size of both the insert and the vector: 
 
vector (ng) x size of insert (kb)                        3 
           size of vector (kb)                                   1 
 
The reaction was then placed at 4°C overnight. The next day, the ligation 




Agarose gel electrophoresis was used to visualise DNA fragments produced 
by restriction enzyme digests and PCR (Sambrook et al., 2001). Gels were 
made by dissolving (by microwave heating) the appropriate amount of 
agarose (normal or low melt agarose) in 1xTBE (10xTBE buffer/1 litre: 108g 
Tris base, 55g Orthoboric acid, 40ml 0.5M EDTA (pH8.0)) or 1xTAE (10xTAE 
? ng of insert 
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buffer/1 litre: 48.4g Tris base, 10.9g Glacial Acetic acid, 2.92g EDTA) and 
pouring the molten agarose into a plastic mould, after adding the 
appropriate amount of Ethidium Bromide (5µl / 100ml agarose –Sigma stock 
solution: 10mg/ml). A 0.8% gel was used to visualise DNA fragments 
between 1-10 kb. For smaller fragments the percentage of agarose used 
varied between 1-2%. The sizes of the gels used were: 6x5cm and 6x10cm and 
were typically run at 50 or 100V. DNA was loaded onto the gels using a Gel 
Loading Solution (Sigma) (2µl for 10µl DNA). The size of DNA fragments 
was visualised using a range of molecular weight markers, such as Molecular 
Weight Marker X (Roche), Generuler 50bp DNA ladder (Fermentas). Gels 
were visualised using a short wavelength UV transiluminator and 
photographed using the Gel Doc analysis system (Kodak). 
 
2.1.3 Plasmid DNA propagation 
 
2.1.3.1 Transformation of competent cells 
 
2.1.3.1.1 Subcloning Efficiency DH5α  Competent Cells (Invitrogen) 
 
The competent cells were thawed on wet ice and the required number of 
eppendorf tubes were placed on ice. The cells were gently mixed and 50µl of 
them were aliquoted into the chilled tubes. Any unused cells were refrozen 
in an ethanol bath for 5 minutes before returning to the -80°C freezer. 5µl of 
the DNA (plasmid, linear or circular) was added undiluted to the cells and 
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incubated on ice for 30 minutes. 2.5µl of the pUC19 control DNA was also 
added to an aliquot of cells. The cells were then heat-shocked for 20 seconds 
in a 37°C water bath without shaking, and then placed on ice for 2 minutes. 
950µl of room temperature LB medium (Luria Bertani medium: 1% Bacto-
triptone (Difco), 0.5% Bacot-yeast (Difco) extract, 125nM NaCl) was added to 
the cells and the tubes were then shaken at 225rpm (37°C) for 1 hour. The 
cells were then spun down for 10 seconds at 1,000rpm in a microcentrifuge, 
the supernatant was discarded, leaving a small amount behind. The pellet 
was then resuspended in the remaining LB supernatant and spread on LB 
agar (LB medium containing 1.5% agar (Difco)) plates with 100µg/ml 
ampicillin and incubated overnight at 37°C. The next day, one colony per 
propylene tube was set up with 3ml of LB (100 µg/ml ampicillin) and left to 
grow, swirling overnight (37°C, 225 rpm), after streaking on a LB plate with 
100µg/ml ampicillin and incubated overnight at 37°C. If the bacterial mix in 
the polyporopylene tube was cloudy the next day, this would indicate 
growth of the vector, and therefore, the bacterial mixture was purified 
(Section 2.1.4.1 or 2.1.4.2) and tested by enzymatic digests and then, if 
positive, used to make a larger bacterial preparation. The large culture was 
set up by adding 2ml of the small culture to 500ml and left swirling 
overnight, or by using some of the re-streaked colony.  Again, this culture 
was cleaned (Section 2.1.4.3) and then the OD260 was measured.  Glycerol 
stocks of the reaction mixture were also made (850µl bacterial culture + 150µl 




2.1.3.1.2 XL2-Blue Ultracompetent Cells (Stratagene) 
 
The competent cells were thawed on wet ice and the required number of 
polypropylene tubes was placed on ice. The cells were gently mixed and 50µl 
of them were aliquoted into the chilled tubes. 1µl of the provided β-
mercaptoethanol was added to the cells, the tubes were gently swirled and 
incubated on ice for 10 minutes, swirling every 2 minutes. 5µl (~50ng) of the 
DNA (plasmid, linear or circular) was added undiluted to the cells. 1µl of the 
pUC18 control DNA, previously diluted 1 in 10 in distilled water, was also 
added to an aliquot of cells. The cells were gently swirled and then left on ice 
for 30 minutes. The cells were then heat-shocked for 30 seconds in a 42°C 
water bath without shaking, and then placed on ice for 2 minutes. 900µl of 
room temperature LB medium was added to the cells and the tubes were 
then shaken at 225rpm (37°C) for 1 hour. The cells were then spun down for 
10 seconds at 1,000rpm in a microcentrifuge, the supernatant was discarded, 
leaving a small amount behind. The pellet was resuspended in the remaining 
LB supernatant and spread on LB plates with 100µg/ml ampicillin and 
incubated overnight at 37°C. The next day, one colony per propylene tube 
was set up with 3ml of LB (100 µg/ml ampicillin) and left to grow, swirling 
overnight (37°C, 225 rpm), after streaking on a LB plate with 100µg/ml 
ampicillin and incubated overnight at 37°C. If the bacterial mix in the 
polyporopylene tube was cloudy the next day, this would indicate growth of 
the vector, and therefore, the bacterial mixture was purified (Section 2.1.4.1 
or 2.1.4.2) and tested by enzymatic digests and then, if positive, used to make 
a larger bacterial preparation. The large culture was set up by adding 2ml of 
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the small culture to 500ml and left swirling overnight, or by using some of 
the re-streaked colony.  Again, this culture was cleaned (Section 2.1.4.3) and 
then the OD260 was measured.  Glycerol stocks of the reaction mixture were 
also made (850µl bacterial culture + 150µl 100% glycerol) and stored at -80°C.  
 
2.1.4 DNA Purification 
 
2.1.4.1 QIAprep miniprep method (Qiagen) 
 
1.5 ml of a small bacterial cell culture was centrifuged in a tabletop centrifuge 
for 2 min at 13,000 rpm. The supernatant was removed and the bacterial cell 
pellet was resuspended in 250µl Buffer P1 and transferred to a 1.5 ml 
microcentrifuge tube. 250µl buffer P2 was added and the tube was gently 
inverted 4-6 times to mix. 350µl of buffer N3 was added and the tube was 
inverted immediately 4-6 time to mix. The solution was centrifuged for 10 
minutes at 13,200 rpm in a tabletop microcentrifuge, and a compact white 
pellet was formed. The supernatants were applied to a QIAprep Spin 
Column by pipetting. The mix was centrifuged for 30-60 sec, and the flow-
through was discarded. The QIAprep Spin Column was washed by adding 
0.5ml Buffer PB and centrifuging for 30-60 seconds and the flow-through was 
discarded. The column was then washed by adding 0.75ml Buffer PE and 
centrifuging for 30-60 seconds. The flow-through was discarded and the 
column was centrifuged for an additional 1 minute to remove residual wash 
buffer. The QIAprep Spin Column was placed in a clean 1.5 ml 
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microcentrifuge tube and to elute the DNA, 50µl of nuclease free water was 
added to the centre of the column and left to stand for 1 minute. The 
QIAprep Spin Column was then centrifuged for a final minute to elute the 
DNA, which was collected in the microcentrifuge tube. The DNA was then 




2.1.4.2 Wizard Plus SV minipreps DNA purification system (Promega) 
 
The bacterial cells grown overnight from a small culture were harvested by 
centrifugation for 5 minutes at 13,200rpm in a tabletop centrifuge. The 
supernatant was poured off and the inverted tube was blotted on a paper 
towel to remove the excess media. 250µl of Cell Resuspension Solution was 
added to the pellet which was completely resuspended by vortexing or 
pipetting. 250µl of Cell Lysis Solution was added and the lysate was mixed 
by inverting the tube four times. The cell suspension was incubated until it 
was clear for5 minutes. 10µl of Alkaline Protease Solution was added and 
mixed by inverting the tube four times. The lysate was then incubated for 5 
minutes at room temperature. 350µl of Neutralisation Solution was added 
and immediately mixed by inverting the tube four times. The bacterial lysate 
was then centrifuged at 13,200rpm in a microcentrifuge for 10 minutes at 
room temperature. The cleared lysate was then decanted into the prepared 
spin column provided with the kit, leaving the white precipitate behind. The 
 
 51 
spin column with the supernatant was then centrifuged at maximum speed 
for 1 minute. The spin column was then removed from the tube and the 
flowthrough was then discarded from the collection tube. The spin column 
was then reinserted into the collection tube. 750µl of Column Wash Solution, 
previously diluted with 95% ethanol (as instructed in the product manual) 
was added to the column. The column was then centrifuged at maximum 
speed for 1 minute at room temperature. The spin column was removed and 
the flowthrough was discarded. The wash procedure was then repeated 
using 250µl of Column Wash Solution. The spin column was then transferred 
to a new sterile 1.5ml eppendorf tube and the plasmid was eluted using 50µl 
of nuclease free water to the spin column. The tube was then centrifuged at 
maximum speed for 1 minute at room temperature. The purified plasmid 




2.1.4.3 QIAprep maxiprep method (Qiagen) 
 
The bacterial cells from a large culture were harvested by centrifugation at 
6000 x g for 15 min at 4°C. All traces of supernatant were removed by 
inverting the open centrifuge tube until the entire medium had been drained 
(the protocol could be stopped here and continued later by freezing the 
pellets at -20°C). The bacterial pellet was then resuspended completely in 
10ml of Buffer P1 by vortexing and/or pipetting up and down until no cell 
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clumps remained. 10ml buffer P2 were added and mixed gently by inverting 
4-6 times and then incubated at room temperature for 5 minutes. The lysate 
appeared viscous at this stage of the protocol. 10ml of chilled buffer P3 were 
added to the lysate, mixed immediately by inverting 4-6 times and then 
incubated on ice for 20 minutes. The lysate was then mixed and centrifuged 
at 20,000 x g for 30 minutes at 4°C (in non-glass tubes). The supernatant 
containing the plasmid DNA was removed promptly. Once again, the 
supernatant was centrifuged at 20,000xg for 15 minutes at 4°C and the 
supernatant containing the DNA plasmid was removed promptly. Adding 
10ml of buffer QBT equilibrated a QIAGEN-tip 500, and the column was 
allowed to empty by gravity flow. The supernatant from the last 
centrifugation was then added to the QIAGN-tip and allowed to enter the 
resin by gravity flow.  The column was then washed with 2x30 ml of buffer 
QC. The DNA was then eluted by adding 15ml of buffer QF. The DNA was 
then precipitated by adding 10.5ml (0.7 volumes) room temperature 
isopropanol, mixed immediately and centrifuged at 15,000xg for 30 minutes 
at 4°C. The supernatant was carefully decanted and the DNA pellet was 
washed with 5ml of room temperature 70% ethanol. The mixture was then 
centrifuged at 15,000 x g for 10 minutes at 4°C, and then the supernatant was 
carefully decanted without disturbing the pellet. The pellet was air-dried for 
10 minutes, and redissolved in 500µl nuclease-free water, incubated at 37°C 





2.1.4.4 QIAquick Gel Extraction Kit (Qiagen) 
 
This method was used to extract DNA from an agarose gel (Section 2.1.2). 
The gel slice containing the DNA band was excised with a clean, sharp 
scalpel. The gel slice was weighed and 3 volumes of buffer QG were added 
to 1 volume of gel (i.e., 100–200µl for each 100mg of gel). The sample was 
incubated at 50°C for 30 min until the gel slice had completely dissolved. The 
tube was vortexed every 2-3 minutes. 1xgel volume of isopropanol was 
added and mixed. A QIAquick spin column was placed in a 2ml collection 
tube and the sample was applied to the column and centrifuged at 13,200rpm 
on a tabletop centrifuge for 1 minute. For sample volumes more that 800µl, 
the remaining sample was loaded and spun again. The flow-through was 
discarded and the QIAquick Spin Column was placed back into the same 
collection tube. 0.5ml of buffer QG was added to the column and centrifuged 
for 1 minute (optional) to remove all traces of agarose. To wash, 0.75ml 
Buffer PE was added to the column and centrifuged for 1 minute. The flow-
through was discarded, and the column was spun for an additional minute. 
Residual ethanol from Buffer PE was not completely removed unless the 
flow-through was discarded before this additional centrifugation. The 
QIAquick Spin Column was placed into a clean 1.5ml microcentrifuge tube. 
To elute the DNA, 50µl of nuclease-free water was added to the center of the 
QIAquick Spin Column and centrifuged for 1 min. Alternatively, for 
increased DNA concentration, 30µl of water was added to the center of the 
column, let to stand for 1 min, and then centrifuged. The DNA was then 




2.1.4.5 Ethanol precipitation of DNA fragments 
Two volumes of 96% ethanol were added to the DNA solution along with 
1/10 volume of 3M Sodium Acetate (pH5.2) and mixed by inverting. The 
DNA was normally visible as a white precipitate. If this was not the case, the 
solution was placed at -20°C from 1 hour-overnight. The solution was then 
spun at maximum speed for 10 minutes at 4°C (for low concentrations) or at 
room temperature (when the precipitate was clearly visible). The pellet was 
then washed twice in 80% ethanol, by adding the latter and centrifuging for 5 
minutes. The pellet was then centrifuged for 2 minutes and the remaining 
ethanol was removed. The DNA pellet was then left to dry under saran rap 
for 5-10 minutes. The DNA was resuspended in the appropriate amount of 
nuclease-free water, typically 500µl for DNA extracted from a large bacterial 
culture.  
 
2.1.4.6 Chlorophorm extraction of DNA fragments 
An equal volume of chlorophorm was added to the DNA solution and then 
vortexed to mix. The solution was then spun at maximum speed in a tabletop 
microcentrifuge for 2 minutes. The supernatant containing the DNA was 
removed and placed in a new eppendorf tube. Then an ethanol precipitation 




2.1.4.7 Phenol-chlorophorm extraction of DNA fragments 
An equal volume of phenol was added to the DNA solution which was then 
vortexed to mix. The solution was then spun at maximum speed in a tabletop 
microcentrifuge for 2 minutes. The supernatant containing the DNA was 
removed and placed in a new eppendorf tube. An equal volume of 
chlorophorm was added, the solution was vortexed and then centrifuged for 
2 minutes. The supernatant was transferred to a new eppendorf tube and an 
ethanol precipitation was performed as described in section 2.1.4.5. 
 
2.1.5 DNA quantification 
The concentration of nucleic acids was determined using ultraviolet (UV) 
absorbance spectrophotometry (GeneQuant spectrophotometer). The 
absorbance of light of 260nm wavelength was measured for each sample. 
This is directly proportional to the amount of DNA in a solution. 1 O.D. at 
260nm for double-stranded (ds) DNA is equal to 50µg/ml of dsDNA. Two 
independent measurements of the samples were always taken and distilled 
water was used as a blank. 
 
2.1.6 Polymerase Chain Reaction 
Each 50µl reaction contained: 25-100ng of template DNA, , 5µl 10xPCR buffer 
(Stratagene), 0.5µl 25mM dNTP, 0.5µl 20µM forward primer, 0.5µl 20µM 
reverse primer, 1µl pFu Turbo DNA polymersase (Stratagene), and then 
made up to 50µl with PCR grade water. Thermal cycle conditions to amplify 
EGFP cDNA from the pEGF-C1 vector (Clontech) were as follows: 95°C for 4 
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minutes (denaturation), 95°C for 45 seconds (separation), gradient of 
annealing temperature (10-15°C below melting temperature of primers) for 
30 seconds (for example, a gradient from 55°C to 64°C: 55.2°C, 56.6°C, 59.3°C, 
62.4°C), 72°C for 1 minute (extraction), 24 thermal cycles were used to 
amplify EGFP DNA from pEGFP-C1 vector (Clontech). 5µl of PCR product 
was used for agarose gel electrophoresis to visualise the amplified DNA. In 
the case of the polyglycine linker, the 2 primers were annealed by combining: 
10µg of each oligo, 7µl 5M NaCl, up to 200µl PCR TE. This mix was placed at 
98°C for 5 minutes, the heating block was switched off and allowed to cool 
down. The poluglycine linker insert was then placed at 20°C for use in a 
ligation. 
 
2.1.6.1 Primer sequences 
 






















2.1.6.2 ZERO Blunt TOPO  PCR cloning Kit (Invitrogen) 
 
This cloning kit was used for the direct insertion of blunt-end PCR products 
into a supplied plasmid vector containing a multiple cloning site. The blunt 
PCR product was produced by PCR, as described above in section 2.1.6. The 
TOPO cloning reaction was set up as follows: 1-4µl PCR product (previously 
phenol/chlorophorm extracted), 1µl salt solution (provided with the kit), 1µl 
pCR II-Blunt-TOPO vector, distilled water up to 6µl. The reaction was gently 
mixed and incubated at room temperature for 5 minutes. The reaction was 
then placed on ice and was immediately used to transform One Shot 
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competent cells provided with the kit. 2µl of the reaction was added to one 
vial of cells which were then gently mixed and incubated on ice for 30 
minutes. The cells were then heat-shocked for 30 seconds at 42°C without 
shaking and then immediately transferred to ice. 250µl of room temperature 
LB medium was added to the cells, the tube was tightly capped and the 
shaken horizontally for 1 hour at 37°C at 225rpm. 10-50µl of the 
transformation was spread onto pre-warmed LB plates containing 50µg/ml 
kanamycin antibiotic. The plates were then incubated overnight at 37°C. an 
efficient reaction produced several hundred colonies which were then picked 
and screened.  
 
2.1.7 Cloning Strategy 
 
The purpose of this experiment was to create EGFP fusion proteins of Gab1α 
and Gab1β, and to then transfect these into Gab1β -/- mouse ES cells. The 
first fusion that was created was EGFP-Gab1β, where EGFP was fused to the 
N-terminal of Gab1β. EGFP was PCR-amplified from the vector pEGFP-C1 
(BD Biosciences Clontech) (Figure 2.1), with added NotI sites at either end of 
the PCR-amplified EGFP. The blunt PCR-amplified EGFP fragment was then 
inserted into the TOPO PCR vector as previously described (Section 2.1.6.2). 
The EGFP fragment was then cut out of the TOPO vector using NotI and 
then inserted in frame into a NotI site found between the CAG promoter and 
the Gab1β cDNA in the vector called pCAGIP-Gab1β (previously generated 
in the laboratory by T. Burdon and L. Sutherland) (Figure 2.2). The EGab1α 
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vector was constructed by PCR-amplifying the PH domain from a vector 
called pCAGIP-Gab1α (T. Burdon & L. Sutherland) and inserted into the 
NotI site between the EGFP and Gab1β cDNA in the vector EGFP-Gab1β. 
The second variant of the fusion vectors was constructed by inserting a 
polyglycine linker between the EGFP and Gab1 proteins in the EGab1β and 
EGab1α vectors. The polyglycine linker was made by annealing 2 
polyglycine linkers. The oligonucleotides were annealed by mixing them at a 
1:1 molar ratio in a microcentrifuge tube (200pmol each).  
 
 
Figure 2.1: Map of pEGFP-C1 vector (BD Bioscences Clontech). 
 
The mixture was then made up to 7µl with dH2O and heated to 70°C for 5 
minutes. then 1µl of 10xDNA polymerase buffer (0.5M Tris, 0.1M MgCl2, 
10mM DTT, 0.5mg/ml BSA) was added. The mixture was allowed to cool to 
room temperature and incubated for 1 hour. The annealed oligonucleotides 
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were then digested with NotI and ligated to the linearised EGab1β or 
EGab1α vectors. The third variant of the fusion vectors was constructed by 
fusing EGFP to the C-terminal of Gab1β separated by a polyglycine linker. A 
similar approach as before was used, only EGFP was PCR-amplified from the 
pEGFP-C1 vector using primers that would add an XhoI site at either end of 
the fragment. The PCR-amplified fragment was then digested with XhoI and 
inserted into an XhoI site found at the C-terminal end of Gab1β in the 




Figure 2.2:  Cloning strategy for EGFP-Gab1β. EGFP was PCR amplified and then inserted into a NotI site between the CAG promoter and the Gab1β 




Figure 2.3:  Cloning strategy for EGFP-GLY6-Gab1β. The two oligonucleotides were annealed and inserted into the NotI site betweent he EGFP and 









2.2 Embryonic Stem Cell culture 
Unless stated, all Embryonic Stem cell culture was performed following a 
standard protocol (Pollard and Walker, 2004). ES cells were maintained in 
BHK-21 (Glasgow MEM) medium (Sigma). To 500 ml ES cell medium 50 ml 
Foetal Bovine Serum (FBS, FSB001141, Cambrex) 5.6 ml L-glutamine 
(200mM), 5.6 ml non-essential amino acids, 5.6 ml sodium pyruvate 
(100mM), 1.1 ml β-mercaptoethanol (50mM) and 300 µl ESGRO (LIF - 106 
units) was added using a sterile filter. The medium was then stored at 4°C. 
 
2.2.1 Treatment of plastics 
All flasks and petri dishes were treated with 0.1% gelatin for 5-30 minutes 
before the addition of ES cells, in order to facilitate their adhesion. 5 ml of 
gelatin were added to a standard 25 cm2 flask (T25). 1 ml was added to each 
well of a 24-well plate, whilst 14 ml were added to a 75 cm2 (T75) and 10 ml 
to a 10 cm petri dish. The gelatin was removed by aspiration before the 
addition of the ES cells.  
 
2.2.2 Resuscitation of frozen ES cell stocks 
Vials (cryotubes) containing ES cells were removed from the -150°C storage. 
The sealed vial was then placed into a waterbath at 37°C for 2 minutes, or 
until all cells were thawed. The cells were then transferred to a tissue culture 
hood after the vial had been washed with 70% ethanol, and were then added 
into a sterile 15ml tube containing 5ml ES medium. The cells were pelleted 
 
 65 
by centrifugation for 3 minutes at 1000 rpm, and the medium was then 
removed by aspiration. The cells were then resuspended in 6ml fresh 
medium and then transferred to a previously gelatinised T25 flask.  
 
2.2.3 Propagation of ES cells 
ES cells were propagated in T25 flasks until the cells were 90-95% confluent. 
The cells were then split into either two T25 flasks or moved to one T75 flask. 
The medium was changed at least 2 hours before splitting the cells. The 
medium was then removed by aspiration and the cells were washed with 5 
ml 1xPBS (0.17M NaCl, 3.4mM KCl, 4mM Na2HPO4, 2.4mM KH2PO4). 0.5ml 
of TVP (1 ml 2.5% Trypsin, 0.0037g Na2EDTA, 1ml chicken serum – made up 
to 10 ml with PBS, filtered) was added to the flask and the cells were 
incubated for 3 minutes at 37°C to lift them from the flask. The cells were 
then removed from the surface of the flask by vigorous tapping and 5 ml 
fresh medium were added to the flask to wash any remaining cells off the 
surface. The cells were then transferred to a sterile 15 ml tube and the cells 
were pelleted for 3 minutes at 1000 rpm. The medium was aspirated off, the 
cells were resuspended in 5 ml of medium to create a single-cell suspension. 
To cells that were transferred to 2 T25 flasks, 1/6 of the cell mixture was 
added to each flask already containing 5ml of new medium. For cells being 
moved to a T57 flask, 1/3 of the mixture was added to the flask, which 
already contained 9 ml of fresh medium. The cells were then grown 




2.2.4 Preparation of frozen ES cell stocks 
Storage of ES cell lines was done when the cells reached confluence and did 
not require further propagation. Cells were stored at -150°C in a filtered 
freezing mixture, which retained the integrity of the cells. Cell lines intended 
to be frozen were treated in the same way as propagating cell lines were. The 
cells were removed as previously described in Section 2.2.3. The pelleted 
cells were then resuspended in 1 ml ES medium before 1ml of freezing mix 
(3ml ES cell medium, 1 ml DMSO, 1ml foetal calf serum, filtered and stored 
at -20°C until use) was added, and the cells were gently mixed. The cell 
mixture was then aliquoted into pre-chilled cryotubes and stored overnight 
at -80°C, before transferring them to 150°C for long term storage.  
 
 
2.2.5 Introduction of DNA into cells 
 
2.2.5.1 Preparation of DNA 
The DNA was always prepared as described in Section 2.1.4. The DNA 
(around 30µg) from a maxiperep would then be used in an enzymatic digest 
(Section 2.1.1.1) in order to linearise the vector in question. The digest was 
then run on an agarose gel, the required band was cut out and cleaned as 




2.2.5.2 Transfection of DNA using Lipofectamine 2000 (Invitrogen) 
0.5x106 cells were plated into 9.6cm2 wells in 3ml of medium to ensure even 
plating. The next day, the cells was fed with 2ml of medium. Two hours 
later, 5µl lipofctamine/well was mixed with 250µl optimem and left to stand 
for  minutes. Then, 2µg of DNA/welll was added to 250µl of optimem 
(Invitrogen). The DNA mixture was added to the lipofectamine solution, 
mixed and left to stand for 30 minutes. The total 500µl was then added to the 
9.6cm2 well containg the plated ES cells, and left overnight. 
 
2.2.5.3 Selection of ES clones 
The next day, the medium was changed after 12 hours incubation with the 
lipofectamine/vector mix. The transfected cells were then split ¼ and ¾ into 
10cm dishes. The next day, the medium on the plates was changed to a 
medium containing a selection antibiotic, typically puromycin at a 
concentration of 1.5 µg/ml. The cells were grown for 9 days under selection.  
The cells had a media change at 48 hour intervals, until colonies of ~5mm 
were observed. The colonies were then transferred to 2-3 previously-
gelatinised 24 well plates in the following way. 100µl of trypsin was added to 
wells of a 96 well plate. The medium of the 10cm dishes was changed to 5ml. 
then, using the a pipette tip, colonies were picked, added to the trypsin and 
left at 37°C for 2-3 minutes until dissociated. The dissociated cells were then 
transferred to a well of a 24 well plate containing  1ml of selection medium. 




2.2.5.4 Expansion of clones 
Each clone was then expanded to a 6well plate. The cells were PBS-washed, 
200µl of trypsin was added to the 24-well, and the cells were left in the 
incubator for 5 minutes. During this incubation time, 3 ml of fresh selection 
medium was added to each well of previously-gelatinised 6 well plates. The 
cells were vigorously resuspended in the trypsin by pipetting up and down 
in the 24 well plate, and were then added to a well of the 6 well plate, 
resuspending again. The cells were then left to grow until confluent. They 
were then propagated into T25 culture flasks as described in Section 2.2.3. 
Subsequently, once cells were routinely cultured, protein was extracted and 
analysed on Western blots.  
 
 
2.2.6 Neural differentiation of ES cells 
 
An adherent monoculture system was used to differetiation ES cells into 
neuron-like precursors (Ying and Smith, 2003; Ying et al., 2003b). A mixed 
formulation of basal media and supplements provides optimum cell viability 
and efficient neural differentiation. This formulation called N2B27 contained 
DMEM/F12 medium (Gibco) supplemented with modified N2 (Gibco), 
which containes insulin, apo-transferin, progesterone, putrescine and sodium 
selenite. This mixture was then supplemented with BSA combined with 




0.7x105 or 1x105 cells were plated in 90mm wells at varying densities in 
N2B27 plus 100 units/ml LIF and allowed to plate overnight. Cells were then 
transferred to N2B27 medium alone or containing 2ng/ml FGF4 with or 
without 1µg/m heparin. The medium supplemented with FGF4 and heparin 
was then changed every two days. Once the cells looked like neural 
precursor-like cells, they were fixed and stained for Tuji and or Oct4, as wel 
as DAPI. In order to investigate the effect of insulin on the emergence of 
neural precursors, Helen Murray provided me with a cocktail of N2B27 
supplement without added insulin. The concentrations of insulin used were: 
0 µg/ml (zero), 0.25 µg/ml (low) and 25 µg/ml (high).   
 
2.3 Analytical methods 
 
2.3.1 Western blotting 
Cells were lysed using a 1% SDS solution (4xlysis buffer: 40ml glycerol, 12g 
SDS, 25mls 1M TrisHCl pH 6.8, 0.02% Bromophenol Blue, 20ml β-
mercaptoethanol; store at -20°C). Cells were washed once in PBS and 1ml of 
1x lysis buffer/9.6cm2 well of a 6-well plate was added on ice. The gloopy 
protein lysate was tehn scraped off the well and into an eppendorf tube and 
stored on ice. The lysate was then sonicated, and stored at -20°C. When ready 
to run on a Western blot, the protein lysate was thawed at 37°C and then 
heated to 98°C for 5 minutes. The samples were then spun and vortexed 




One dimensional gel electrophoresis under denaturing conditions (in the 
presence of Sodium Dodecyl Sulphate - SDS -) separates proteins based on 
their molecular size as they move through a polyacrylamide gel matrix 
toward the anode (Ansubel et al., 1994). The polyacrylamide gel is cast as a 
separating gel topped by a stacking gel, in glass plates which are secured in 
an electrophoresis apparatus. The glass plate sandwich of the electrophoresis 
apparatus (Biorad) was assembled according to the manufacturer’s 
instructions using two clean glass plates and 0.75mm spacers and locked to 
the casting stand. The separating gel solution (standard 10% seperating gel: 
6ml dH20, 5ml 40% Acrylamide, 3.2ml 2% Bis solution, 5ml 1.5M Tris pH 8.8, 
200µl 10% SDS, 200µl 10% APS, 12µl TEMED) was applied (immediately after 
making to avoid polymerisation) to the sandwich along an edge of one of the 
spacers until the height of the solution was around 5 cm (or around 1 cm 
below the comb). The desired percentage of the acrylamide gel in the 
separating gel depended on the molecular size of the protein. Generally, 8% 
gels (7.6ml dH2O, 4ml 40% acrylamide –Sigma-, 2.6ml 2% Bis solution –
Biorad-, 5ml 1.5M Tris pH 8.8, 200µl 10% SDS, 200µl 10% APS, 12µl Temed –
Sigma-) were used for SDS-denatured proteins of 60-200 KDa, 10% for 16-70 
KDa and 15% gels for SDS-denatured proteins of 12-45 KDa. The top of the 
gel was then covered with a layer of isopropanol to provide a barrier to 
oxygen, which inhibits polymerisation, and also allows a flat interface to 
form during gel formation. The gel was allowed to set for 30-60 minutes. 
Then, the layer of isopropanol was poured off and the stacking gel (same for 
all: 6.6ml d H2O, 0.625ml 40% acrylamide, 0.4ml 2% Bis solution, 0.65ml 1M 
Tris pH6.8, 50µl 10% SDS, 50µl 10% APS, 5µl TEMED) was poured gently 
 
 71 
into the assembly and the comb was inserted. The mixture was allowed to set 
for at least 10 minutes before removing the comb and placing the assembly in 
the electrophoresis tank, which was filled with running buffer (5x Running 
Buffer: 30gr Tris, 188gr Glycine, 10gr SDS, up to 2 litres with distilled H2O). 
The sample wells were washed with running buffer before loading the 
samples, gel and a prestained protein standard was included (SeeBlue Plus 2, 
Invitrogen) The power supply was then connected and run at a constant 
current (usually ~15 mA for a mini gel). After the bromophenol blue tracking 
dye had reached the bottom of the separating gel, the power supply was 
disconnected and the gel was disassembled. Proteins were transferred to a 
Hybond ECL nitrocellulose membrane (Amersham Pharmacia biotech) for 
Western blotting using a wet blotting device (Criterion blotter, Biorad). The 
nitrocelulose membrane was cut to size, soaked in dH2O for 10 minutes and 
then in 1x transfer buffer (10x Transfer buffer: 116gr Tris, 58.6gr Glycine, 
75.2ml 10% SDS, up to 2 litres with distilled H2O) for another 10 minutes. The 
gel and nitrocellulose membrane were sandwiched between 3M filter paper 
and placed into the folding plastic cassettes. The cell was filled with 
1xTransfer buffer (100ml 10xTransfer buffer, 200ml 100%ethanol, 700ml 
distilled H2O), an ice pack and magnetic stirrer were added, and the whole 
blotter was placed on ice on a magnetic block. The transfer was run for 75 
minutes at 90Volts. Once the transfer was complete, the membrane was 
blocked overnight in 5% fat-free milk powder (Marvel, Nestle) made up in 
1xTBST (25xTBS: 125gr Tris, 400gr NaCl, pH 7.6, up to 2 litres with distilled 
H2O; TBST: 80ml TBS, 2x1ml Tween 20, up to 2 litres with distilled H2O). The 
membrane was probed with the required antibody in a 5% BSA (Sigma) 
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made in TBST for 1 hour. After washing 3x20 minutes in TBST, the 
membrane was incubated in 1:5000 diluted anti-rabbit IgG HRP conjugate 
(Amersham Pharmacia biotech) in a 5% mixture of blocking buffer (1ml 5% 
milk block diluted in 10ml TBST) for 1 hour. The membranes were then 
washed 3x20 minutes in TBST. Detection of HRP labeled antibodies was 
done using ECL western blotting detection reagents (Amersham Pharmacia 
biotech) following manufacturers instructions and exposed to BioMax Light-
1 film (Eastman Kodak). To strip, membranes were washed 2x5 minutes in 
TBST and then incubated with Restore Western blot Stripping buffer (Pierce) 






10mM Tris HCl pH7.4 
0.5% NP40 
 
6x106 cells were plated in a 10cm2 dish and allowed to grow overnight. On 
the day of the experiment, to 50ml lysis buffer the following were added: 
10µl/ml phosphatase inhibitor cocktail 2 (Sigma) and 1µl/ml protease 
inhibitor cocktail (Sigma; dilute stock powder in 1000µl). The medium was 
removed from the plate of cells, which were then washed once with PBS. In 
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order to induce the signalling pathways, the cells were starved of growth 
factors, using a serum-free medium for 3 hours. An induction of 10 minutes 
with FCS and/or LIF was followed by a wash with PBS. 1ml of lysis buffer 
was added, and the plates of lysing cells were immediately placed on ice. 
The cells were scraped off, transferred into eppendorfs and then vortexed for 
30 seconds. Lysates were then spun for 10 minutes and the supernatant 
containing the protein was transferred to another eppendorf tube. The 
amount of protein was then measured by a BCA protein assay (Pierce), and 
all samples were made up to the same concentration in a total volume of 
around 1ml (1µg/ml minimum concentration was achieved). Equally, a small 
amount (usually around same concentration, but around 100µl total volume) 
from each sample was put aside, loading buffer was added, the sample was 
boiled and then stored in the freezer (control lysates sample). To the 
immunoprecipitation sample, 5-10µl (depending on the antibody, different 
amounts of antibody were used; manufacturers instructions were followed 
with all antibodies) of antibody was added, and was then allowed to rotate 
for 1 hour at 4˚C. Then, 30µl of a 50% slurry of Protein Sepharose A 
(Amersham) was added, and the lysates were left to rotate at 4˚C overnight. 
The next day, the sepharose beads were collected by spinning the lysates for 
5-10 seconds at 5000rpm. The beads were then washed 4 times with lysis 
buffer leftover from the day before (spin, remove supernatant, add lysis 
buffer, mix gently, spin again). It was important not to lose the pellet of 
sepharose beads, which had the immunoprecipitates bound to them. 
Eventually, after the last wash, the supernatant was removed and the 
agarose beads were resuspended in 2x sample buffer and lysis buffer and 
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made up to a volume of around 70-100µl. The lysates were then stored at -
20˚C. When the samples were analysed on Western blots, the 
immunoprecipitates were mixed, and the amount required to run on a gel 
was removed and heated at 98°C for 5 minutes. The samples were then 




2.3.3.1 Protocol A (Gab1 staining) 
1x105 cells were plated in a 1.9cm2 well of a 4-well plate and left to grow 
overnight. The next day, the cells were washed in PBS and then fixed in 4% 
paraforlaldehyde (made in PBS) for 10 minutes. The fixed cells were the 
washed twice in PBS and either stored at 4°C or blocked straight away. The 
plate was washed 4x5 minutes in PBST (1xPBS, 0.3% Triton X-100 –Sigma-), 
and then blocked (blocking solution: 10% goat serum –Sigma- in PBST, 1% 
BSA -Sigma-) for 2 hours at room temperature. Once blocked, the primary 
antibody diluted in blocking solution was added (e.g. Gab1: 1/500) straight 
after removing the block without washing, and left overnight at 4°C. The 
next day, the stained plates were washed 4x5 minutes with PBST. The 
secondary antibody diluted in blocking solution (e.g. Alexa 568 - IgG: 
1/1000) was then added and left for 2 hours at room temperature and in the 
dark. After 2 hours, the plates were washed 4x5 minutes with PBST in the 
dark to ensure minimum loss of fluorescence. The plates were then stained 
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with 1/500 DAPI (1 µg/ml; Amersham) in PBS for 5 minutes and then 
washed with PBS for another 5 mintues.  
 
2.3.3.2 Protocol B (Oct4 staining) 
5x105 cells were plated in a 9.6cm2 well of a 6-well plate and left to grow 
overnight. The next day, the cells were washed twice in PBS and then fixed 
in 4% paraforlaldehyde (made in PBS) for 20 minutes. The fixed cells were 
the washed twice in PBS. The cells were then permeabilised for 5 minutes in 
100% ethanol. The plates were then washed 1x5 minutes with PBS and 
blocked (blocking solution: 10% goat serum in PBS-T; PBS-T: 10% Tween 20 –
Sigma- in PBS) for 30 minutes at room temperature. Once blocked, the 
primary antibody diluted in 1% goat serum in PBS-T was added (e.g. Oct4: 
1/200) straight after removing the block without washing, and left overnight 
at 4°C. The next day, the stained plates were washed 3x5 minutes with PBS-
T. The secondary antibody diluted in 1% goat serum in PBS-T was then 
added and left for 1 hours at room temperature and in the dark with shaking. 
The plates were then washed 3x10 minutes with PBS-T in the dark to ensure 
minimum loss of fluorescence. The plates were then stained with 1/500 






2.3.4 List of Antibodies 
 
p44/42 MAPK (Cell Signalling; #9101) 
 ERK2 (BD Transduction; 610104) 
pAKT (Serine 473) (Cell Signalling; #9271) 
AKT (Cell signalling, #9272) 
pGSK3β (Serine 9) (Cell Signalling; #9336) 
GSK3β (Cell Signalling; #9315) 
SHP2 (Santa Cruz; sc-280) 
p85 subunit (PI3K) (Upstate; 06-195) 
pSTAT3 (Serine 705) (Cell Signalling; #9131) 
STAT3 (Santa Cruz; sc-482) 
pTyr (Upstate; 05-321) 
OCT3/4 (Santa Cruz; sc-5279) 
TUJI (Covance; MMS-435P) 
pGab1 (Tyrosine 627) (Cell Signalling; #3231)  
pGab1 (Tyrosine 307) (Cell Signalling; #3234)  
Gab1 (rabbit polyclonal) (Dr Toshio Hirano, Osaka University, Japan) 
ECL-HRP linked Secondary antibodies (Amersham) 




CHAPTER 3: CHARACTERISING THE BIOCHEMICAL EFFECTS OF 
GAB1β  ON ES CELLS 
3.1 Introduction  
 
Gab1α is a scaffolding adapter molecule that contributes to the specification 
and/or amplification of signal transduction pathways (Nishida and Hirano, 
2003; Pawson and Scott, 1997). Gab1α is tyrosine phosphorylated in response 
to various growth factors, cytokines and chemicals activating RTKs. Growth 
factors include: EGF (epidermal growth factor) (Holgado-Madruga et al., 
1996; Kameda et al., 2001b; Montagner et al., 2005), PDGF (Platelet Derived 
Growth Factor) (Kallin et al., 2004), HGF (Hepatocyte Growth Factor) 
(Hoffmann et al., 2005). Gab1α is also phosphorylated in response to the 
cytokines Interleukin-6 (Podar et al., 2004) and LIF (Takahashi-Tezuka et al., 
1998). It is also phosphorylated in response to oxidative stress caused by 
hydrogen peroxide (Holgado-Madruga and Wong, 2003). The tyrosine 
phosphorylation of Gab1α and its recruitment to receptors results in the 
activation of two major signalling pathways, the Shp2/ERrk and PI3K/Akt 
cascades. For example, Gab1α in complex with Shp2, has been shown to 
promote Erk signalling to enhance epidermal cell proliferation and oppose 
terminal differentiation of stratified epithelial cells in response to EGF (Cai et 
al., 2002). Using Gab1α-deficient immortalised fibroblasts, Gab1α has also 
been shown to act upstream of Ras for EGF receptor/ErB-mediated Erk 
activation (Yamasaki et al., 2003). Furthermore, the activation of Erk in 
response to EGF, PDGF and HGF is reduced in Gab1α-deficient primary 
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fibroblasts (Itoh et al., 2000). Interestingly, expression of a Gab1 mutant 
lacking the PH domain in fibroblasts does not interfere with EGF-induced 
Erk activation (Cunnick et al., 2000). This suggests that the Gab1 PH domain 
is not required for EGF-induced Erk activation. Therefore, Gab1β, which 
lacks the PH domain, should also be able to mediate EGF-induced Erk 
activation in ES cells.  
 
As Gab1α has been shown to be phosphorylated in response to various 
growth factors and cytokines, one may expect that Gab1β may also have this 
ability as it still retains motifs that are required to do so, such as the tyrosine 
phosphorylation sites for Shp2 and PI3K. FBS, which is routinely used to 
culture mouse ES cells, is known to contain a myriad of growth factors, EGF 
possibly being one of them. Although the levels of EGF in bovine serum have 
not been reported, human serum has been reported to contain EGF in the 
range of 1±0.5 ng/ml (Sporn, 1991). The cytokine LIF, routinely used to 
maintain ES cell self-renewal, is also involved in Gab1α-mediated signal 
transduction (Takahashi-Tezuka et al., 1998). Gab1α has been shown to link 
the cytokine receptor gp130 to the activation of the Mapk Erk in response to 
IL6 (Interleukin 6), a close relative to LIF (Takahashi-Tezuka et al., 1998). In 
this study, the authors demonstrated that Gab1α is tyrosine phosphorylated 
and forms a complex with both Shp2 and PI3K in response to IL6, via the 
gp130 receptor. As previously described, gp130 forms a heterodimer receptor 
complex with the LIF receptor (LIFR) in response to LIF, and this leads to 
activation of Stat3, a signal required for the maintenance of ES cell self-
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renewal (Niwa et al., 1998). Furthermore, Gab1α has been shown to interact 
with Shp2 and PI3K in cultured cardiomyocytes in response to LIF and the 
Gab1α-Shp2 interaction leads to the activation of the Mapk Erk5 (Nakaoka et 
al., 2003). Gab1α-deficient embryonic fibroblasts have been demonstrated to 
have markedly reduced levels of activated Erk1 and Erk2 in response to IL6 
(Takahashi-Tezuka et al., 1998). These data suggest that Gab1α is an 
important regulator of Erk signalling in response to IL6, and therefore 
potentially in response to LIF. Whether the PH domain is crucial for these 
signalling cascades is still not clear. The PH domain of Gab1α has been 
shown to be both essential and non-essential for the mediation of signalling. 
For example, the PH domain is not required for EGF-induced Erk2 activation 
in fibroblasts (Cunnick et al., 2000). This is also true for a naturally occurring 
PH domain-deficient form of Gab1α, that arises during the neoplastic 
progression of SHE (Syrian hamster embryo) cells, which is tyrosine 
phosphorylated in response to EGF activation, and also forms a complex 
with the EGFR (Kameda et al., 2001). The PH domain however, has also been 
shown to be required for LPA (lysophosphatidic acid)-induced Erk2 
activation (Cunnick et al., 2000). Therefore, whether the PH domain is 
required for efficient signalling via Gab1 proteins may depend on the 
receptors Gab1 is conveying signals from. This means that whether Gab1β 
will have similar effects on the signalling pathways that Gab1α takes part in, 




Apart from inducing Erk activation, Gab1α has also been shown to activate 
Akt, the PI3K effector, in response to various cytokines and growth factors. 
For example, Gab1α -/- fibroblasts, lack the ability the mediate the same high 
levels of EGF-induced Akt activation, compared to +/+ fibroblasts (Mattoon 
et al., 2004). Furthermore, Gab1α has been shown to potentiate the PI3K/Akt 
signalling cascade in response to VEGF (Dance et al., 2006) and NGF 
(Holgado-Madruga et al., 1997). Gab1α has also been shown to take part in a 
transactivation pathway with the EGF receptor (Laffargue et al., 1999). The 
authors of this study demonstrated that the actovation of PI3K by LPA in 
non-myeloid-derived cell lines is conditioned by the ability of LPA to 
transactivate the EGFR/Gab1α pathway. Apart from all the above, Gab1α 
has also been shown to mediate PI3K activation in response to Fibroblast 
Growth Factor (FGF) in mouse embryonic fibroblasts (Lamothe et al., 2004) 
and Glial cell line-Derived Neurotrophic Factor (GDNF) in human primitive 
neuroectodermal tumour cells (Maeda et al., 2004). Although there is no data 
linking Gab1α and PI3K in response to LIF, it would be interesting to see 
whether Gab1β, the predominant Gab1 protein in ES cells, is actually 
involved in the regulation of the PI3K pathway and whether this is in 
response to LIF or any other growth factor or cytokine. LIF has been shown 
to induce the activation of the PI3K pathway in ES cells, which leads to the 
phosphorylation of Akt, GSK3α, Gsk3β and S6 protein (Paling et al., 2004). 
Interestingly, using pharmacological inhibitors, blocking PI3K-dependent 
signalling reduces ES cell self-renewal by increasing the activation of the 
MAPK Erk (Paling et al., 2004). Furthermore, Akt has been identified in an 
RNA interference-based screen for positive regulators of ES cell self-renewal 
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(Pritsker et al., 2006). These data are supported by the demonstration that a 
myristoylated, active form of Akt can maintain the undifferentiated 
phenotype in mouse ES cells, without the addition of LIF (Watanabe et al., 
2006).  The precise mechanism of how this occurs, however, is still elusive. 
Apart from Akt, Glycogen Synthase Kinase 3 β (GSK3β) has also been shown 
to play a key role in the maintenance of mouse ES cell self-renewal by 
regulating Nanog expression (Storm et al., 2007). All the above data suggest 
that the PI3K pathway may participate in the maintenance of self-renewal in 
response to LIF. Though a clear link has not been demonstrated, as an 
adaptor protein Gab1β may act as a bridge between LIF and PI3K in ES cells.  
 
Gab1α was initially discovered as an IRS-1-like adaptor protein (Holgado-
Madruga et al., 1996) and is phosphorylated at PI3K and Shp2 binding sites 
in response to signals from the insulin receptor (Rocchi et al., 1998). Insulin 
signalling is important for normal growth and development as well as for 
normal homeostasis of glucose, fat and protein metabolism (Le Roith and 
Zick, 2001). Insulin and IGF1 are closely related cytokines, whose biological 
effects are mediated by binding to their respective cell surface type 1 tyrosine 
receptors (Nguyen et al., 2007). In the presence of insulin for example, the 
insulin receptor (IR) phosphorylates insulin receptor substrate (IRS) proteins 
that are linked to the activation of two main signalling pathways: the PI3K 
pathway, which is responsible for most of the metabolic actions of insulin, 
and the MAPK pathway, which regulates expression of genes and cooperates 
with the PI3K pathway to control cell growth and differentiation (Avruch, 
1998; Taniguchi et al., 2006). PI3K is important for many insulin responses, 
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including glucose uptake, general and growth-specific protein synthesis, and 
glycogen synthesis (White, 1998). In ES cells, the insulin pathway activates 
PI3K (Welham et al., 2007), a signal important for the maintenance of ES cell 
proliferation and pluripotency, through the activation of Akt-dependent 
inactivation of GSK3β (Paling et al., 2004; Welham et al., 2007). Furthermore, 
the inhibition of GSK3β has been demonstrated to be important in the 
maintenance of the undifferentiated state of mouse ES cells (Sato et al., 2004). 
More recently, IRS1 has been claimed to regulate murine ES cell self-renewal 
(Rubin et al., 2007). In this study, the authors demonstrated that the 
differentiation of ES cells by LIF withdrawal was associated with a reduction 
in IRS1 expression and a decrease in Akt and GSK3 phosphorylation. The 
suggestion that IRS1 may directly interfere with differentiation means that 
IRS1 may also have an effect on the MAPK signalling pathway, as the latter 
is a pro-differentiative pathway (Burdon et al., 1999b). This is supported by 
the fact that IGF1 and insulin have been shown to activate Erk in mouse ES 
cells (Nguyen et al., 2007). During development however, the physiological 
roles of IGF1 and insulin are not clear (Kaye, 1997) and the biological roles of 
insulin and IGF1 in ES cells are of interest. In a study aimed at unravelling 
the biochemical factors that control ES cell self-renewal in culture, the role of 
insulin in ES cells was questioned (Ying et al., 2008). In this study, the 
authors developed a medium that contained 3 basic components: inhibitors 
against Erk, FGF and GSK3. This medium was able to delineate the 
minimum requirements for the maintenance of ES cell self-renewal and 
which are capable of eliminating differentiation-inducing signals coming 
from Erk, FGF and GSK3. When insulin was omitted, ES cells were more 
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sensitive to the FGF and Erk inhibitors, and although they remained mostly 
undifferentiated over four weeks of culture, after the first passage the 
propagation rate declined steadily. This suggests that the presence of insulin 
sensitised the cells to differentiation-inducing signals. Furthermore, it 
suggests that insulin promotes long-term growth capability but does not 
dictate the fate choice between self-renewal and lineage commitment (Ying et 
al., 2008).     
   
IRS proteins contain several common structures with Gab1 proteins. For 
example, they contain: an NH2-termnal PH domain and/or a PTB domain 
that mediates protein-lipid or protein-protein interactions; multiple COOH-
terminal tyrosine residues that create SH2-protein binding sites; proline rich 
regions to engage SH3 domains; and serine/threonine-rich regions which 
regulate overall function through other protein-protein interactions (White, 
1998). The insulin receptor substrate, IRS-1, was the first docking protein 
identified and serves as the prototype for this class of molecules (Sun et al., 
1991). These common features are what lead to the discovery of Gab1a as an 
IRS-1-like protein (Holgado-Madruga et al., 1996). All the data on the effects 
of insulin, IGF1  and IRS1 on the PI3K and Erk pathways in ES cells, suggest 
that Gab1β may take part in the regulation of these pathways, as it is so 
closely related to IRS1. Furthermore, considering that insulin has been shown 
to have a background role in the propagation of ES cells, rather than a direct 
one in the fate-decision process of ES cells, Gab1β may take part in this 
signalling pathway. Insulin proved non-essential to an extent, but not 
completely dispensable for ES cells when the minimum requirements for the 
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maintenance of ES cell self-renewal were determined (Ying et al., 2008). This 
is similar to Gab1β in that it is expressed and takes part in major signalling 
pathways, but it is not required for the maintenance of self-renewal and 
pluripotency of ES cells.  
 
The requirement for the PH domain for the function of Gab1α is still not 
clear. For example, the PH domain of Gab1α has been shown to be essential 
for the ability of Gab1α to support branching morphogenesis downstream 
from the Met receptor tyrosine kinase in epithelial cells, in concert with PI3K 
activity (Maroun et al., 1999a). The Gab1α PH domain is even more 
important for recruitment in BCR signalling as a PH domain deletion mutant 
fails to become tyrosyl phosphorylated upon BCR engagement (Ingham et 
al., 2001). In other pathways, however, the PH domain appears to be 
dispensable for recruitment. For example, expression of a Gab1α mutant 
lacking the PH domain in fibroblasts does not interfere with EGF-induced 
Erk activation (Cunnick et al., 2000). The majority, however, of the data point 
to a requirement of the PH domain for the function of Gab1α. Studies in 
other species also suggest this. For example, PH domain mutants of the 
Drosophila melanogaster Gab1α homologue, DOS, fail to function in Sevenless 
signalling and to rescue the lethal phenotype of DOS loss-of-function mutant 
flies (Bausenwein et al., 2000). Similarly, a PH doman mutant of C. elegans 
SOC1, the Gab1α nematode homologue, is non-functional (Liu and 




In terms of insulin signalling, the IRS1 PH domain has been shown to be 
required for insulin-stimulated tyrosine phosphorylation of IRS1 and IRS1-
associated PI3K activity (Myers et al., 1995; Yenush et al., 1996). Furthermore, 
the Gab1α PH domain has been suggested to be important for Gab1α 
tyrosine phosphorylation and subsequent Shp2 association after insulin 
stimulation (Rocchi et al., 1998). Based on these data, Gab1β would not be 
expected to be tyrosine phosphorylated or form a complex with Shp2 in 
response to insulin or IGF. In the same publication however, the authors 
suggest that the PH domain of Gab1α is required only when low levels of 
receptor are present. This may mean that the role of the PH domain depends 
on the environment of receptors and activators that the protein is present. 
Gab1β may have a completely separate and distinct biochemical role in ES 
cell insulin signalling compared to Gab1α, which is independent of the PH 
domain. Therefore, as well as providing information on the biological role of 
Gab1β, investigating its biochemical activity in response to insulin/IGF will 
prove useful in understanding the importance of the PH domain for this 
protein. 
      
The aim of this chapter is to establish whether Gab1β, despite the absence of 
the PH domain, is an active participant in the Shp2 and PI3K pathways in ES 
cells, or whether it acts as a dominant negative regulator by binding and 
mislocalising these effectors. I aim to investigate this by determining whether 
Gab1β can form complexes with Shp2 and PI3K. Then, in order to determine 
whether it acts as a positive or a negative effector, I aim to establish the 
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biochemical potential of Gab1β by performing inductions with LIF, FBS and 
insulin on Gab1β-targeted ES cells. The biochemical output of these 
inductions will be measured by detecting the levels of Erk, Akt and/or 
GSK3β phosphorylation in response to the inductions. In addition to 
investigating the biochemical output of Gab1β, I also aim to establish its 



















3.2.1 Gab1β activation 
 
Upon growth factor or cytokine stimulation, Gab1α undergoes rapid tyrosine 
phosphorylation, creating a number of docking sites to mediate interactions 
with SH2 domain-containing proteins, such as the tyrosine phosphatase Shp2 
and the p85 subunit of PI3K (Liu and Rohrschneider, 2002). In this section I 
aim to determine whether Gab1β also undergoes rapid phosphorylation 
resulting in complex formation with Shp2 and PI3K in murine ES cells. 
Therefore, mouse ES cells, which highly express Gab1β, were starved and 
then induced with growth factors in order to activate the signalling 
pathways of interest, namely the Shp2 and PI3K pathways. Briefly, 6x106 
cells were plated overnight in a 10cm culture dish. The next day, the cells 
were starved of all growth factors and cytokine for 3 hours and then induced 
with either 10% Foetal Bovine Serum (FBS) or 1000units/ml Leukemia 
Inhibitory Factor (LIF) for 10 minutes. The cells were lysed  and then, a Gab1-
specific antibody, which recognises both Gab1α and Gab1β, was used to 
isolate all Gab1 protein and protein complexes, which were isolated on 
protein sepharose-A beads overnight. Immunoprecipitates were run on 
Western blots, which were probed with antibodies against Gab1 
phosphorylated at tyrosines 627 and 307, as well as an antibody raised 
against pan phosphotyrosine. Tyrosine 307 corresponds to the binding site 
for PLCγ whilst tyrosine 627 corresponds to the binding site for Shp2. The 





Figure 3.1: Tyrosine phosphorylation state of Gab1β protein complexes in murine ES cells in 
response to FBS and LIF. In both experiments (a&b, c&d), cells were induced with 10% FBS 
or 1000 units/ml LIF for 10 minutes. a) Gab1β, depicted by arrows, is phosphorylated at 
tyrosines 307 and 627 in response to FBS or LIF; Gab1β is also phosphorylated at multiple 
tyrosines in response to FBS; whether it is phosphorylated at multiple tyrosines in response 
to LIF is still unclear, as the sample is underloaded. b) Erk is phosphorylated in response to 
either FBS or LIF, whilst Stat3 is phosphorylated in response to only LIF. c) Gab1β is clearly 
phosphorylated at tyrosines 307 and 627 in response to LIF; Gab1β is also phosphorylated at 
multiple in response to either FBS or LIF. d) Erk is phosphorylated in response to FBS or LIF, 
which confirms the activation of the cells.    
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The tyrosine phosphorylation sites 307 and 627 on Gab1β are both 
phosphorylated in response to LIF (Figure 3.1a & 3.1c). Gab1β also seems to 
be phosphorylated in response to FBS (Figure 3.1a). Gab1β is also tyrosine 
phosphorylated at tyrosines in response to FBS or LIF (Figure 3.1b). Erk is 
phosphorylated in response to FBS or LIF in both experiments (Figure 3.1b & 
3.1d). This confirms the activation of the cells in response to both FBS and 
LIF. As expected, Stat3 is also phosphorylated only in response to LIF (Figure 
3.1b). 
 
3.2.2 Gab1β interactions 
 
The Gab1 immunoprecipitation experiment described in the previous section 
showed that Gab1β is tyrosine phosphorylated in response to either LIF or 
FBS. To determine whether Gab1β associates with Shp2 and PI3K, any 
potential Gab1β-Shp2 and Gab1β-PI3K protein complexes were isolated 
using Shp2 or PI3K-specific antibodies respectively. The experiment was 
performed as described previously in Section 3.2.1. The complexes were 
analysed on Western blots probed with a Gab1-specific antibody. The data 
shows that Gab1β forms complexes with Shp2 in response to either LIF or 
FBS (Figure 3.2). The Western blots showed that Gab1β binds more Shp2 in 
response to LIF than in response to FBS. This suggests that LIF is a more 
effective inducer of Gab1β-Shp2 complex formation. In combination with the 
results in Figure 3.1, which showed that Gab1β is phosphorylated at the 
binding site for Shp2 in response to LIF, these data suggest that Gab1β is 
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recruited to the LIFR/gp130 receptor dimer in response to LIF, is then 
phosphorylated at site 627, the binding site for Shp2, which then allows the 




Figure 3.2: Isolation of Gab1β-Shp2 complexes in mouse ES cells using an Shp2-specific 
antibody. Shp2 forms a complex with Gab1β in response to both LIF and FBS as seen in two 
separate experiments (a&b). Gab1β forms more complexes with Shp2 in response to LIF, 
than in response to FBS.  
 
Gab1β also forms a complex with the p85 subunit of PI3K in response either 
LIF or FBS (Figure 3.3). In both experiments, there is a higher basal level of 
Gab1β-PI3K complexes present in uninduced immunoprecipitates when 
compared to the basal level of Gab1β-Shp2 complexes. This shows that in 






Figure 3.3: Isolation of Gab1β-p85 subunit of PI3K in mouse ES cells using a PI3K-specific 
antibody. The p85 subunit of PI3K forms a complex with Gab1β in response to both LIF and 
FBS as seen in two separate experiments (a&b).  
 
3.2.3 Effect of Gab1β  on downstream signalling 
 
The data in Figure 3.1 show that Gab1β is phosphorylated in response to its 
recruitment to the LIFR/gp130 dimer receptor as well as to other unknown 
receptors that get activated in response to FBS. Gab1β also associates with 
Shp2 (Figure 3.2) and PI3K (Figure 3.3) in response to either LIF or FBS. To 
determine whether Gab1β acts in a positive or negative manner in these 
complexes, the effect of this association on downstream signalling pathways 
from Shp2 and PI3K was investigated.  
 
In the following experiments, previously generated Gab1β-targeted ES cell 
lines made by Dr. T. Burdon and L. Sutherland were used. Before 
investigating the role of Gab1β in downstream Shp2 and PI3K signalling, the 
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Gab1β expression profiles of Gab1β-deficient cell lines was confirmed. These 
cells were generated by homologous recombination using the IOUD2 cell line 
(Burdon T., unpublished). The IOUD2 cell line carries a β-galactosidase 
neomycin fusion gene (βgeo) inserted into the untranslated region of the 
Oct4 gene (Mountford et al., 1994). Two rounds of electroporation and 
selection for homologous recombination, using a resistance marker, were 
used to generate Gab1β knockout ES cells. To confirm the Gab1β expression 
profile of various Gab1β-targeted cells before using them in the following 
experiments cell protein lysates of Gab1β wildtype (+/+), heterozygous (+/-) 
or knockout (-/-) cells: C1 (+/+), 46 (+/-), 26 (-/-), HT (+/+), 153 (+/-) and 55 
(-/-) were analysed by immunoblotting. Western analysis of protein lysates 
from these six targeted clones confirmed the Gab1β genotypes (Figure 3.4). 
As Gab1β gene expression decreased, so did the amount of Gab1β protein, 
with the knockouts giving rise to no Gab1β protein.     
 
 
Figure 3.4: Screening of Gab1β-targeted cell lines for Gab1β protein expression. a) The 
expression of Gab1β is confirmed in all three cell lines b) Three other cell lines were screened 
and their genotype was also confirmed. The expression of Gab1α protein seems unaffected 
by the Gab1β targeting event. The blots were also probed with a Stat3-specific antibody as a 
loading control.   
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The effectors investigated downstream of PI3K were Akt and GSK3β, both of 
which have been shown to be important for the maintenance of ES cell self-
renewal (Paling et al., 2004; Sato et al., 2004; Watanabe et al., 2006). PI3K has 
been reported to be important for the maintenance of the undifferentiated 
state of ES cells by forced expression of a dominant-negative p85 mutant and 
treatments with LY294002, a specific inhibitor of PI3K (Paling et al., 2004). 
Akt has been shown to be sufficient for the maintenance of pluripotency in 
mouse ES cells, by expressing a constitutively active myristoylated form of 
Akt in ES cells. This form allowed for the maintenance of the 
undifferentiated state of the cells in the absence of LIF (Watanabe et al., 
2006). Activation of the WNT signalling pathway has been suggested to be 
sufficient for the maintenance of mouse and human ES cells, by the inhibition 
of GSK3β (Sato et al., 2004). GSK3β has also been suggested to have a role in 
PI3K-dependent regulation of Nanog expression (Storm et al., 2007; Welham 
et al., 2007). Activation of an inducible form of Nanog prevents the loss of 
self-renewal observed in the presence of PI3K inhibitors (Welham et al., 
2007). The effector investigated downstream of Shp2 was the MAPK Erk. 
Signal transduction via the gp130/LIF pathway induces the activation of the 
mitogen activated protein kinases (MAPK) Erk1 and Erk2, in addition to 
Stat3 (Burdon et al., 2002; Qu and Feng, 1998). This activation results from 
the association of gp130 with the protein tyrosine phosphatase Shp2 (Fukada 
et al., 1996). In contrast to increased Stat3 phosphorylation, LIF-stimulated 
Erk phosphorylation levels are decreased in Shp2-deficient ES cells, 
compared to wildtype or Shp2-mutant cells reconstituted with wildtype 
Shp2 expression (Feng, 2007; Qu and Feng, 1998; Qu et al., 2001). The 
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activation of Erk, in response to LIF-stimulated Shp2 recruitment, has been 
shown to promote the differentiation of ES cells (Burdon et al., 1999b).                  
 
In all the following induction experiments, 1x106 Gab1β-targeted ES cells 
(Figure 3.4) were plated in 9.4 cm2 wells and allowed to grow overnight. The 
next day, cells were starved of all cytokine and growth factors in a serum-
free medium for 3 hours and then induced with 1000 units/ml LIF or 10% 
FBS for 5, 10 or 15 minutes. The cells were then lysed for protein, which was 
analysed on Western blots probed with phospho-specific antibodies for Erk, 
Akt and GSK3β. The antibody against phosphorylated Erk recognises the 
phosphorylation of threonines 202 and 204 on Erk1 and the phosphorylation 
of threonines 185 and 187 on Erk2. The antibody against phosphorylated Akt 
recognises the phosphorylation of serine 473, whilst that of GSK3β recognises 
the phosphorylation of serine 9.  
 
3.2.3.1 Effect of Gab1β  on PI3K and Shp2 signalling in response to Foetal 
Bovine Serum  
 
The basal levels of Erk phosphorylation between the three different cell lines 
did not differ greatly, with the Gab1β +/- cell line having a slightly lower 
basal level of Erk phosphorylation compared to +/+ and -/- cells (Figure 
3.5). Upon induction with FBS, there was no significant difference between 
the levels of Erk phosphorylation in Gab1β wildtype, +/- and -/- cells at any 
of the three timepoints. Any slight differences in the levels of Erk 
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phosphorylation between cell lines can be attributed to slight differences in 
protein loading. There is an acute increase in Erk phosphorylation upon 5 
minutes of FBS induction, which then gradually decreases as the induction 
time increases. This suggests that the effect of FBS on the activation of Erk is 
acute and not sustained.  
 
 
Figure 3.5: The effect of FBS stimulation on Erk phosphorylation of Gab1β-targeted ES cells. 
Cells were induced with 10% FBS for 5, 10 and 15 minutes. The presence/absence of Gab1β 
does not have an effect on Erk phosphorylation in response to FBS.   
 
When Gab1β-targeted ES cells (C1 +/+, 46 +/- and 26 -/-) were induced with 
FBS, Gab1β -/- cells, exhibited less Akt phosphorylation compared to 
wildtype cells after 10 minutes of induction, despite the similar low levels of 
Akt phosphorylation in the uninduced conditions (Figure 3.6a). The same 
result was obtained when the experiment was performed with different 
Gab1β-targeted ES cells (HT +/+, 153 +/- and 55 -/-) (Figure 3.6b). 
Interestingly, the level of Akt phosphorylation of +/- cells after induction 
was similar to the level of -/- cells in both experiments. This suggests that 
there may be an optimum amount of Gab1β that is required for the efficient 
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downstream potentiation of Akt, and that only Gab1β wildtype cells are 
capable of transmitting this effect.  
 
 
Figure 3.6: The effect of FBS on the phosphorylation of Akt of Gab1β-targeted ES cells. Cells 
were induced with10% FBS for 10 minutes. a) (C1 +/+, 46 +/-, 26 -/-): Gab1β potentiates Akt 
phosphorylation, but not GSK3β phosphorylation in response to FBS. b) (HT +/+, 153+/-, 55 
-/-): Gab1β may potentiate Akt phosphorylation. 
 
These data demonstrate that, in response to FBS, Gab1β potentiates the 
phosphorylation of Akt. Although the magnitude of AKT activation may 
vary somewhat between cell lines, this could mean that Gab1β is a positive 
regulator of PI3K signalling despite the lack of a PH domain. Most 
importantly however, these data indicate that Gab1β does not act in a 
dominant negative manner by binding and mislocalising PI3K. Interestingly, 
Gsk3β phosphorylation does not differ between Gab1β wildtype and 
knockout cell lines, upon FBS stimulation. Although phosphorylated in 
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response to PI3K activation, Akt and Gsk3β may not necessarily translate 
into the same biochemical effect. Gsk3β phosphorylation may be 
independent of Akt phosphorylation. Furthermore, the kinetics of Gsk3β 
activation may be different to that of Akt.  
 
3.2.3.2  Effect of Gab1β on PI3K and Shp2 signalling in response to 
Leukaemia Inhibitory Factor 
 
Inductions were again performed as described in section 3.2.3. After 
starvation however, Gab1β-targeted cells (C1 +/+, 46 +/-, 26 -/-) were 
induced with 1000 units/ml LIF for 5, 10 and 15 minutes. Protein lysates 
were analysed on Western blots probed with antibodies against 
phosphorylated Erk, Akt or GSK3β. Similar low levels of phosphorylated Erk 
were observed in uninduced conditions in all three cell lines (Figure 3.7). At 
all three induction timepoints, however, Gab1β -/- cells exhibited lower 
levels of Erk phosphorylation when compared to wildtype and +/- cells. 
Importantly, unlike in Figure 3.6, where the -/- and +/- cells had a similar 
pattern of Akt phosphorylation in response to serum, in response to LIF, 
there is a gradual decrease in Erk phosphorylation as the amount of Gab1β 
decreases from wildtype cells to -/- cells. This suggests that there is a 






Figure 3.7: The effect of LIF stimulation on the levels of Erk phosphorylation in Gab1β-
targeted ES cells (C1 +/+, 46 +/-, 26 -/-). Cells were induced with 1000 units/ml LIF for 5, 10 
and 15 minutes. Gab1β enhances Erk phosphorylation in response to LIF at all three 
timepoints.  
 
Gab1β +/+ cells exhibited slightly higher levels of Stat3 phosphorylation at 
tyrosine 705 upon induction with LIF at all 3 timepoints. This however could 
be attributed to the higher levels of total Stat3 protein. Densitometric analysis 
of the Western blots in Figure 3.7 probed with phosphorylated Erk and 
unphosphorylated Erk2 supports this data. There is a clear decrease in the 
quantity of phosphorylated Erk when normalised to total levels of Erk2 
(Figure 3.8). This confirms that Gab1β does indeed potentiate Erk 





Figure 3.8: Densitometric analysis of Western blots in Figure 3.7. Values were obtained by 
dividing the total optical density of the phosphorylated Erk signal over the optical density of 
the unphosphorylated Erk2 signal. The densitometric data confirm the Western blot data in 
Figure 13. Therefore, Gab1β does indeed potentiate Erk phosphorylation in response to LIF, 
based on this data alone.  
 
These data demonstrate that Gab1β is a positive regulator of Erk 
phosphorylation in response to LIF, and not a dominant negative adaptor 
protein. This means that the PH domain is not required for the biochemical 
potential of Gab1β to potentiate Erk phosphorylation. This also suggests that 
the PH domain is potentially redundant for the protein’s ability to take part 
in signalling pathways, and that Gab1β can indeed convey downstream 






The same experiment was repeated with different Gab1β wildtype, +/- and -
/- cell lines (HT +/+, 153 +/-, 55 -/-) in order to confirm the data in Figure 
3.7. Again, low levels of unphosphorylated Erk were observed in uninduced 
conditions. At all three timepoints, Gab1β -/- cells exhibited lower levels of 
Erk phosphorylation compared to wildtype and +/- cells (Figure 3.9).  
 
 
Figure 3.9: The effect of LIF stimulation on the levels of Erk phosphorylation in Gab1β-
targeted ES cells (HT +/+, 153 +/-, 55 -/-). Cells were induced with 1000 units/ml LIF for 5, 
10 and 15 minutes. Gab1β may enhance Erk phosphorylation in response to LIF. 
 
Densitometric analysis of the Western blots in Figure 3.9 probed with 
phosphorylated Erk and unphosphorylated Erk2 supports this data. There is 
a decrease in the amount of phosphorylated Erk when normalised to the total 
levels of Erk2 (Figure 3.10). This confirms that Gab1β potentiates Erk 





Figure 3.10: Densitometric analysis of Western blots in Figure 3.9. Values were obtained by 
dividing the total optical density of the phosphorylated Erk signal over that of 
unphosphorylated Erk2. The analysis confirms that Gab1β potentiates Erk phosphorylation 
in response to LIF. 
 
The data so far indicate that Gab1β is an active signalling protein in the LIF-
Shp2-Erk signalling cascade. To avoid the possibility that what has been 
observed is due to clonal variations of the cell lines used, the induction 
experiment was repeated using a Gab1β knockout cell line transfected with a 
Gab1β expression vector. This cell line, called Gab1β restored, was generated 
in the lab by Dr. Thomas Burdon, by transfecting the -/- cells with a vector 
that had the Gab1β cDNA under the control of a strong CAG promoter, 




Figure 3.11: The effect of LIF on the levels of Erk phosphorylation in Gab1β and Gab1α 
restored cells. Cells were induced with 1000 units/ml LIF for 10 minutes. a) Both Gab1α and 
Gab1β restored cells exhibit similar levels of Erk phosphorylation as +/+ cells. Gab1β -/- 
cells exhibit lower levels of Erk phosphorylation compared to all 3 other cell lines. b) Gab1β 
+/+, Gab1β and Gab1α restored cell lines exhibit higher levels of Erk phosphorylation 
compared to Gab1β -/- cells.  
 
The expression of Gab1β in these cells was demonstrated by Western blot 
(Figure 3.11a). The re-expression of Gab1β in these cells should in theory also 
restore their ability to potentiate Erk phosphorylation in response to LIF. The 
induction experiment was repeated using these cells, as well as Gab1β -/- 
that had Gab1α protein introduced into them (Gab1α restored). When 
compared to Gab1β +/+ (C1), Gab1β restored cells did indeed reinstate the 
 
 103 
levels of Erk phosphorylation when induced with 1000 units/ml LIF for 10 
minutes (Figure 3.11). Interestingly, overexpressing Gab1α in Gab1β -/- cells 
also restored the levels of Erk phosphorylation. This suggests that even 
though Gab1α is not a “native” protein in ES cells, it can still act 
biochemically in response to LIF. Therefore, although the levels of Gab1α are 
negligible in ES cells, it still has the ability to participate in the same 
signalling pathways as Gab1β does in ES cells, when overexpressed. Their 
common structure allows this, despite the presence of a PH domain in 
Gab1α. Gab1α has in fact been shown to participate in the LIF signalling 
pathway. It acts as an adapter molecule in transmitting signals to the Erk 
MAPK for the cytokine receptor gp130 (Takahashi-Tezuka et al., 1998). This 
study demonstrated that Gab1α forms a complex with Shp2 as well as the 
p85 subunit of PI3K in response to IL6. The authors showed that the complex 
between Gab1α and Shp2 acts upstream of Erk in gp130 signalling.       
 
Upon induction with LIF, the levels of Akt phosphorylation did not differ 
greatly between Gab1β wildtype and -/- cells (Figure 3.12). This was in stark 
contrast to the increase in Akt phosphorylation in respone to FBS in Gab1β 
wildtype cells (Figure 3.6). Though not clear, there was a slight increase in 
the levels of Akt phosphorylation in the wildtype cells, but this could be 
attributed to increased levels of unphosphorylated Akt, in the samples. 
Though there seems to be a slight increase in the levels of GSK3β 
phosphorylation in the Gab1β wildtype cells compared to the -/- cells, this 
could be attributed to an increase in the levels of unphosphorylated GSK3β, 
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which has not been demonstrated. Therefore, one would suggest that Gab1β 
does not have a positive or a negative effect on Akt or GSK3β 
phosphorylation in response to LIF induction. 
 
 
Figure 3.12: The effect of Gab1β on the levels of Akt and GSK3β phosphorylation in response 
to LIF. Cells were induced with 1000 units/ml for 10 minutes. Gab1β does not significantly 
potentiate Akt or GSK3β phosphorylation in response to LIF. Gab1β cell lines used: C1 +/+, 
46 +/-, 26 -/-. 
 
3.2.3.3  Effect of Gab1β on Shp2 signalling in response to co-stimulation 
with Leukemia Inhibitory Factor and Foetal Bovine Serum 
 
Murine ES cells are routinely cultured in a growth medium that contains LIF 
and FBS. It is the combination of these two supplements that maintains their 
self-renewal and pluripotency in culture, although BMP has been shown to 
replace the requirement for FBS (Qi et al., 2004; Ying et al., 2003a). 
Nevertheless, in order to simulate the effect of LIF and FBS on the 
biochemical pathways that Gab1β regulates in ES cells, the next set of 
inductions were performed using complete ES cells medium containing LIF 
and FBS as an inducer.  Induction experiments were performed as previously 
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described. The cells were induced with complete ES cell growth medium 
containing LIF and FBS for 5, 10 and 15 minutes. Protein lysates were 
screened on Western blots probed with an antibody against phosphorylated 
Erk. The results suggest that Gab1β enhances Erk phosphorylation at 10 
minutes of LIF and FBS induction (Figure 3.13). At 5 and 15 minutes 
however, there was no difference in the levels of Erk phosphorylation 





Figure 3.13: The effect of Gab1β on the levels of Erk phosphorylation in response to FBS and 
LIF combined. Cells were induced with 1000 units/ml LIF and 10% FBS for 5, 10 and 15 
minutes. a) At 5 and 15 minutes of induction, there is no significant difference in the levels of 
Erk phosphorylation between Gab1β-targeted ES cells (C1 +/+, 46 +/-, 26 -/-). At 10 
minutes, however, Gab1β may enhance Erk phosphorylation upon induction, as the -/- cells 
seem to exhibit less Erk phosphorylation compared to +/+ and +/- cells. b) In the second 
experiment, Gab1β -/- cells exhibited slightly less Erk phosphorylation in response to co-






Figure 3.14: Densitometric analysis of Western blot in Figure 3.13a. Values were obtained by 
dividing the total optical density of the phosphorylated Erk signal over that of 
unphosphorylated Erk2. The densitometric data confirm that at 5 minutes there is no 
significant difference in the levels of Erk phosphorylation between Gab1β-targeted ES cells. 
at 10 and 15 minutes, Gab1β potentiates Erk phosphorylation in response to co-stimulation 
with LIF and FBS.  
 
Interestingly, in response to LIF and FBS combined, Gab1β still potentiates 
Erk phosphorylation. The induction timepoint at which it does so, however, 
is still not clear. The two experiments produced differing results. In the first 
one, Gab1β clearly enhanced Erk phosphorylation after 10 minutes of 
induction (Figure 3.13a). This was confirmed by densitometric analysis, 
which also revealed that Gab1β -/- cells potentiate Erk phosphorylation at 
the 15 minute timepoint as well, in response to co-stimulation. In the second 
one, however Gab1β seemed to potentiate Erk phosphorylation at all 3 
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timepoints (Figure 3.13b). In light of the denitometric data, however, Gab1β 
did not seem to have an effect on Erk phosphorylation in response to co-
stimulation (Figure 3.15). This suggests that whether Gab1β has an effect on 
Erk activation in response to LIF and FBS co-stimulation, is still not clear.  
Figure 3.15: Densitometric analysis of Western blot in Figure 3.13b. Values were obtained by 
dividing the total optical density of the phosphorylated Erk signal over that of 
unphosphorylated Erk2. The densitometric data indicate that Gab1β may not potentiate Erk 
phosphorylation in response to co-stimulation with LIF and FBS. 
 
Independently of Gab1β, the co-stimulation with LIF and FBS caused a 
double wave of Erk phosphorylation. The highest activation was exhibited at 
5 minutes, whilst the lowest was at 10 minutes; at 15 minutes, cells exhibited 
increased levels of Erk phosphorylation. This could be due to LIF and FBS 
activating Erk at different timepoints and the wave we are seeing is a 
culmination of both these signals. This suggests that although in FBS 
inductions the loss of Gab1β did not have an effect on the phosphorylation of 
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Erk, some factors contained within it may have an effect. It would be 
interesting to see which of the many factors that exist in serum actually cause 
this effect.  
3.2.3.4 Effect of Gab1β  on PI3K and Shp2 signalling in response to 
Insulin/Insulin Growth Factor 
 
In order to investigate the effects of Gab1β on PI3K signalling in response to 
IGF in ES cells, inductions were performed as previously described in Section 
3.2.3. Briefly, 1x106 Gab1β-targeted ES cells plated overnight were starved of 
cytokines and growth factors for 3 hours, before being induced with 
100ng/ml IGF for 10 minutes. Protein lysates were analysed on Western blots 
probed with antibodies against phosphorylated and unphosphorylated Erk 
and Akt. Gab1β -/- cells exhibited slightly higher levels of Erk 
phosphorylation compared to wildtype cells in response to IGF (Figure 3.16). 
The increase in Erk1 phosphorylation (upper band) was more pronounced 
than the increase in Erk2 phosphorylation (lower band). As the levels of Erk 
phosphorylation do not increase greatly upon IGF induction, and in order to 
confirm the stimulation of the cells, the levels of Akt phosphorylation should 





Figure 3.16: The effect of Gab1β on Erk phosphorylation in response to IGF. Cells were 
induced with 100ng/ml of IGF for 10 minutes. Gab1β -/- cells exhibited slightly higher 
levels of Erk phosphorylation upon induction.  
 
The experiment was repeated using different Gab1β-targeted cell lines (HT 
+/+, 55 -/-). Results show that Gab1β seems to repress Erk activation in 
response to IGF in this set of cells as well, as Gab1β -/- cells exhibited lower 
levels of Erk phosphorylation than wildtype cells (Figure 3.17). The increase 
in Erk1 phosphorylation (upper band) was more pronounced than the 
increase in Erk2 phosphorylation (lower band).  
 
 
Figure 3.17: The effect of Gab1β on Erk phosphorylation in response to IGF. The induction is 
not as strong as expected. However, Gab1β -/- cells exhibited slightly higher levels of Erk 
phosphorylation upon induction. This suggests that Gab1β may repress Erk 
phosphorylation in response to IGF. Cell lines used: HT +/+ and 55 -/-.   
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Densitometric analysis of the Western blot in Figure 3.17 confirms that Gab1β 
-/- cells exhibit slightly higher levels of Erk phosphorylation in response to 
IGF, compared to Gab1β +/+ cells (Figure 3.18). The levels of 
phosphorylated Akt would have indicated the level of induction in response 
to IGF. This would confirm the stimulation with IGF.   
 
Figure 3.18: Densitometric analysis of Western blot in Figure 3.17. Values were obtained by 
dividing the total optical density of phosphorylated Erk over that of total Erk2. The analysis 
shows that the levels of phosphorylated Erk did not increase greatly upon IGF induction. 
Gab1β -/- cells exhibit slightly higher levels of Erk phosphorylation compared to Gab1β +/+ 
cells in response to IGF. 
 
In order to confirm these data, the induction experiment was repeated using 
a Gab1β -/- cell line, which had Gab1β expression restored to wildtype 
levels. Results show that when Gab1β expression is restored in the -/- cells, 
they exhibit similar levels of Erk phosphorylation with Gab1β +/+ cells, 
which are lower than those of Gab1β -/- cells (Figure 3.19). The 
overexpression of Gab1α also repressed Erk activation in response to IGF 
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despite the fact that it has been shown to be required for insulin-stimulated 
Erk activation in hepatocytes (Bard-Chapeau et al., 2005). Therefore, the 
expression of either Gab1α or Gab1β in ES cells results in a repression of IGF-
stimulated Erk phosphorylation. Firstly, this suggests that the PH domain is 
not responsible for this repression. Secondly, it demonstrates the modularity 
of Gab1 proteins, in that either isoform can take part in the same signalling 
pathway and produce the same effect. This suggests that Gab1β does not act 
in a dominant negative way in ES cells, but that it actively participates as a 
repressor of IGF signalling.   
 
Figure 3.19: The effect of Gab1β on Erk phosphorylation in response to IGF. Cells were 
induced with 100ng/ml IGF for 10 minutes. Gab1β restored and Gab1β +/+ cells exhibited 
lower levels of Erk phosphorylation compared to Gab1β -/- cells in response to IGF. The 
overexpreesion of Gab1α in Gab1β -/- cells, also restores the repressio of AKT 
phosphorylation in reposne to IGF.   
 
In order to investigate the effect of Gab1β on PI3K signalling in response to 
IGF in ES cells, inductions were performed as previously described in Section 
3.2.3. Cells were induced with 100ng/ml IGF for 10 minutes. Gab1β -/- cells 
exhibited higher levels of Akt phosphorylation compared to Gab1β +/+  cells 
(Figure 3.20). Therefore, Gab1β represses Akt signalling in response to IGF. 
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This suggests that Gab1β acts as a negative regulator of Akt signalling. 
Whether it does so in a dominant negative fashion is still not clear.  
 
Figure 3.20: The effect of Gab1β on Akt phosphorylation in response to IGF. Upon induction. 
Cells were induced with 100ng/ml IGF for 10 minutes. Gab1β -/- cells exhibited less Akt 
phosphorylation in response to IGF, compared to Gab1β +/+ cells.  
 
In order to examine the temporal regulation of Akt phosphorylation by 
Gab1β in response to IGF, the experiment was repeated over various 
timepoints (5, 10 and 20 minutes). At all three timepoints, Gab1β -/- cells 
exhibited higher levels of Akt phosphorylation compared to Gab1β +/+ cells 
in response to IGF (Figure 3.21).  
 
 
Figure 3.21: The effect of Gab1β on Akt phosphorylation in response to IGF. Cells were 
induced with 100ng/ml IGF for 5, 10 and 20 minutes. Upon induction at all three timepoints, 
Gab1β -/- cells exhibited more Akt phosphorylation compared to  +/+ cells. The repression 




Figure 3.22: Densitometric analysis of Western blot in Figure 3.21. Gab1β -/- cells exhibit 
higher levels of Akt phosphorylation compared to Gab1β +/+ cells in response to IGF. 
Values are corrected to total unphosphorylated Akt. The analysis confirms that Gab1β 
represses Akt phosphorylation in response to IGF. 
 
In order to confirm these data, the induction experiment was repeated using 
the Gab1β -/- cell line, which had Gab1β expression restored to wildtype 
levels (Gab1β restored). Results show that when Gab1β expression is 
restored in the -/- cells, they exhibit similar levels of Akt phosphorylation 
with Gab1β +/+ cells, which are lower than those of Gab1β -/- cells (Figure 
3.23). This confirms the previous conclusion from Figure 3.21, that Gab1β 





Figure 3.23: The effect of Gab1β on Akt phosphorylation in response to IGF in Gab1β 
restored cells. Cells were induced with 100ng/ml IGF for 10 minutes. The re-expression of 
Gab1β restores the repression of Akt phosphorylation upon IGF induction. Gab1β -/- cells 
exhibit more Akt phosphorylation in response to IGF compared to Gab1β +/+ and Gab1β 
restored cells. The overexpression of Gab1α in Gab1β -/- cells also restores the repression of 
Akt phosphorylation in response to IGF.  
 
Interestingly, overexpressing Gab1α in Gab1β -/- cells also had an effect on 
the levels of Akt phosphorylation. Even though Gab1α has been shown to be 
a positive regulator of IGF signalling in hepatic cells (Bard-Chapeau et al., 
2005), our data suggests that its overexpression in ES cells represses Akt 
phosphorylation. Therefore, the presence of a PH domain does not contribute 
to the repression of Akt in response to IGF. Most importantly, however, it 
suggests that Gab1β is a negative effector of Akt signalling in response to 
IGF, but not a dominant negative one. If it were a dominant negative effector, 
then one would expect the overexpressed Gab1α protein to have an opposite 
or an inactiving effect to that of Gab1β, and that it would potentiate Akt 
signalling in response to IGF. As the two isoforms have the same effect on 
the IGF pathway, this means that the inhibitory effect is not a dominant 
effect in the case of Gab1β, which lacks the PH domain. Gab1 proteins in ES 
cells act to repress Akt signalling in response to IGF stimulation.    
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3.2.4 The effect of insulin on the growth of Gab1β-targeted ES cells 
 
In the previous sections, Gab1β was shown to repress Akt and Erk 
phosphorylation in response to IGF. What this means biologically for an ES 
cell, however, is not known. IGF1 receptor activation leads to Erk 
phosphorylation in mouse ES cells and this may be associated with increased 
growth and proliferation (Nguyen et al., 2007). This suggests that Gab1β, as it 
represses Erk in response to IGF, it is acting to restrict the growth of ES cells. 
In this next section, I investigated this hypothesis. In order to investigate the 
potential role of Gab1β in the growth of ES cells in response to insulin a 
clonal colony-forming assay was performed. In this experiment, cells were 
plated at very low density (300 cells/9.4 cm2 area) and allowed to grow for 5 
days in the presence or absence of 25 µg/ml insulin. The cells were then 
stained for AP. The undifferentiated state of ES cells is characterised by high 
level of expression of Alkaline Phosphatase (AP) (Pease et al., 1990). AP-
stained colonies were counted according to the intensity of staining, which 
was either none (AP negative), mild (AP partial) and strong (AP positive). 
This clonal colony-forming assay allows the analysis of a single stem cell’s 
potential to self-renew and propagate, by detecting clonal growth in the 
presence or absence of insulin. In other words, it examines the clonogenic 
potential of a single pluripotent ES cell.  
 
The medium used was a defined medium originally used to provide 
optimum cell viability and efficient neural differentiation (Ying and Smith, 
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2003). It is a mixed formulation of basal media and supplements called 
N2B27, and includes DMEM/F12 medium supplemented with modified N2, 
which contains insulin, apo-transferin, progesterone, putrescine and sodium 
selenite. This mixture is then supplemented with BSA combined with 
Neurobasal (Gibco) medium with added B27 (Gibco). Furthermore, in order 
to use this medium for ES cell maintenance, LIF, BMP and insulin were 
added. This medium was provided by Helen Murray and was used to 
observe the effects of insulin on the growth of Gab1β-targeted ES cells, in a 
defined environment without FBS supplementation. The cells were therefore 
stained for AP after being grown in the presence or absence of insulin for five 
days.  
 
Results show that across all cell lines used, the addition of insulin does not 
significantly increase the clonogenic potential of cells, as the number of AP 
positive cells does not change greatly when insulin is added to the cultures 
(Figure 3.24). Furthermore, though both Gab1β restored cell lines have a 
similar pattern, wildtype C1 +/+ cells gave rise to much fewer colonies, 
mainly the positive and partial ones. Furthermore, 26 -/- cells interestingly 
had much fewer AP colonies of all intensities, compared to both Gab1β 
restored cell lines, but less compared to C1 +/+ cells. This pattern did not 
match that of VC -/- cells (Gab1β -/- cells transfected with an empty vector), 
which had more AP positive cells compared to Gab1β restored cells, as well 
as C1 +/+ cells. Gab1α restored cells gave rise to the fewest colonies of all 
intensities compared to the other cell lines. This suggests that Gab1α may 
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Figure 3.24: The effect of insulin on the growth of Gab1β-targeted ES cells, Gab1a and Gab1β 
restored cells. Across all cell lines used, the addition of insulin does not significantly increase 
the clonogenic potential of cells, as the number of AP positive cells does not change when 
insulin is added. Although both Gab1β restored cell lines have a similar pattern, wildtype C1 
+/+ cells gave rise to much fewer colonies, mainly the positive and partial ones. 26 -/- cells 
had much fewer AP colonies of all intensities, compared to both Gab1β restored cell lines, 
but less compared to C1 +/+ cells. This pattern did not match that of VC -/- cells, which had 
more AP positive cells compared to Gab1β restored cells, as well as C1 +/+ cells. Gab1α 
restored cells gave rise to the fewest colonies of all intensities compared to the other cell 
lines.  
 
These results suggests that Gab1β, and its repression effect on Erk activation 
in response to IGF, does not have a role in the control of ES cell growth in 
response to insulin. This could be attributed to IGF and insulin having 
different effects, despite their similarities. Whilst there is receptor crosstalk, 
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the prevailing view is that the insulin receptor (IR) tends to regulate 
metabolic activities related to glucose and energy homeostasis, whilst the 
IGF receptor (IGF-1R) is mainly involved in regulation of cell proliferation, 
anti-apoptosis, differentiation and cell motility (Nguyen et al., 2007; Rother 

























In this chapter I aimed to characterise the biochemical potential of Gab1β in 
signalling pathways that are key to the maintenance of ES cell self-renewal, 
proliferation and pluripotency, namely the Shp2 and PI3K pathways. 
Published data suggests that the PH domain is crucial for the ability of 
Gab1α to function as an adaptor protein. It was therefore surprising to find 
that Gab1β is phosphorylated in response to LIF and FBS and that this leads 
to the formation of complexes with Shp2 and PI3K. Furthermore, despite the 
lack of this critical domain, Gab1β may potentiate Akt phosphorylation in 
response to FBS, but more importantly enhances Erk phosphorylation in 
response to LIF.  Furthermore, the lack of a PH domain did not interfere with 
the ability of Gab1β to repress Akt and Erk phosphorylation in response to 
IGF.  
 
An important question that arose early on was whether Gab1β actually had 
the ability to participate in the pathways in question as it lacked a domain 
that has been demonstrated to be crucial for its function. The PH domain has 
been shown to be critical for EGF-induced activation of Erk and PI3K in 
epithelial cells (Itoh et al., 2000). Furthermore, the Gab1α PH domain has 
been shown to be required for its tyrosine phosphorylation and association 
with Shp2 after insulin stimulation (Rocchi et al., 1998). As mentioned in the 
introduction of this chapter, most of the data points to the PH domain being 
a crucial component for Gab1α’s function as an adaptor protein. Therefore, it 
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was expected that the lack of the PH domain would not allow Gab1β to 
participate in signalling pathways. As it retains all other motifs and binding 
sites, it was hypothesised that it may act as a dominant negative antagonist 
that would be phosphorylated, bind and mislocalise proteins.  For example it 
could act as a sink for pro-differentiative factors, which would partially 
explain its abundance in ES cells. It therefore came as a surprise when we 
found that not only is Gab1β able to be phosphorylated in response to 
cytokine and growth factor stimulation, but this leads to an active complex 
with Shp2 and PI3K, thereby potentiating Erk and Akt phosphorylation 
downstream. Not only does this mean that Gab1β is a participant in 
pathways that are important for the maintenance of ES cells self-renewal and 
proliferation, but that it is a positive effector within them. What is intriguing, 
though, is that Gab1β potentiated the activation of Erk, a pro-differentiative 
factor, in response to LIF. There are two questions that arise from this 
finding. Firstly, why would an ES cell-associated protein potentiate the 
activation of a pro-differentiative factor? Secondly, why would it do so in 
response to LIF, the very factor that is crucial for the maintenance of ES cell 
self-renewal? 
 
The effect of the activation of Erk in response to LIF is still unknown in ES 
cells. As Erk has been shown to act as a pro-differentiative signal rather than 
contributing to self-renewal (Burdon et al., 1999b), one might hypothesise 
that the activation in response to LIF may be in charge of this effect. The 
addition of MEK inhibitors to growth medium for example has been shown 
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to promote self-renewal (Burdon et al., 1999a). Using the same inhibitors, the 
persistence of Oct4 positive cells increases during isolation of murine ES cells 
(Buehr and Smith, 2003). Furthermore, Shp2 mutant ES cells exhibit reduced 
LIF dependency compared to wildtype ES cells (Qu and Feng, 1998). This is 
supported by the fact that BMP4 has been shown to maintain self-renewal by 
inhibiting Erk (Qi et al., 2004). Therefore a model seems to be emerging, 
whereby the activation of Erk via Shp2 and in response to LIF does not 
contribute to self-renewal. Based on the data obtained in this chapter, where 
Gab1β may fit into this model has become clearer. The activation of the 
LIFR/gp130 dimer receptor in response to LIF recruits Shp2, where it 
associates with Gab1β, and this promotes the phosphorylation of Erk. Self-
renewal assays using Gab1β-targeted cells show that the lack of Gab1β does 
not have an effect on the self-renewal of the cells (Burdon T. unpublished). 
This supports the finding that Gab1β potentiates Erk in response to LIF. If 
Gab1β was involved in the maintenance of ES cell self-renewal, the 
potentiation of Erk in response to LIF would be contradictory. Therefore, it is 
the significance of LIF-induced ERK phosphorylation which is the key issue. 
Why does a cytokine required for the maintenance of ES cells activate a pro-
differentiative factor? Gab1β merely acts as an adaptor protein that 
potentiates this signalling pathway. LIF also activates Stat3, which is crucial 
for the self-renewal of ES cells (Niwa et al., 1998). Therefore, the efficiency of 
self-renewal is dependent on both the Stat3 and Erk signals activated 
downstream from the LIF receptor (Burdon et al., 1999a). The addition of 
MEK (and Gsk3) inhibitors to the growth medium of ES cells, can maintain 
self-renewal without the addition of LIF, BMP or serum (Ying et al., 2008). 
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This suggests that LIF-induced Stat3 activation may act to block Erk-induced 
differentiation of ES cells, and that the natural path for an ES cell, is for it to 
differentiate. Gab1β may be part of the natural differentiation pathway, and 
therefore is able to potentiate Erk activation in response to LIF.   
 
The effect of Gab1β on Erk activation could also have nothing to do with pro-
differentiative effects. Gab1β may also have a dominant negative role in the 
potentiation of ERK phosphorylation in response to LIF stimulation. It may 
act to mislocalise it in order to produce a different effect. Erk has been shown 
to translocate to the nucleus of cultured epithelial cells by binding to the Met 
Binding Domain (MBD) of Gab1α, which has a Nuclear Localisation 
Sequence (NLS) within its PH domain (Osawa et al., 2004). Gab1β could 
therefore bind activated Erk, after potentiating its phosphorylation, and then 
mislocalising it, due to the lack of a NLS in the N-terminal domain. This 
would therefore restrict Erk to the cytoplasm and inhibit its pro-
differentiative effects. This suggests that Gab1β could act to bind and 
mislocalise Erk and its pro-differentiative effects.  
 
Interestingly, the GRB2/MEK pathway has been shown to repress Nanog, in 
mouse ES cells (Hamazaki et al., 2006). As previously described, Nanog is a 
homeobox gene and a key intrinsic regulator of ES cells self-renewal. The 
MEK inhibitor PD98059 as well as GRB2 deficiency prevents the 
differentiation of mouse ES cells into primitive endoderm induced by Nanog 
repression. This suggests that Erk activation represses Nanog upon ES cell 
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differentiation into primitive endoderm and that Grb2 is required for this. 
Gab1β could take part in the repression of Nanog by potentiating Erk 
activation. Though not demonstrated, Gab1β is likely to require GRB2 in 
order to bind to Shp2 and enhance Erk activation. The abundance of Gab1β 
in ES cells does not mean that its potential role should be associated with 
self-renewal and pluripotency. ES cells must express proteins that are present 
in order to regulate their transitions into differentiated cells types. For 
example, UTF1 (undifferentiated embryonic cell transcription factor), a 
chromatin-associated protein, is involved in ES cell differentiation, and is not 
required for the self-renewal of the cells (van den Boom et al., 2007). Under 
the transcriptional control of Oct4, and despite its high abundance in ES cells, 
UTF1 is an example of a protein that is involved in ES cell differentiation. 
Therefore, Gab1β may act as an adaptor protein regulating the transition of 
ES cells into primitive endoderm by repressing Nanog via Erk 
phosphorylation. Experiments looking at the potential effect of Gab1β on the 
repression of Nanog would be very interesting. These could be done using 
Gab1β-targeted ES cells and checking whether the lack of Gab1β affected the 
transition into primitive endoderm induced by the repression of Nanog.  
 
Another example of a gene that is highly expressed in ES cells but is involved 
in their differentiation is the FGF4 gene (Kunath et al., 2007; Wilder et al., 
1997). FGF4 null ES cells are not affected in their ability to self-renew (Wilder 
et al., 1997). Although they are still able to differentiate, the growth and 
survival of the differentiated progeny is compromised. Furthermore, Erk 
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activation in response to FGF4 has been shown to trigger the transition of ES 
cells from self-renewal to lineage commitment (Kunath et al., 2007). In this 
study the authors demonstrated that Erk acts to promote the transition of ES 
cells into a state where they are responsive to pro-differentiative cues. Gab1β 
could participate in this Erk-induced transition by activating it in response to 
FGF4.  However, when FGF4 inductions were performed using Gab1β-
targeted ES cells, there was no difference in the levels of Erk activation upon 
induction (data not shown).  
 
As well as boosting Erk activity, Gab1β may also enhance Akt 
phosphorylation in response to FBS. The PI3K pathway is important for the 
maintenance of ES cell self-renewal. For example, a myristoylated, active 
form of Akt can maintain the undifferentiated phenotype in mouse ES cells, 
without the addition of LIF (Watanabe et al., 2006). Gab1β -/- cells, though, 
showed no effect on Akt activation in response to LIF. This suggests that 
Gab1β does not take part in the self-renewal effects mediated by LIF-induced 
Akt. This is supported by the fact that Gab1β -/- cells do not have impaired 
self-renewal (Burdon T., unpublished).  Even though BMP has been shown to 
replace the requirement for FBS in ES cells culture (Ying et al., 2003a), the fact 
that Gab1β does not affect self-renewal, despite the effect on Akt activation, 
suggests an alternative role. For example, Akt activation is involved in many 
other pathways that control the cell proliferation, growth and survival 
(Jirmanova et al., 2002; Sun et al., 1999; Takahashi et al., 2003). Indeed, Gab1β 
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-/- cells show a deficit in their growth during long-term competition assays 
(Burdon T., unpublished). 
 
Additionally, the lack of Gab1β does not seem to have an effect on the 
phosphorylation of GSK3β at serine 9. This can be attributed to the fact that 
FBS contains a myriad of growth factors that may have a varying effect on 
PI3K signalling and therefore any significant difference in GSK3β 
phosphorylation levels would be masked. Furthermore, this could be 
attributed to a potential maximum level of GSK3β activation. FBS clearly 
causes the phosphorylation of GSK3β but any significant difference is 
masked as the phosphorylation has reached its maximum. However, 
stimulation with FBS at a lower concentration may allow small differences to 
appear. Inductions with varying concentrations of FBS and at shorter 
timepoints may reveal subtle differences in GSK3β activation in the Gab1β-
targeted ES cells. Interestingly, however, despite the potential effect of Gab1β 
on the phosphorylation of serine 9 on Akt in response to FBS, GSK3β 
remained unaffected in Gab1β-deficient cells. This suggests that the true 
measure of PI3K activity is not as clear-cut. It may be that, depending on the 
receptor and the substrate, different branches of the PI3K pathway are 
activated, whilst others remain unaffected. It may be that the PI3K effectors 
are differentially activated by substrates in order to have alternative 




In this chapter I also aimed to characterise the potential role that Gab1β has 
in IGF signalling in ES cells. I showed that Gab1β represses both Akt and Erk 
phosphorylation in response to insulin. Additionally, as the overexpression 
of Gab1α also had the same repressive effects, Gab1β does not act in a 
dominant negative manner to mislocalise Gab1α effectors. Gab1β has an 
active inhibitory effect on IGF signalling. Furthermore, clonal assays showed 
that Gab1β does not have an effect on ES cell growth in response to varying 
amounts of insulin. 
 
Gab1α was originally described as an IRS1-like protein (Holgado-Madruga et 
al., 1996) and its involvement in insulin/IGF signalling has been 
demonstrated. For example, liver-specific Gab1α knockout mice show 
enhanced hepatic insulin sensitivity with reduced glycemia and improved 
glucose tolerance (Bard-Chapeau et al., 2005). This indicates that  Gab1α is a 
negative modulator of insulin signalling in the mouse liver. Gab1α was 
shown to repress Akt activation in response to insulin, via activation of Erk. 
The data presented in this chapter supports this repressive role for both 
Gab1α and Gab1β. Furthermore, Gab1α has been shown to be tyrosine 
phosphorylated by the insulin receptor to allow its association with PI3K and 
Shp2 (Rocchi et al., 1998). Gab1α is also capable of restoring the negative 
effects of IRS1 deletion in 3T3 fibroblasts (Winnay et al., 2000).  
 
Studies show that insulin and IGF1 stimulate the metabolism and growth of 
preimplantation embryos, but in ES cells little is known of the connection 
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between intracellular insulin signalling and cellular growth responses during 
development (Harvey and Kaye, 1992; Nguyen et al., 2007). In rabbit 
blastocysts, insulin has a growth effect by activating Erk and regulating 
GLUT4 transcription (Navarrete Santos et al., 2004). Whether there is a 
similar mechanism in mice is still unclear. IGF1 and insulin receptor 
activation leads to Erk phosphorylation in mouse ES cells and that this is 
associated with increased growth and proliferation (Nguyen et al., 2007; Ying 
et al., 2008). The fact that Gab1β represses Erk phosphorylation in response 
to IGF implies that Gab1β would actually act to restrict the growth of ES 
cells. Our data do not fully support this hypothesis, as Gab1β did not have an 
obvious effect on the growth of mouse ES cells in response to insulin.  
 
A recent report has suggested that IRS1 may regulate murine ES cell self-
renewal and its presence is critical for LIF-mediated self-renewal. Knocking 
down IRS1 by siRNA resulted in a severe reduction in Oct4 protein 
expression and that Akt and GSK3β phosphorylation were repressed (Rubin 
et al., 2007). The knock down also impaired the expression of Id proteins, 
which are known to inhibit differentiation in ES cells (Ying et al., 2003a). Our 
data suggests that Gab1β is not involved in this IRS-mediated positive effect 
on self-renewal, as Gab1β represses Akt activation in response to IGF. This 
would imply that Gab1β is not involved in the regulation of the self-renewal 
of ES cells. This is consistent with previous data that Gab1β is not involved in 
this process (Burdon T., unpublished) and that Gab1β promotes Erk 
phosphorylation in response to LIF (Figure 13). Though Gab1α has been 
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shown to be critical for insulin-stimulated Erk activation in the mouse liver, 
this was accompanied by a reduction in Akt phosphorylation (Bard-Chapeau 
et al., 2005). Gab1β also had a negative effect on Akt activation in response to 
IGF in ES cells. This suggests that in the liver, Gab1α acts to sensitise it to 
insulin and also at the biochemical level, acts to repress Akt activation. A 
similar role for Gab1β in ES cells is possible.  
The PH domain of Gab1α has been reported to be required for the 
association of the protein with Shp2 (Rocchi et al., 1998), and one would 
assume for the activation of Erk, after insulin stimulation. This implies that 
Gab1β is not able to activate Erk in response to insulin. Our data supports 
this and further suggests that Gab1β actually represses Erk phosphorylation 
in response to insulin. Therefore, Gab1β acts as a negative regulator of Erk 
activation in response to insulin. This shows that Gab1β is a multifunctional 
adaptor protein that, depending on the receptor type, can either act 
positively or negatively. For example, our data shows that in response to LIF, 
Gab1β promotes Erk phosphorylation, but in response to insulin, it represses 
it.  
 
The literature suggests that Gab1 proteins are truly multifunctional adaptor 
proteins which, depending on the receptor and cell type, act as potentiators 
or repressors. Our data supports this modularity and indicates that Gab1β 
may act as an activator and repressor of the same signalling pathways.  
Gab1β potentiates Erk, and potentially Akt, in response to LIF, but acts as a 
repressor of Erk and Akt in response to insulin signalling. The potentiation of 
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ERK activation by Gab1β in response to LIF may translate into Gab1β having 
a role in either balancing the contradictory signals of Stat3 and Erk, or in 
promoting the differentiation of ES cells. The repression of Erk activation in 
response to insulin is likely not to translate into an effect on the growth of the 
ES cells. Though clear conclusions cant be made about the functional 
meaning of these contradictory effects of Gab1β, what is clear is that Gab1β 
adapts the signalling responses of many other receptors and therefore in 
order to obtain a complete “signalling picture” all the pathways that Gab1β 
takes part in must be investigated. This, is beyond the scope of this 


















Gab1β is ES cell-associated and lacks an important structural component, the 
PH domain. The PH (Pleckstrin homology) domain was first identified as a 
100-120 residue stretch of amino acid-sequence similarity that occurs twice in 
pleckstrin (the major PKC substrate in platelets) and is found in numerous 
other proteins with membrane-associated functions (Haslam et al., 1993). PH 
domains recognise membranes in a target-specific manner (Lemmon and 
Ferguson, 2000). They recognise a membrane component and then bind to 
them. They are also the most common domain in the human genome and are 
best known for their ability to target cellular membranes by binding 
specifically to phosphoinositides (Lemmon, 2004). There are common 
structural similarities between the PH domain and lipid-binding proteins, 
which allow the PH domain to target cellular membranes.  
 
Most PH domains bind to phosphoinositides, and some have been shown to 
drive membrane tranlsocation of their host proteins through specific, high-
affinity recognition of phosphoinositides head groups (Kavran et al., 1998). 
More specifically, PH domains are well known effectors of the lipid second 
messengers PtdIns(3,4,5)P3 (PIP3 or phosphatidylinositol triphosphate) and 
PtdIns(3,4)P2 (PIP2 or phsophatidylinositol diphospate), which are generated 
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transiently upon activation of almost all cell surface receptors (Cantley, 2002; 
Lemmon, 2008). Interestingly, a PH domain that recognises only PIP3 will be 
recruited transiently to the plasma membrane, whilst one that binds to both 
PIP3 and PIP2 will remain membrane associated for longer (Ferguson et al., 
2000). Whether the PH domain of a protein recognises PIP3 only or both PIP3 
and PIP2, will therefore have a significant impact on the time course of its 
response to PI3K activation (Ferguson et al., 2000). The PH domain of Akt 
specifically recognises one or both of these second messengers with high 
affinity and specificity (Lemmon, 2004). This takes place in response to 
receptor-induced recruitment of PI3K to the plasma membrane (Gold et al., 
2000). This allows PI3K to phosphorylate phospshoinositides and results in 
the production of novel phospholipids, which are present at very low levels 
before receptor engagement (Gold et al., 2000). PI3K phosphorylates PIP2, 
and this in turn yields PIP3 (Stephens et al., 1991). Both PIP3 and PIP2 
function as second messengers by acting as ligands for the PH domains that 
are found in a number of cytosolic signalling proteins (Toker and Cantley, 
1997). PIP3 and PIP2 can therefore recruit PH domain-containing proteins, 
such as Akt, to regions of the plasma membrane to which PI3K has been 
recruited (Gold et al., 2000). Akt is a serine threonine kinase, which is defined 
by an NH2-terminal regulatory domain of protein-protein interactions that 
contains the PH domain (Bos, 1995; Downward, 1995). The activity of a 
protein with a point mutation of Arg to Cys in the Akt PH domain is not 
significantly increased by PDGF treatment or by expression of an activated 
form of PI3K (Franke et al., 1997). This establishes the PH domain of Akt as 
an important structural feature for the function of Akt and its activity in 
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response to PDGF and PI3K. Furthermore, a PH domain-GFP fusion protein 
is predominantly cytosolic in unstimulated cells, but undergoes a transient 
relocalisation to the plasma membrane upon signal-dependent activation of 
PI3K (Lemmon, 2008; Varnai and Balla, 2006; Venkateswarlu et al., 1998). 
Another protein whose PH domain has been shown to be crucial for its 
localisation is Arno, a member of the family of guanine nucleotide exchange 
factor for ARFs (Adipose Ribosylation Factors) (Donaldson and Klausner, 
1994; Venkateswarlu et al., 1998). When Arno is tagged with GFP, it has been 
shown to localise exclusively in the cytoplasm of 3T3 L1 adipocytes. 
Stimulation with insulin, however causes a rapid PH domain-dependent 
translocation to the plasma membrane (Venkateswarlu et al., 1998).  
 
The Gab1α PH domain is located at the NH2 terminal of the protein and is 
the most conserved structural element among Gab family members (Nishida 
and Hirano, 2003). The PH domain of Gab1α has been shown to contain a 
conserved motif, which has been used to predict high-affinity binding of a 
subset of PH domains to PI3K products such as PIP2 and PIP3 (Isakoff et al., 
1998). This binding was shown in an in vivo assay in yeast. Using a GFP-
Gab1α PH domain fusion strategy, the PH domain was shown to specifically 
bind to PIP3 (Rodrigues et al., 2000), which then leads to the membrane 
recruitment of Gab1α in response to EGF stimulation. Furthermore, the 
Gab1α PH domain has been shown to be essential for the targeting of Gab1α 
to the proximity of the cellular membrane at sites of cell-cell contact in 
MDCK cells (Maroun et al., 1999a), which is dependent on the provision of 
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PIP3 by PI3K as an anchor for Gab1α. Interestingly, overexpression of the 
p110 and p85 subunits of PI3K (Klippel et al., 1994), which causes elevated 
PI3K activity in the absence of external stimulation, induces the translocation 
of Gab1α from the cytosol to the membrane in cells maintained at low serum 
concentrations (Maroun et al., 1999b).  
 
Within the PH domain, a putative NLS (Nuclear Localisation Sequence) has 
been observed in the Gab1α sequence, at amino acids 15-23 (Osawa et al., 
2004). An NLS has been classically defined as an amino acid sequence motif 
that is both necessary and sufficient for transport of the protein to the 
nucleus (Terry et al., 2007). Eukaryotic cells are characterised by distinct 
nuclear and cytoplasmic compartments that are separated by the nuclear 
envelope, a double membrane that is continuous with the endoplasmic 
reticulum (ER). The nuclear envelope is penetrated by nuclear pore 
complexes (NPCs), which allow exchange of macromolecules between the 
two compartments (Gorlich and Kutay, 1999). The NPCs of the nuclear 
membrane essentially act as stations of intercomminucation between the 
cytoplasm and the nucleus (Sorokin et al., 2007). The NPC consists of about 
30 different proteins, called nucleoporins (Rout and Aitchison, 2000), and 
forms a channel and regulates the nucleocytoplasmic transport of RNA and 
proteins (King et al., 2006; Suntharalingam and Wente, 2003). As the NPC 
acts as an entry/exit station in/out of the nucleus (Rout et al., 2000), they 
allow the passive diffusion of ions and small molecules through aqueous 
channels with a diameter of 9nm (Paine et al., 1975), whilst they are >60MD 
macromolecular structures themselves (Cronshaw et al., 2002; Rout et al., 
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2000). Though passive movement can take place, the translocation of cargoes 
larger than 40kDa generally requires specific transport receptors (Fried and 
Kutay, 2003; Pante and Kann, 2002; Terry et al., 2007). Therefore, 
nucleocytoplasmic transport depends on the interplay between soluble 
transport factors, their cargoes and the NPC. It is a set of proteins called 
karyopherins (kaps, also known as importins/exportins) which bind to 
specific import or export signals and mediate substrate docking to the NPC 
(Rout and Aitchison, 2000). An example of an import signal is the NLS of 
Gab1α, which allows the translocation of the protein from the cytoplasm into 
the nucleus. Not much is known about the role of Gab1α in the nucleus. Data 
suggests that Gab1α may be responsible for the transport of other proteins 
that are too large to passively diffuse into the nucleus and lack an NLS of 
their own. An example of such a protein is the MAPK Erk (Osawa et al., 
2004). In this study, the authors hypothesised that Gab1α facilitates the 
translocation of Erk to the nucleus. Erk nuclear translocation is required in 
order for it to activate transcription factors such as ETS-like transcription 
factor-1 and EGR1 (Early Growth response factor 1) (Kaufmann et al., 2001). 
This takes place in response to endothelial cell migration during wound 
repair after arterial injury (Osawa et al., 2004) (Khachigian et al., 1996; 
Santiago et al., 1999). The lack of an NLS as well as the 40-50kDa size of Erk 
suggested that Erk would require another protein that would mediate its 
translocation. The potential role of Gab1α in this process is supported by 
data that suggests that activated Erk interacts with Gab1α (Roshan et al., 
1999). In this study, using GST-tagged MBD and Gab1α, the authors 
demonstrated that the MBD domain of Gab1α associates with 
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phosphorylated Erk2 and more weakly with Erk1. Therefore, as Gab1α can 
associate with phosphorylated Erk, it seems plausible that the NLS of Gab1α 
can act as a nuclear translocator of other proteins that associate with it. 
 
The aim of this chapter is to determine the localisation of Gab1β within ES 
cells and to see whether the lack of a PH domain and an NLS affects this. 
This was done by, transfecting EGFP-tagged Gab1α or Gab1β into both 
fibroblasts and Gab1β -/- cells, and observing the movement of the proteins 





















4.2.1 Construction of Gab1-EGFP fusion vectors 
 
The lack of a Gab1β-specific antibody meant that I was unable to specifically 
stain ES cells for Gab1β without also detecting Gab1α. Therefore, a cloning 
strategy was devised, whereby Gab1β was specifically tagged with EGFP. 
The cloning strategy relied upon the availability of an expression vector 
which contained the Gab1α or Gab1β cDNA under the control of a strong 
promoter. The vector used to clone EGFP into as a fusion to the Gab1 cDNA, 
was called pCAGIP-Gab1 (previously generated in the laboratory by T. 
Burdon and L. Sutherland) (Figure 4.1a). This vector had many advantages. 
The CAG promoter is a strong and ubiquitous promoter and has been shown 
to produce high levels of expression both in vivo and in vitro (Alexopoulou et 
al., 2008; Niwa et al., 2000). The vector also contained a polyoma virus origin 
of replication, PYori, which, upon interaction with the T antigen, allows 
efficient replication of incoming plasmids (Jackson et al., 2002). This episomal 
expression construct contains a polyoma virus origin of replication, which 
can be transfected into E14/T ES cells. These cells stably express the polyoma 
large T antigen and the interaction of the large T antigen with the polyoma 
origin of replication allows efficient episomal propagation of incoming 
plasmids. This system has high transfection efficiencies (supertransfection), 
and high levels of expression can be achieved and maintained (Jackson et al., 
2002). The SV40ori is similar to the PYori in that it also bypasses cellular 
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controls on replication and exhibits uncontrolled, high-level replication in 
permissive cells (Chittenden et al., 1991). Plasmids containing the SV40 
origin of replication are rapidly amplified when transfected into COS7 cells 
(Gluzman, 1981). COS7 cells constitutively express SV40 large T antigen, the 
only viral protein required for SV40 replication (Chittenden et al., 1991). The 
IRES (Internal Ribosome Entry Site) is a cis-acting element that recruits the 
small ribosomal subunits to an internal initiator codon in the mRNA, thereby 
promoting the internal initiation of translation of RNA (Martinez-Salas, 
1999). The use of bicistronic expression vectors in which the first gene is 
translated in a cap-dependent manner, Gab1 in our case, and the second one, 
puromycin resistance gene in our case, in an IRES-dependent manner, allows 
improved efficiency of selection during transgenesis (Martinez-Salas, 1999). 
This system ensures that over 90% of cells expressing the selectable marker 
should also express the gene of interest, Gab1 (Martinez-Salas, 1999).  
 
This vector was used as a basic backbone in which EGFP was cloned into as a 
fusion to Gab1α or Gab1β. Three variations of this EGFP-Gab1 vector were 
made. In the first simple variation (Figure 4.1b), EGFP was cloned into a 
Not1 restriction site at the N-terminal of Gab1. In the second variation 
(Figure 4.1c), EGFP was again cloned into the same NotI restriction site, with 
an added polyglycine linker, consisting of 6 consecutive glycines. This 
glycine linker served to connect EGFP and Gab1 in a flexible manner. The 
presence of a linker allows for the proper folding of the fusion protein, which 
in turn is important for the function. Glycine-rich linkers are more flexible 
than non-glycine linkers, because the absence of a β-carbon permits the 
 
 138 
polypeptide backbone to access dihedral angles that are energetically 
forbidden for other amino acids (Ramachandran and Sasisekharan, 1968). 
Too much linker flexibility however, has been shown to be detrimental to 
single-chain protein stability (Robinson and Sauer, 1998).  In the third version 
(Figure 35d), EGFP was cloned into an XhoI restriction site at the C-terminal 
end of Gab1α or Gab1β with a polyglycine linker separating the two.  
 
 
Figure 4.1: Gab1-EGFP fusion strategy. a) pYCAGIP backbone vector contained Gab1 cDNA 
under the control of a strong CAG promoter, along with an IRES element, puromycine 
resistance gene, SV40ori and PYori. b) pEGFP-GAB1 vector: EGFP was cloned into NotI 
resitriction site, fused to Gab1. c) pEGFP-GLY6-GAB1 vector: EGFP was cloned into the same 
NotI site as before but with a polyglycine linker separating it and Gab1. d) pGAB1-GLY6-
EGFP: EGFP was cloned into an XhoI site at the C-terminal of Gab1 along with a polyglycine 
linker separating it and Gab1. 
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4.2.2 Expression of Gab1 fusion proteins in COS7 cells 
 
These six variations of the basic vector (3 for Gab1α and 3 for Gab1β) were 
transiently transfected initially into COS7 cells, which constitutively express 
the SV40 large T antigen, the only viral protein required for SV40 replication 
(Chittenden et al., 1991) which allow high levels of plasmid replication. Once 
transfected, images of the cells were taken under UV fluorescence to see 
whether an EGFP-positive protein could be detected (Figure 4.2). Cells were 
also transfected with non-EGFP myc-tagged Gab1α or Gab1β. These acted as 
controls once the transfected cells were lysed for protein and run on a 
Western blot (Figure 4.4). COS7 cells were also transfected with an EGFP 
control plasmid which was constructed in the same way as the first fusion 
plasmid (Figure 4.3) but with a couple of extra amino acids between EGFP 
and Gab1β, which rendered Gab1β cDNA out of frame, and therefore no 
Gab1β protein was transcribed. The cells were then lysed for protein, which 
was then analysed on a Western blot probed for Gab1 protein using a Gab1-
specific antibody (Figure 4.4). The fluorescent images (Figure 36) show that 
all six fusion plasmids produce a green fluorescent protein. Furthermore, the 
Western blot demonstrates that the fusion plasmids also give rise to Gab1a or 
Gab1β protein, of a larger size than the Gab1α-myc and Gab1β-myc proteins 
respectively. This is due to the fusion of the proteins with EGFP, which has a 
size of ~30kDa. Gab1α and Gab1β fluorescent proteins were predominantly 
restricted in the cytoplasm of the ES cells, unlike the EGFP protein, which 
was expressed in the cytoplasm and nucleus. This suggests that the presence 









Figure 4.3: EGFP control vector transfection of COS7 cells. COS7 cells were transfected with 
plasmids containing EGFP alone, or myc-tagged Gab1α and Gab1β, containing no EGFP. 
The control cells were transfected with lipofectamine alone with no plasmid.  
 
 
Figure 4.4: Expression of fusion proteins in COS7 cells. Transiently tasnected COS7 cells 
were lysed and their protein was analysed on a Western blot probed with aGab1 antibody, 
which detects both Gab1α and Gab1β. All vectors gave rise to a fusion protein which was 
larger than the untagged protein, as indicated by the migration on the blot.  
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4.2.3 Gab1-EGFP localisation in 10T1/2 fibroblasts 
 
Prior to investigating the localisation of Gab1β in ES cells, I investigated its 
transient localisation in 10T1/2 fibroblasts. The latter cells have a much 
larger cytoplasm compared to ES cells, which would potentially allow the 
visualisation of any change in the localisation of the fluorescent proteins. The 
vectors chosen to perform this experiment with were the plasmids EGFP-
Gab1α and EGFP-Gab1β. They were chosen as they gave rise to the brightest 
fluorescent fusion proteins out of all 3 variations of the plasmid.  The two 
plasmids were transiently transfected into 10T1/2 fibroblast cells using 
Lipofectamine 2000 (Invitrogen). The cells were either left to transfect for 4 
hours or overnight. Lipofectamine 2000 is recommended to be left on cells for 
a minimum of 4 hours, but longer should increase the number of positive 
transfectants according to the manufacturer. Longer periods of transfection 
with Lipofectamine 2000, however, is known to be toxic to the cells (Corsi et 
al., 2003; Green et al., 2008). The medium was then changed to normal 
growth medium for around 1 hour and then the cells were starved of all 
growth factors and cytokines for 3 hours. Then, the cells were induced with 
either 1000 units/ml LIF or 1µl/ml FBS. Images were then taken at 10 and 60 
minutes in order to observe the localisation of the tagged proteins, and their 





Figure 4.5: EGFP-Gab1α and EGFP-Gab1β transient expression in 10T1/2 fibroblast cells 
after 4-hour transfection. Cells were induced with 1000units/ml LIF or 10% FBS for 10 and 
60  minutes.  
 
After the 4-hour transfection, the fusion proteins were clearly expressed in 
the cytoplasm of the fibroblasts (Figure 4.5). Upon induction, however, the 
expression pattern of neither fusion protein changed. Though EGFP-Gab1β 
fusion protein does not have a NLS, EGFP-Gab1α does, and therefore would 
be expected to enter the nucleus upon stimulation. This suggests that the 
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proteins may not be fully functional, and therefore cannot react to the 
stimulation. After the overnight transfection, a similar pattern emerged 
(Figures 4.6 & 4.7). In uninduced conditions, the fusion proteins were 
localised in the cytoplasms and some nuclei of the fibroblasts, in contrast to 
the EGFP protein alone (Figure 4.6c), which was expressed in the whole 
fibroblast. This suggests that the addition of either Gab1α or Gab1β to EGFP 
restricts it to the cytoplasm. No change in localisation was observed for 
either fusion protein after LIF stimulation (Figure 4.6). After 10 and 60 
minutes of FBS induction, EGFP-Gab1α expression was observed in the 
whole fibroblast. This was also the case for EGFP-Gab1β after 60 minutes of 
FBS stimulation. This is somewhat surprising as Gab1β lacks a NLS, it should 
not be able to translocate to the nucleus. Furthermore, in the uninduced cells 
of these transfections, there were cells which also exhibited fluorescence in 
their nuclei. This suggests that what was observed may have been a result of 
the harsh toxic effects of Lipofectamine. When the experiment was repeated, 
no change in localisation was observed for either EGFP-Gab1α, or EGF-
Gab1β (Figure 4.7). These data suggest that the localisation of the fusion 
Gab1β protein is not affected by the lack of a PH domain or NLS. Whether 
this is due to EGFP affecting the localisation of the fusion Gab1β, or whether 
the localisation of Gab1 proteins is not affected by the absence of the PH 
domain, is still unclear. These observations, however, do not necessarily 
mean that the fusion proteins are not biochemically functional. They may 




Figure 4.6: EGFP-Gab1α and EGFP-Gab1β transient expression in 10T1/2 fibroblasts. EGFP-
Gab1α localised to the whole of the cell in response to LIF after 10 minutes, as well as in 
response to FBS. EGFP-Gab1β was expressed in the whole fibroblast after 60 minutes of FBS 







Figure 4.7: EGFP-Gab1α and EGFP-Gab1β transient expression in 10T1/2 fibroblasts. There 








4.2.4 Gab1 localisation in ES cells 
 
4.2.4.1  Fusion protein expression and localisation in ES cells 
 
The six fusion plasmids (Figure 4.1) were stably transfected into Gab1β -/- 
ES cells using Lipofectamine 2000. Cells were transfected overnight with 
lipofectamine in a well of a 6-well dish with 5µg DNA. The next day, the cells 
were split into 2x10cm2 dishes (3/4 and 1/4) and allowed to grow overnight. 
The day after the medium was changed to a medium containing 150 µg/ml 
of puromycin. The medium was then changed every 2 days until colonies 
were big enough to pick and transfer to 24-well plates. Once propagated, 
transfected cells were then moved to wells of a 6-well dish from which they 
were frozen down. The expression of the fusion proteins was confirmed by 
Western blot (Figure 4.8). Cell lysates were obtained from all 6 fusion 
plasmid transfections and analysed on a Western blot probed with a Gab1-
specific antibody. 
 
One clone from each fusion plasmid transfection was plated and fluorescent 
images were taken in order to detect the expression of the EGFP fusion 
protein (Figure 4.9). The fluorescent proteins seem to be restricted in the 
cytoplasm of the ES cells, whether they are fused to Gab1α or Gab1β (Figure 
4.9a). This is in stark contrast to the EGFP protein without a fused Gab1 
protein, which is expressed in the whole of the ES cell, including the 





Figure 4.8: Expression of Gab1β fusion proteins in Gab1β -/- cells. Lysates were analysed on 
Western blots probed with aGab1 and aSHP2 antibodies.   
 
More specifically, the variation of the fusion protein where EGFP was 
directly fused to the N-terminal of Gab1α or Gab1β, was localised diffusely 
in the cytoplasm of the cells. EGFP-Gab1β was brighter compared to EGFP-
Gab1α. This may be due to differences in amounts of protein rather than 
intensity of fluorescence. The second variation of the fusion proteins, where 
EGFP was fused to the N-terminal of the Gab1 proteins linked by a 
polyglycine linker, also gave a similar pattern. Both EGFP-GLY6-Gab1α and 
EGFP-GLY6-Gab1β were restricted in the cytoplasm of the cells. Similarly to 
the first variants, EGFP-GLY6-Gab1β seemed brighter compared to EGFP-
GLY6-Gab1α. Interestingly, EGFP-GLY6-Gab1β was also expressed in a body 









Figure 4.9b: Expression of EGFP alone in Gab1β -/- cells. The fluorescent EGFP protein is 
expressed in the whole are of the cells. The control cells were transfected with an empty vector 
CAG-IP.  
 
In the cells expressing the third variant of the fusion proteins, where EGFP was 
linked to the C-terminal of the Gab1 proteins via a polyglycine linker, Gab1α-
GLY6-EGFP and Gab1β-GLY6-EGFP showed very distinct patterns of 
expression. Firstly, Gab1α-GLY6-EGFP was not as bright compared to the other 
Gab1α fusion proteins, but was still retained in the cytoplasm of the cells. 
Gab1β-GLY6-EGFP, however, had a very different expression pattern compared 
to the other Gab1β fusion proteins. It seemed restricted to the membranes of the 
cells, rather than expressed diffusely in the cytoplasm. Furthermore, like EGFP-
GLY6-Gab1β, it was also expressed in a small body in or near the nucleus. 
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Interestingly, unlike EGFP-GLY6-Gab1β, this body appeared in the majority of 
cells. In order to investigate the expression of these fusion proteins in this 
distinct body, GAB1β-GLY6-EGFP, EGFP-GLY6-GAB1β and EGFP-GLY6-GAB1α 
cell lines were fixed in 4% paraformaldehyde for confocal imaging after 
induction with FBS and LIF. In unstimulated cells Gab1β-GLY6-EGFP was 
restricted to the membranes of the cells, as well as the distinct body near the 
nucleus (Figure 4.10, upper panel). Upon stimulation with LIF+FBS, the 
expression of the fusion protein was more distinct and slightly brighter at the 
membranes at points of cell to cell contact. This effect was more pronounced 
upon stimulation with LIF alone, whereby the fusion protein was distinctly 
localised at points of cell to cell contact. The EGFP-GLY6-Gab1β fusion protein 
in unstimulated cells, was expressed diffusely in the cytoplasm of the cells 
(Figure 4.10, middle panel). There were some cells that also expressed the 
fusion protein in this distinct body near the nucleus. Upon stimulation with 
LIF+FBS, the expression of the protein was slightly more distinct. Upon LIF 
stimulation, this distinct expression, potentially at the membrane, was more 
pronounced, and potentially at points of cell to cell contact. In comparison to 
Gab1β-GLY6-EGFP, which was expressed in the distinct body in the majority of 
cells, EGFP-GLY6-Gab1β  was only expressed in the body of some cells. In the 
case of EGFP-GLY6-Gab1α, in unstimulated cells, the fusion protein was 
expressed diffusely throughout the cytoplasm (Figure 44, lower panel). Upon 
stimulation with LIF+FBS, EGFP-GLY6-Gab1α expression was more distinct, 
specifically at the membrane of the cells. Interestingly, EGFP-GLY6-Gab1α was 






Figure 4.10: Expression of Gab1β-GLY6-EGFP, EGFP-GLY6-Gab1β and EGFP-GLY6-Gab1α in 
Gab1β -/- cells stimulated with FBS and/or LIF. Cells were induced with either 100 units/ml 






4.2.4.2  Immunohistochemical detection of Gab1β  expression in ES cells 
 
By tagging Gab1 proteins with EGFP, the lack of a PH domain and NLS in 
Gab1β did not alter the localisation compared to that of Gab1α. The data 
suggests that the fusion proteins are restricted in the cytoplasm due to the 
presence of Gab1. However, the three different variants of the fusion plasmids 
gave rise to proteins that were differentially expressed in transiently and stably 
transfected cells. Namely, EGFP-GLY6-Gab1β and Gab1β-GLY6-EGFP were 
similarly expressed in a distinct body near or perhaps within the nucleus of the 
cells. Their localisation at the membrane, however, was different. Gab1β-GLY6-
EGFP was localised distinctly at the membrane, whilst EGFP-GLY6-Gab1β was 
more diffuse along the membrane and the cytoplasm. The third variant, EGFP-
Gab1β was not expressed in the perinuclear body, but its expression was still 
restricted in the cytoplasm of the cells. Therefore, in order to confirm which 
pattern of expression represents the real Gab1β pattern, immunohistochemical 
staining was performed on wildtype ES cells (C1 +/+), as well as Gab1β -/- 
cells overexpressing Gab1β (Gab1β restored cells). 500,000 cells per 1.9 cm2 well 
of a 4-well plate were plated and allowed to grow overnight.  The next day cells 
were fixed in 4% PFA and stained using a Gab1-specific antibody, which detects 
both Gab1α and Gab1β. After being stained with the appropriate secondary 
antibody and DAPI, which stains the nucleus, images were taken. Similar 
patterns of expression emerged when both cell lines were stained for Gab1. 
Gab1 was expressed distinctly at the cell membrane, in a distinct body near or 
within the nucleus as well as diffusely in the nucleus itself (Figure 4.11). 
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Importantly, this antibody detected both Gab1α and Gab1β protein expression, 
and therefore the nuclear staining may be due to the small amount of Gab1α 
protein expressed in ES cells. This was confirmed when Gab1 protein 
expression was compared in Gab1β +/+ and -/- cells (Figure 4.12).     
 
In order to compare the expression pattern of Gab1 to the pattern of the 
previously generated EGFP-tagged Gab1 expressing cell lines, the same staining 
protocol was performed using EGFP-Gab1β, EGFP-GLY6-Gab1β and Gab1β-
GLY6-EGFP cell lines. EGFP-Gab1β was, as previously shown in Figure 4.9a, 
expressed diffusely in the cytoplasm of the cell, as seen by both 
immunohistochemical staining (TRITC), as well as by the fluorescent expression 
of the EGFP-tagged protein (Figure 4.13, upper panel). A similar pattern was 
observed with EGFP-GLY6-Gab1β, but this fusion protein was also expressed in 
this distinct body near the nucleus (Figure 4.13, middle panel). At this point, it 
is not yet clear whether the fusion protein is expressed in the nucleus. Any 
nuclear expression however, is likely to be attributed to the little Gab1α 
expression in the cells. In the case of the third fusion protein, Gab1β-GLY6-
EGFP, expression was observed at the cell membrane as well as in the body 
near the nucleus (Figure 4.13, lower panel). In contrast to the other two fusion 
protein variants, and as observed previously, Gab1β-GLY6-EGFP is not 







Figure 4.11: Gab1β wildtype ES cells stained for Gab1. Gab1β wildtype C1 and Gab1β restored cells, using a Gab1-specific antibody, which detects both 




Figure 4.12: Comparison of Gab1 expression in Gab1β +/+ and -/- cells. Gab1β wildtype C1 and Gab1β restored cells, using a Gab1-specific antibody, 




Figure 4.13: Expression of fusion proteins in ES cells. EGFP-Gab1β, EGFP-GLY6-Gab1β and Gab1β-GLY6-EGFP  cell lines were stained using a Gab1-
specific antibody, which detects both Gab1α and Gab1β. EGFP-Gab1β and EGFP-GLY6-Gab1β are expressed diffusely in the cytoplasm. Gab1β-GLY6-




Figure 4.14: Expression of Gab1α in ES cells. Gab1β -/- cells expressing EGFP or Gab1α were stained for Gab1. Gab1α is expressed diffusely in the 
cytoplasm and nucleus of the cells. Gab1α is clearly expressed in Gab1β -/- cells as well.  
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EGFP-expressing cells and Gab1β -/- cells overexpressing Gab1α (Gab1α 
restored) were also stained for Gab1. The results indicate that a Gab1 protein 
is expressed in Gab1β -/- cells expressing EGFP, as well as Gab1β -/- cells 
(Figure 4.14). This suggests that ES cells express a small amount of Gab1α 
protein, which is spread diffusely in both the cytoplasm and nucleus of ES 
cells. The same expression pattern was observed for Gab1α restored cells. 
Gab1α expression was detected in the whole of the cell, including the 
nucleus.  
 
4.2.4.3  Movement of Gab1 proteins in ES cells 
 
What has been demonstrated so far using the EGFP-tagged Gab1 proteins is 
that Gab1 expression is restricted in the cytoplasm and is not localised in the 
nucleus of ES cells under normal culture conditions. Furthermore, tagging 
Gab1β at different termini with EGFP affects the expression pattern. The data 
demonstrated that the third variant, where EGFP was fused to the C-terminal 
of Gab1β via a polyglycine linker, exhibited an expression pattern similar to 
that of wildtype Gab1β in ES cells. Gab1β is expressed distinctly at the 
membrane of the cell as well as in a distinct body near or potentially within 
the nucleus. In order to determine the role of the PH domain and NLS in 
determining Gab1β localisation, induction experiments were performed as 
previously described in Section 4.2.3. 500,000 cells per 1.9cm2 well were 
plated and allowed to grow overnight. The next day, cells were induced with 
a combination of 100 units/ml LIF and 10% FBS for 10 minutes. Gab1β 
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wildtype cells (C1 +/+), Gab1β overexpressing Gab1β knockout cells (Gab1β 
restored +/+) as well as the three stable cell lines expressing the three 
variations of the EGFP-tagged Gab1β, were used in this experiment. Gab1β 
knockout cells expressing either EGFP or Gab1α, were also used. Similar 
expression patterns were observed in C1 +/+ (Figure 4.15), Gab1β restored 
+/+ (Figure 4.16) and Gab1β-GLY6-EGFP expressing (Figure 4.17) cells. 
Although the antibody recognises both Gab1α and Gab1β proteins, the 
amount of Gab1α expressed in ES cells is minimal. Therefore any staining 
would be expected to be attributed mainly to Gab1β expression. In 
uninduced cells, Gab1β was expressed distinctly at the membrane as well as 
in a distinct body near the nucleus. It is clear form the merged images that 
this body is not within the nucleus as the Gab1β staining does not match that 
of DAPI. This suggests that there is a highly specific region near the nucleus 
of ES cells where Gab1β is localised. Upon induction, the expression within 
this body does not change. However, Gab1β expression seems much more 
diffuse within the cytoplasm compared to uninduced cells. The membranes 
are not so distinctly stained, and some expression is also detected in the 
nuclei, as indicted by the merged images of all 3 cell lines. This however, 
could be attributed to the detection of endogenous Gab1α expression within 
these cells. The change in localisation of Gab1β could either be attributed to 
the movement of Gab1β or indeed to a change in the shape of the cells. 
Under serum-starvation conditions, ES cells tend to round up and tighten up. 
The addition of serum during the induction period may lead to an acute 
effect on the cell shape and therefore, what we are actually seeing is a 
redistribution of internal Gab1β during this cell shape change.  
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In unstimulated EGFP-GLY6-Gab1β expressing cells, Gab1 was expressed 
diffusely in the cytoplasm, unlike the three aforementioned cell lines (Figure 
4.18). The membranes were not distinctly stained, but expression was 
detected in a similar body near the nucleus. Upon induction the expression 
pattern did not change significantly, and there was little to no expression in 
the nuclei. EGFP-Gab1β expressing cells exhibited a similar pattern to that 
observed previously in Figure 4.9a (Figure 4.19). There was no change in the 
expression pattern upon stimulation of the cells. Gab1 expression was 
detected diffusely in the cytoplasm of the cells. In some cells, under both 
conditions, expression was detected in a body near the nucleus. Gab1α-
overexpressing Gab1β knockout cells (Gab1α restored) exhibited a similar 
change in expression pattern compared to Gab1β (Figure 4.20). Gab1α was 
localised in the perinuclear body of few cells in both stimulated and 
unstimulated conditions. Upon stimulation, Gab1α was localised more 
diffusely in the cytoplasm of the cells, compared to unstimulated cells. The 
protein was also expressed in the nuclei of some cells upon stimulation. 
EGFP-expressing Gab1β -/- cells had a distinct pattern of expression 
compared to all other cell lines. Gab1α expression was detected in the whole 
cell, including the nucleus (Figure 4.21). In theory, this expression pattern 
should be similar to that of Gab1α restored cells. This was not the case, and 
in conjunction with the fact that the pattern is very similar to that of EGFP 
(Figure 4.14, upper panel), this can probably be attributed to background 




Figure 4.15: Localisation of Gab1 in ES cells. Gab1β wildtype C1 cells were induced for 10 minutes with 100 units/ml LIF combined with 10% FBS, fixed 




Figure 4.16: Localisation of Gab1 in ES cells. Gab1β restored cells were induced for 10 minutes with 100 units/ml LIF combined with 10% FBS, fixed 





Figure 4.17: Expression of Gab1β-GLY6-EGFP in ES cells. Gab1β-GLY6-EGFP cells were induced for 10 minutes with 100 units/ml LIF combined with 
10% FBS, fixed and then stained for Gab1 using a Gab1-specifc antibody. Upon induction, Gab1 protein expression was more diffuse in the cytoplasm 




Figure 4.18: Expression of EGFP-GLY6-Gab1β in ES cells. EGFP-GLY6-Gab1β cells were induced for 10 minutes with 100 units/ml LIF combined with 




Figure 4.19: Expression of EGFP-Gab1β in ES cells. EGFP-Gab1β cells were induced for 10 minutes with 100 units/ml LIF combined with 10% FBS, 
fixed and then stained for Gab1 using a Gab1-specifc antibody. No significant changes were observed in the expression pattern of Gab1β upon 
induction. Gab1 expression was observed diffusely in the cytoplasm of the cells , whilst some cells also exhibited expression in a distinct body near the 




Figure 4.20: Expression of Gab1α in ES cells. Gab1α-overexpressing ES cells were induced for 10 minutes with 100 units/ml LIF combined with 10% 
FBS, fixed and then stained for Gab1 using a Gab1-specifc antibody. Upon induction, Gab1α was expressed more diffusely in the cytoplasm of cells. In 




Figure 4.21: Expression of Gab1α in EGFP-expressing ES cells. EGFP-expressing Gab1β -/- cells were induced for 10 minutes with 100 units/ml LIF 
combined with 10% FBS, fixed and then stained for Gab1 using a Gab1-specifc antibody. No significant changes were observed in the expression 
pattern of Gab1α upon induction. Gab1α expression was detected in the whole cell, including the nucleus.
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4.2.4.4  Biochemical function of EGFP-Gab1 fusion proteins 
 
In order to determine whether the Gab1 EGFP fusion proteins were 
functional, their phosphorylation in response to LIF, as well their 
participation in the Shp2 signalling pathway were investigated. Gab1 
proteins were immunoprecipitated from Gab1β -/- cells (transfected with 
empty CAGIP vector), Gab1β +/+ cells (C1 +/+) as well as one clone from 
each EGFP fusion transfection. 6x106 cells were plated in a 10cm dish and 
allowed to grow overnight. The next day cells were starved of all growth 
factors and cytokines for 3 hours and were then induced with 1000units/ml 
LIF for 10 minutes. The cells were lysed and their protein was incubated 
overnight with an anti-Gab1 antibody and protein sepharose beads. The next 
day, the beads were repeatedly washed and then resuspended in lysis buffer. 
The immunoprecipitates were then screened on a Western blot probed for 
pGab1 Tyr-627, Shp2 and Gab1 (Figure 4.22). The data confirms that all six 
fusion plasmids give rise to their respective Gab1 proteins in the stably 
transfected ES cells. Furthermore, all six fusion proteins are phosphorylated 
at tyrosine 627 in response to LIF, albeit at different levels. The EGFP-GLY6-
GAB1 proteins seemed to exhibit less phosphorylation than the other tagged 
proteins. Nevertheless, this suggests that the tagged proteins are functional 
in that they have the ability to bind to an effector in response to an inducing 
factor. Therefore, in response to this phosphorylation, the tagged proteins 
also form a complex with Shp2 in response to LIF. Again, this suggests that 
they are functional proteins that are able to take part in the signalling 




Figure 4.22: Expression and phosphorylation of EGFP-tagged Gab1α and Gab1β proteins 
stably transfected in Gab1β -/- cells. All six fusion plasmids give rise to their respective 
Gab1α or Gab1β EGFP fusion proteins, as indicated by the screening of the Western blot 
with aGab1 antibody which detects both Gab1α and Gab1β.  
 
An important part of Gab1β protein function is its ability to potentiate Erk 
phosphorylation in response to LIF (Figure 3.7). Therefore, it was crucial to 
see whether the fusion proteins also did the same. In the next experiment, 
cells were starved of growth factors for 3 hours and the induced with 1000 
units/ml LIF, protein lysates were obtained and screened on Western blots 
probed for phosphorylated Erk (Figure 4.23). The data suggests that the 
EGFP-tagged proteins may not have the ability to potentiate Erk 
phosphorylation in response to LIF, despite their own phosphorylation and 
association with Shp2. This suggests that although partially functional, the 






Figure 4.23: Erk phosphorylation in response to LIF in EGFP-tagged fusion proteins. Similar 
levels of Erk phosphorylation were observed in all lysates, as well as in CAGIP Gab1β -/- 
cells. All cells exhibited similar levels of Stat3 phosphorylation compared to C1 wildtype 
















In this chapter I aimed to characterise the role of the PH domain in the 
localisation of the Gab1 proteins. Initially, in order to visualise the 
localisation of the proteins, plasmids containing EGFP-tagged Gab1α and 
Gab1β were constructed. Three versions for each were constructed, and all 
plasmids gave rise to fluorescent Gab1 proteins (Figure 4.9), when stably 
transfected into Gab1β -/- cells. All EGFP-tagged proteins were localised to 
the cytoplasm of the cells, but distinctions as to whether they were localised 
at the membranes could not be made. When the fusion proteins were 
transiently transfected into 10T1/2 fibroblast cells, their expression was 
retained in the cytoplasm even upon growth factor stimulation with LIF or 
FBS. All 6 fluorescent proteins were phosphorylated at tyrosine 627 (the 
binding site for Shp2) in response to LIF in ES cells, and subsequently formed 
a complex with Shp2. This however did not translate into an effect on the 
levels of ERK phosphorylation. None of the Gab1β fusion variants 
potentiated ERK activation in response to LIF, as Gab1β has previously been 
shown to (Figure 3.7). Therefore, despite the fact that they form a complex 
with Shp2, they did not enhance Erk activation. This means that somehow, 
the fusion with EGFP, at either terminal, inhibits Gab1β’s ability to potentiate 
Erk phosphorylation.   
 
In terms of expression levels, all 6 plasmids gave rise to similar levels of 
protein expression. In the Gab1-GLY6-EGFP, where Gab1 is tagged at the C-
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terminal, the intensity of the fluorescence of the proteins was much lower 
compared to the other variations of the fusion proteins. Furthermore, the 
patterns of expression differed amongst the three variants, although they 
were all restricted to the cytoplasm of the cells. EGFP-Gab1β was expressed 
diffusely in the cytoplasm, whilst EGFP-GLY6-Gab1β was expressed at the 
membrane as well as in a distinct body near the nucleus. Gab1β-GLY6-EGFP 
had a similar pattern, and was localised more clearly at the membrane as 
well as in the perinuclear body. This was confirmed by confocal microscopy. 
This expression patterns is similar to the one observed in Gab1β +/+ and 
Gab1β restored cells. Therefore, this is a representative pattern of Gab1β 
expression in ES cells. Gab1α was also demonstrated to be restricted in the 
cytoplasm when overexpressed in Gab1β -/- ES cells. This was also true for 
the three fusion variants, EGFP-Gab1α, EGFP-GLY6-Gab1α and Gab1α-GLY6-
EGFP.  
 
The differences in expression amongst the Gab1β fusion variants suggests 
that the placement of EGFP on Gab1β significantly affects its expression 
pattern. When directly tagged at the N-terminal, where the PH domain in the 
long form of the protein resides,  EGFP altered the normal localisation of 
Gab1β. In wildtype cells, Gab1β is expressed at the membrane as well as in a 
distinct body near the nucleus. This expression pattern was still not 
completely restored when EGFP was linked to the N-terminal of Gab1β via a 
polyglycine linker. The linker was added to allow the fusion protein to form 
the correct primary structure, which is crucial for its function. EGFP-GLY6-
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Gab1β was expressed in the perinuclear body, and less diffusely in the 
cytoplasm compared to EGF-Gab1β. In the third fusion variant, EGFP was 
linked to the C-terminal of Gab1β via a polyglycine linker. The expression 
pattern of Gab1β-GLY6-EGFP was very similar to that observed in wildtype 
cells. Its expression was distinct at the membrane as well as in the 
perinuclear body. These results show that EGFP at the N-terminal acted as a 
barrier to the proper localisation of Gab1β. Even the addition of the linker 
did not completely restore the wildtype pattern of expression. Interestingly, 
all the Gab1α fusion variants had similar patterns of expression. Gab1α was 
expressed diffusely in the cytoplasm. This is the same pattern as EGFP-
Gab1β. Therefore, in the same way EGFP acted as a barrier to the expression 
pattern of Gab1β, so may the PH domain in Gab1α. This suggests that a 
novel domain found at the N-terminal of the protein, after the PH domain, 
may be responsible for the localisation of Gab1β, and fusing EGFP in close 
proximity alters its localisation. This may explain why fusing Gab1β at the C-
terminal did not interfere with the normal localisation of the protein.   
 
The PH domain of Gab1α has been shown to be dispensable for its 
localisation within a cell (Maroun et al., 1999a). Gab1α has been 
demonstrated to localise in the cytoplasm following Met activation  by HGF 
stimulation of 18-hour cultures of MDCK cells (Maroun et al., 1999a). After 
15 minutes of stimulation, Gab1α translocates from the cytoplasm to the 
membrane. Interestingly, however, a ΔPH domain mutant protein also 
translocated to the membrane vicinity in a similar manner to wildtype 
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Gab1α. This suggests that the PH domain may not be solely responsible for 
the movement of Gab1α to the membrane, but the association with the 
receptor may be crucial. While Met activation can result in Gab1α 
localisation at the membrane, the PH domain may act to stabilise its 
interactions with membrane-bound phospholipids and enable Gab1α to 
potentiate and/or compartmentalise the signal downstream from Met 
(Maroun et al., 1999a).  
 
The PH domain is the only conserved structural element between the 
multisite docking proteins Gab1, Gab2 and Dos, the D. melanogaster isoform. 
The deletion or mutation of the PH domain in Dos, has been shown not to 
interfere with the membrane localisation of the protein in photoreceptor cells 
(Bausenwein et al., 2000). The PH domain of Dos, however, was shown to be 
required for normal Dos function. In an attempt to rescue the lethal 
phenotype of Dos mutations, a ΔPH domain Dos mutant was ubiquitously 
expressed in mutated flies. Most animals died as pharate adults, whilst the 
few viable flies suffered from defects in eye morphology and wing vein 
formation. In addition, expression of  the ΔPH domain Dos mutant does not 
restore the loss of R7 cells in the D. melanogaster eye.  
 
Recent evidence shows that most PH domains that have been analysed, bind 
phosphoinositides with only low affinities, if at all, and with little-to-no 
specificity (Kavran et al., 1998; Yu et al., 2004). A genome-wide analysis of 
PH domains in S. cerevisiae showed that only one of the 33 yeast PH domains 
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functions as a high-affinity and specific phosphoinositide-binding module 
(Yu et al., 2004). The authors of this study suggested that, while  
phosphoinositide binding contributes to membrane targeting of most yeast 
PH domains, it does not solely control their location on the membrane. This 
was supported by the data that only 14 out of 33 yeast PH domains showed 
evidence of membrane localisation, of which only 8 were detectably 
membrane-targeted as GFP fusion proteins (Lemmon, 2004; Yu et al., 2004). 
 
Collectively, all these data show that the PH domain is not solely responsible 
for the localisation of Gab1 within a cell. This would suggest Gab1β, despite 
the lack of a PH domain, may still have the ability to move within a cells in 
response to growth factor stimulation. In response to LIF+FBS stimulation 
there was a small change in the expression pattern of Gab1β in ES cells 
(Figures 4.15-4.17). Some protein was also detected in the nuclei of the cells 
upon induction. This however, could be attributed to the small amount of 
Gab1α that cells express which, upon induction, seems to move to the 
nucleus in Gab1β -/- cells overexpressing EGFP (Figure 4.21). The lack of a 
NLS would also suggest that Gab1β does not have the ability to translocate to 
the nucleus. Prior to stimulation, Gab1β was expressed clearly at the cellular 
membrane of ES cells, as well as in a perinuclear body. Upon stimulation 
with LIF+FBS, however, Gab1β was more diffusely in the cytoplasm of the 
cells. This shows that Gab1β, despite the lack of PH domain and a NLS, still 
has the ability to move within a cell in response to growth factor and 
cytokine stimulation. It seems unlikely however, that a protein would be 
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moving away from the membrane in response to growth factor stimulation. 
One would expect that an adaptor protein, such as Gab1β would move to the 
membrane proximal region upon stimulation, in order to bind to the receptor 
and convey downstream signals. The change in localisation that was 
observed could therefore be attributed to a change in cell shape upon growth 
factor stimulation. Cells under serum-starved conditions appear more 
rounded and not adhered to the plastic as flat as they do in normal culture 
conditions. If this observation is true, then it may be expected that upon 
stimulation, the shape of the cells may change and they may appear more 
flattened. Therefore, the change in Gab1β localisation upon stimulation could 
be attributed to a change in the shape of the cells and the subsequent 
redistribution of intracellular compartments, and not to its actual movement 
within the cells.  
 
Gab1β expression was also detected in a body near or within the nucleus of 
ES cells. Data shows that this body is not contained in the nucleus, as it was 
only stained for Gab1 and not DAPI (Figures 4.15-4.18). Therefore, this 
distinct body is found near the nucleus of the cell, but not within it. As an 
adaptor molecule, Gab1β takes part in  signalling downstream from 
receptors, such as the EGF receptor. A major event in the function of 
receptors is their internalisation and recycling back to the surface in 
endosomes, in response to growth factor binding (Oksvold et al., 2001). 
Endosomes are intracellular organelles, which consist of a network of 
vesicles and tubules extending from the cell surface to the perinuclear area. 
 
 178 
As well as being involved in the uptake of nutrients, hormones and growth 
factors, they also take part in the recycling of receptors and ligands (Enrich et 
al., 1999). Such endosomes are called recycling endosomes, which are 
dispersed within the cell. Interestingly, in a study attempting to identify 
EGFR-dependent signalling abnormalities, Gab1α-associated ERK activation 
was shown to be regulated by EGF in early endosomes of mouse 3T3 cells 
(Kostenko et al., 2006). In another study Grb2 was shown to be localised in 
late endosomes of HeLa cells, in response to EGF activation (Oksvold et al., 
2001). Whilst EGFR colocalised with Grb, pERK1 and pERK2, the endosomes 
were negative for transferrin, a classical maker of recycling endosomes (Daro 
et al., 1996). Co-precipiation results showed that internalised EGFR remained 
in complex with Grb2, Shc and Cbl at a timepoint where the receptor had 
reached the late endosomes. Collectively, these studies suggest that Gab1 
proteins could be localised at endosomes. This suggestion, along with the 
fact that Gab1β was shown to be expressed in a distinct perinuclear body, 
may mean that Gab1β is indeed found at endosomes of ES cells. By screening 
for co-localisation of Gab1β with endosome markers, such as transferrin 
(recycling endosomes) or EEA1 (early endosomes) (Mu et al., 1995), the exact 
location of Gab1β and its potential role in the recycling of receptors within 
endosomes could be investigated.            
 
In this chapter, I have attempted to demonstrate the potential role of the PH 
domain and NLS in the localisation of Gab1 proteins. In doing so, I have 
shown that the PH domain is not the only domain that is important for 
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localising Gab1 proteins to the membrane. I have hypothesised that there 
may be another domain at the N-terminal of Gab1β that is also crucial. 
Furthermore, I have demonstrated that Gab1β is expressed in a distinct body 
near the nucleus of ES cells, and I have hypothesised that this may be an 
endosomal compartment, where receptors are recycled. Future experiments 
investigating the colocalisation of Gab1β with endosomal proteins such as 
EGFR, transferrin and EEA1 will prove informative for the function of Gab1β 


















The  abundance of Gab1β in ES cells, suggests that it is involved in pathways 
that regulate ES cell growth and/or self-renewal. My experiments, however, 
demonstrate that Gab1β may actually potentiate the pro-differentiative factor 
Erk (Burdon et al., 1999b) in response to LIF (Figure 3.7). This poses a 
dilemma as to what the function of Gab1β is in ES cells. Its abundance would 
suggest that it is involved in the maintenance of ES cell identity. However, 
the potentiation of Erk that it takes part in suggests that it may be involved in 
the early differentiation of ES cells. The stimulation of Erk by FGF4 was 
recently shown to trigger the transition of pluripotent ES cells from self-
renewal to lineage commitment (Kunath et al., 2007). Although the authors 
suggest that the provision of LIF to self-renewing cultures may intervene 
downstream of Erk via Stat3 to override the autoinductive capacity of FGF4, 
this has not been proven. Therefore, the activation of Erk via Gab1β in 
response to LIF may also stimulate this transition. Furthermore, Gab1β has 
also been shown to have no effect on the self-renewal of ES cells (Burdon T., 
unpublished). Therefore, it is possible that Gab1β is involved in the 




Gab1β is expressed in various areas of the adult mouse in vivo (Burdon T., 
unpublished). The activity of the Gab1β promoter was reported by inserting 
a βgeo resistance gene into Gab1β 5’ exon in E14Tg2a ES cells. Targeted cell 
lines were then injected into blastocysts and mice where the transgene was 
transmitted into the germline were sectioned and stained for LacZ. Along 
with staining in the heart, testes, kidney and pancreas, Gab1β expression was 
also observed in the dentate gyrus of the brain. The dentate gyrus is the 
primary afferent pathway into the hippocampus and it has an important role 
in learning and memory (Galichet et al., 2008). The dentate gyrus of the 
hippocampus, along with the subventricular zone of the lateral ventricle 
wall, is the area of the mouse brain where neural stem cells reside (Gage et 
al., 1995). These neural stem cells can self-renew and give rise to new 
neurons, astrocytes and oligodendrocytes (Gage, 2002; Pierret et al., 2007). 
These data, combined with the evidence that Gab1β is expressed in the 
dentate gyrus, suggest that Gab1β may have a role in the biology of neural 
stem cells.  
 
Mouse ES cells are pluripotent cell lines that, in addition to being able to 
participate fully in foetal development upon re-introduction into blastocysts, 
they also have the capacity to differentiate into various cell types in vitro. In  
order for an ES cell to differentiate, the self-renewing stimulus LIF needs to 
be removed. ES cells then differentiate in suspension into multicellular 
aggregates called embryoid bodies (EBs) (Martin et al., 1977). EBs exhibit 
multilineage developmental potential similar to that in normal mouse 
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embryogenesis and give rise to all three embryonic germ layers (Doetschman 
et al., 1985; Stavridis and Smith, 2003). Neuron-like cells are only a small 
percentage of the total cells and are intermingled amongst other cell types, 
such as skeletal muscle-, cardiac-like cells (Bain et al., 1995). Interestingly, 
EBs were recently shown to demonstrate a certain degree of organisation, 
similar to that of normal embryonic gastrulation (ten Berge et al., 2008). The 
rarity of neuron-like cells has sparked many studies on increasing this small 
proportion of cells in order to better study neural specification. For example, 
retinoic acid (RA) treatment of ES cell –derived EBs causes a high proportion 
of the cells to express multiple neuronal properties, such as class III β-tubulin 
and neurofilament M subunit. This study showed that these cells were 
capable of generating action potentials and also expressed TTX-sensitive 
sodium channels, as well as voltage-gated potassium and calcium channels 
(Bain et al., 1995). RA-induced differentiated cells seem to be a mixture of 
neuronal–like cells such as oligodendrocytes, astrocytes, neurons, as 
indicated by the expression of cell-specific antigens (Fraichard et al., 1995).  
 
Though EB studies have proved useful in the study of neuronal specification, 
it is difficult to manipulate and better understand the process by which an ES 
cell differentiates to a neuron, because of the multitude of cell types within 
an EB. In attempting to solve this problem, Ying et al demonstrated that ES 
cells could convert to neural fates in monolayer adherent culture in defined 
conditions without the need for RA (Ying et al., 2003b). Here, the authors 
demonstrated that, by eliminating inductive signals for alternative fates with 
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the addition of FGF4 to cells at clonal density, ES cells reproducibly commit 
to a neural fate.     
    
The aim of this chapter is to investigate whether Gab1β is involved in the 
neural differentiation of ES cells. At what stage in this differentiation process 
Gab1β may be involved in is an important question as well. Whether or not it 
is involved in the differentiation of ES cells into neural stem cells, or of 
neural stem cells into neural precursors is of great interest. In vivo data 
indicate that Gab1β may be involved in the determination of neural 
precursors from neural stem cells in the adult mouse brain. Therefore, I aim 
to investigate the role of Gab1β during the whole process of ES cell 
differentiation into neural precursors. I plan to do to this by firstly 
establishing the protocol of neural differentiation based on previous 
publications. Using Gab1β-targeted ES cells, I will test the hypothesis that 












5.2.1 Establishing a defined neural monolayer differentiation protocol 
 
To avoid the use of EBs, Ying at al developed an adherent monoculture 
system where, with the addition of FGF, ES cells could be converted to 
neural precursors in defined conditions (Ying and Smith, 2003; Ying et al., 
2003b). It was found empirically that a mixed formulation of basal media and 
supplements provided optimum cell viability and efficient neural 
differentiation (Ying and Smith, 2003). This formulation called N2B27 
contained DMEM/F12 medium supplemented with modified N2, which 
contained insulin, apo-transferin, progesterone, putrescine and sodium 
selenite. This mixture was then supplemented with BSA combined with 
Neurobasal (Gibco) medium with added B27 (Gibco).   
 
In this section, I aimed to establish a reliable neural differentiation protocol 
based on the above formulation. The optimal number of cells plated was 
tested in order to maximise the number of neural precursors obtained during 
the differentiation process. In addition, to assay the effects of FGF4 on the 
emergence of neural precursors, cells were plated in the presence and 
absence of 1µg/ml heparin, the carrier that is required for the efficient 
absorption of FGF4 by the cells (Mummery et al., 1993). The binding of FGFs 
to heparin is required for their binding to the high affinity FGF receptors 
(Yayon et al., 1991).  Briefly, cells were plated in 90mm wells at varying 
densities in N2B27 plus 100 units/ml LIF and allowed to grow overnight. 
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Cells were then transferred to N2B27 medium alone or containing 2ng/ml 
FGF4 and 1µg/m heparin. The medium supplemented with FGF4 and 
heparin was then changed every two days. There were two crucial conditions 
that needed to be tested, the presence of heparin and the number of cells 
plated. Firstly, though heparin has been shown to be required as a carrier for 
FGF4 (Mummery et al., 1993), Ying et al did not use it when testing the 
effects of FGF4 on neural specification (Ying and Smith, 2003; Ying et al., 
2003b). In a more recent publication however, where FGF4-induced Erk 
stimulation was shown to be an autoinductive stimulus for ES cells to exit 
the self-renewal programme, heparin was added to FGF4-supplemented 
N2B27 medium (Kunath et al., 2007). The other condition that needed to be 
tested was the number of cells required for the optimum neural precursor 
generation. These two conditions were tested within the same experiment. 
Gab1β-targeted cells (C1 +/+, 26 -/-, Gab1β -/- with α overexpression and 
Gab1β -/- with β overexpression) were plated for 24 hours at 0.7x105 cells or 
at 1.0x105 cells per 9.4 cm2 well in N2B27 supplemented with LIF and then 
transferred to N2B27 plus FGF4 with or without heparin the next day. The 
medium was changed every two days thereafter. One day after plating (day 
1) and before LIF was removed and FGF4 was added, the plating efficiency 
was examined by taking brightfield pictures using a Nikon microscope 
(Figure 5.1). The medium was then changed to N2B27 supplemented with 





Figure 5.1: The effect of cell plating on the emergence of neural precursor-like cells. Cells were plated in N2B27 medium supplemented with 100 
units/ml LIF at 0.7x105 and 1.0x105 cells per 9.4cm2 well and left to grow overnight. Pictures were taken the next day before the medium was changed 
to N2B27 without LIF but supplemented with FGF4 (with or without heparin). Four Gab1β-targeted cell lines were used: C1 (+/+), HT (+/+), 26 (-/-) 
and 55 (-/-).  
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On day 3, images were taken of all cell lines under the new conditions in 
order to see whether heparin had an effect or not on the emergence of neural 
precursor-like cells. The addition of heparin did enhance the “spiky” 
appearance of the cells, which is characteristic of neural precursors (Figures 
5.2 & 5.3). The number of cells plated did not affect the emergence of neural 
precursor-like cells, which were identified by their spiky and elongated 
appearance. On day 5 of the experiment, the effect of FGF4 on the 
differentiation of the ES cells was more pronounced (Figures 5.4 & 5.5). Cells 
appeared elongated with protrusions, signs of early neural differentiation 
(Kunath et al., 2007). Interestingly, these characteristics were more 
pronounced in the cells that had been supplemented with heparin.  This was 
especially evident in cell line 55 (-/-), where in the absence of heparin, there 
were no live cells visible. This suggests that as ES cells take on their new 
neural fate, they require the efficient presence of FGF4, and without the 
addition of heparin, this is not possible. By day 8 of the experiment, all cells 
grown in N2B27 and FGF4 without heparin had died (images not shown). 
Therefore, the addition of heparin along with the supplementation with 
FGF4 is important for the emergence as well as the survival of differentiated 
neural-like cells. It may be that as neural precursors develop, the localised 
autocrine effects of FGF4 are minimised and therefore the external addition 
of FGF4, which requires heparin, is crucial.  At this stage of the experiment it 
seemed that plating cells at the lower density seemed to be more 
advantageous for the emergence of neural precursor-like cells (Figure 5.6). 
Cells plated at the higher density gave rise to a flattened cell type, and fewer 




Figure 5.2: The effect of heparin on the emergence of neural precursor-like cells on day 3 (0.7x105). The addition of 1µg/ml heparin did  not have an 








Figure 5.3: The effect of heparin on the emergence of neural precursor=like cells on day 3 (1.0x105). The addition of heparin did seem to give the cells an 






Figure 5.4: The effect heparin on the generation of neural precursor-like cells on day 5 (0.7x105). The addition of heparin seemed to enhance the 






Figure 5.5: The effect heparin on the generation of neural precursor-like cells on day 5 (1.0x105) . The addition of heparin seems to enhance the 




Figure 5.6: The effect cell density on the generation of neural precursor-like cells on day 8. Cells grown in the absence of heparin did not survive (image 
not included). Apart from cell line 26 (-/-), more neural precursor-like cells arose when 0.7x105 cells were originally plated. Cells plated at the higher 
density gave rise to a flattened cell type that does not resemble neural-like cells, which exhibit elongated protrusions/axons. 
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On day 10 of the experiment it seemed that apart from cell line C1 (+/+), all 
three other cells lines successfully differentiated into neural precursors when 
plated at 0.7x105 cells/well, as seen by the characteristic axons connecting 
one cell to another (Figure 5.5). In these three cell lines, the emergence of 
differentiated neural cells was more efficient when plated at a lower density, 
as there were more neural-like cells. It was concluded that the favourable 
conditions for maximum neural precursor cell-like generation included 
supplementation of N2B27 with heparin as a cofactor for FGF4. Cells should 
be plated at the lower density of 0.7x105. Apart from establishing an efficient 
neural differentiation protocol, these results also suggest that Gab1β is not 
involved in the differentiation of ES cells into neural precursors as Gab1β -/- 
cells gave rise to comparable levels of neural-like preursor cells to wildtype 
cells.  














Figure 5.7: The effect cell density on the generation of neural precursor-like cells on day 10. Apart from cell line C1 (+/+), the other three cell lines gave 
rise to neural precursors at the lower density. 
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5.2.2 Effect of Gab1β  on neural stem cell differentiation  
 
The results in the previous section suggested that Gab1β is not involved in 
the differentiation of ES cells into neural precursors as Gab1β -/- cells gave 
rise to them very efficiently and there was no difference between them and 
Gab1β +/+ cells. These observations however, were only based on the 
morphology of cells. Although Gab1β did not have an obvious effect on the 
neural differentiation of ES cells, based on the fact that it potentiated Erk 
phosphorylation in response to LIF (Figure 3.7), it may have a subtle role in 
predisposing cells to a differentiated state. In order to establish this, Gab1β-
targeted ES cells were differentiated under the same conditions as before 
using N2B27 and FGF4 and then immunostained for an early-mid neural 
marker α-tubulin (TUJI).  
 
Before determining whether Gab1β is involved in the determination of 
neural cells, Gab1β +/+ and -/- cells were immunostained for Oct4, which is 
required for ES cells to maintain their pluripotent identity (Chambers and 
Smith, 2004; Niwa et al., 2000) and upon withdrawal of LIF, its expression is 
downregulated (Chambers and Smith, 2004; Nichols et al., 1998). This 
established whether the absence of Gab1β had an effect on the levels of Oct4, 
which could ultimately have an effect on the differentiation of the cells. 
0.5x106 cells were plated in a 9.6 cm2 well in normal ES medium 
supplemented with LIF and FBS and allowed to grow overnight. The next 
day, cells were fixed and stained overnight using an anti-Oct4 antibody, and 
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were then stained with the appropriate secondary antibody. Images of the 
stained cells suggest that Gab1β +/+ cells exhibit slightly lower levels of Oct4 





Figure 5.8: The expression of Oct4 in Gab1β +/+ and -/- cells. Although there are not any 
differences in the number of cells stained, the staining of Gab1β -/- (KO26) cells seems to be 
more intense than that of the Gab1β +/+ (C1) cells in both experiments. In the lower panel, 





The experiment was repeated using the same cells stained with the same 
Oct4 antibody, but of a different batch, in order to avoid the possibility that 
the reduced Oct4 staining was due to a weak antibody. The same results 
were observed when this was done (Figure 5.8 lower panel). Gab1β +/+ 
exhibited slightly lower levels of Oct4. This suggests that Gab1β may be 
downregulating Oct4 expression. These results would have to be confirmed 
by immunostaining other Gab1β +/+ and -/- cells for Oct4. Furthermore, it 
would be interesting to see whether there were differences on the levels of 
Oct4 protein expression by Western blot.  
 
The intensity of the Oct4 staining in the two different cell lines using the two 
different antibodies was measured using the programme ImageJ (Abramoff, 
2004). Using this software, the mean grey value of each stain (TRITC for Oct4 
and BLUE for DAPI) was measured. Then, the measurements for Oct4 were 
normalised to DAPI (Oct4/DAPI) and plotted on a graph (Figure 5.9). It 
seems that this clone of Gab1β -/- cells (KO 26 -/-) exhibit more Oct4 staining 
compared to Gab1β +/+ (C1 +/+) cells according to the ImageJ 
measurements. This confirms the visual data in Figures 5.8 & 5.9. Repeating 
this experiment using other Gab1β-targeted cells lines would confirm these 
observations, that Gab1β expression may indeed have a negative effect on 





Figure 5.9: Measurement of Oct4 staining in Gab1β +/+ and -/- cells using ImgeJ software. 
When normalised to total DAPI staining, using either antibodies, Gab1β KO26 -/- cells 
exhibit less Oct4 staining than Gab1β C1 +/+ cells.  
 
In order to determine whether Gab1β has a role in the determination of 
neural progenitors, Gab1β-targeted ES cells were differentiated using the 
N2B27 plus FGF4 method described in the previous section. Briefly, 0.7x105 
cells were plated in a 9.6cm2 well in N2B27 medium plus 100 units/ml LIF 
and allowed to grow overnight. The next day cells were transferred to N2B27 
medium supplemented with 2ng/ml FGF4 and 1µg/m heparin. Pictures of 
the cells were then taken on alternate days and/or were stained with DAPI, 
anti-tubulin (TUJI) and/or -Oct4 antibodies. The experiment was repeated 3 
times (Experiments A, B and C). A table summarising the data can be found 
in Figure 5.10. Images of the cells undergoing neural differentiation can be 
found in: Figures 5.11-5.13 (Experiment A), Figures 5.14-5.20 (Experiment B) 
and Figures 5.21-5.25 (Experinemt C). During the early days of all three 
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experiments (days 1-4), there were no differences in the number of TUJI-
positive cells. Furthermore, no obvious differences in the morphology or 
emergence of neural TUJI-positive axons were observed either. All cell lines 
gave rise to neuronal precursor-like cells which stained for TUJI. On day 5 
however, some differences started to emerge between the Gab1β-targeted 
cells. Gab1β +/+ (C1) had fewer TUJI-positive cells compared to all other cell 
lines, even Gab1β restored +/+ cells. In 2 out of 3 experiments, Gab1β 
restored +/+ cells gave rise to fewer TUJI-positive cells compared to Gab1β -
/- and Gab1α restored cells. Furthermore, Gab1β restored +/+ cells gave rise 
to cells with fewer axons compared to the other two cell lines in the majority 
of the experiments. These data suggest that there may be slight differences in 
the rate at which Gab1β-targeted ES cells differentiate into neural precursors. 
On days 6/7 these differences were not as pronounced. Gab1β +/+ (C1) cells 
still gave rise to fewer TUJI-positive cells than all the other cell lines. Gab1β 
restored +/+ cells had similar levels of TUJI-positive cells as Gab1β -/- cells 
in the majority of the experiments. What was evident on days 6/7 was that 
Gab1α restored cells gave rise to slightly more TUJI-positive cells with more 
protruding axons. This observation became clearer on the latter days of the 
neural differentiation process, where Gab1α restored cells gave rise to TUJI-
positive cells with long, thick axons. This pattern was distinct and the other 
cell lines did not adopt it. During the later days in the neural differentiation 
process (days 8-12), Gab1β restored +/+ and Gab1β -/- cells had similar 
patterns of TUJI expression. Both cell lines gave rise to similar numbers of 
TUJI-positive cells of similar intensity, but neither cell line gave rise to cells 
with thick elongated axons, as observed with the Gab1α restored cells.    
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DAYS 1-4 No significant differences between cell lines 
DAY 5 A B C 
Gab1β  +/+ (C1) Fewer neural-like 
cells compared to 3 
other cell lines 
N/A Few TUJI-positive 
cells  
+ 
Gab1β  restored +/+ Similar number of 
neural-like cells 
compared to -/- and 
α restored 
Fewer TUJI-positive 
cells compared to 





cells compared to -/- 




Gab1β  -/- (26) 
Gab1α  restored 
More axons, but a 
similar number of 
neural-like cells 
compared to β 
restored cells 
More TUJI-positive 
cells and axons 
compared to β 
restored cells;  
+++ 
More TUJI-positive 
cells and axons 
compared to β 
restored cells; rosette 
in -/- cell line 
+++ 
DAY 6/7 A B C 
Gab1β  +/+ (C1) Fewer neural-like 
cells compared to 3 
other cell lines 
N/A Fewer TUJI-positive 
cells  
++ 
Gab1β  restored +/+ Fewer TUJI-positive 
cells compared to -/- 
and α restored 
++++ 
Similar number of 
TUJI-positive cells as 
-/-, but less than α 
restored 
++++ 
Gab1β  -/- (26) Similar number of 
TUJI-positive cells as 
β restored cells, but 
less than α restored; 
presence of rosette 
++++ 
Gab1α  restored 
Similar number of 
neural-like cells 




cells compared to all 
other cell lines; 
presence of rosette 
+++++ 
DAYS 8-12 Gab1β restored +/+ and Gab1β -/- have similar patterns of TUJI 
staining; Gab1α restored cells have many more axons, which are 
thick and elongated, compared to the other two cell lines 
Figure 5.10: Comparison of the neural differentiation of Gab1β-targeted cells. A, B and C 




Figure 5.11: The differentiation of Gab1β-targeted ES cells into neural precursors on days 1 and 3. Similar numbers of cells were plated on day 1 of the 








Figure 5.12: The differentiation of Gab1β-targeted ES cells into neural precursors on days 5 and 7. On day 5, all cell lines exhibit neural outgrowths, 
with C1 +/+ having very few. On day 7, C1 +/+ had very few cells, whilst β +/+ and 26 -/- had similar amounts of neural precursors. Cell line α-/- 







Figure 5.13: The differentiation of Gab1β-targeted ES cells into neural precursors on day 12.  Cells were stained for the neural marker tubulin. All cells 












Figure 5.16: The differentiation of Gab1β-targeted ES cells into neural precursors on day 5. The levels of Oct4 have diminished to give rise to 









Figure 5.18: The differentiation of Gab1β-targeted ES cells into neural precursors on day 8. Cell line 26 -/- has fewer neurons than the other cell lines, 




Figure 5.19: The differentiation of Gab1β-targeted ES cells into neural precursors on day 9. The number of neuronal precursors is the same between β 




Figure 5.20: Measuring the intensity of TUJI staining during the differentiation of Gab1β-targeted ES cells into neural precursors. Values are corrected 
to DAPI intensity. On day 4, Gab1β -/- and Gab1α restored cells have more tubulin expression per cell compared to Gab1β restored cells. On day 9, 




Figure 5.21: The differentiation of Gab1β-targeted ES cells into neural precursors over 7 days. On day 1 similar numbers of cells were plated and evenly 








Figure 5.22: The differentiation of Gab1β-targeted ES cells into neural precursors over 7 days. On day 5, C1 +/+ and β +/+ had similarly less neuronal 




Figure 5.23: The differentiation of Gab1β-targeted ES cells into neural precursors on day 5. C1 +/+ was less efficient at giving rise to tubulin-positive 




Figure 5.24: The differentiation of Gab1β-targeted ES cells into neural precursors on day 7. All cell lines gave rise to tubulin-positive cells. Cell line α -/- 




Figure 5.25: The differentiation of Gab1β-targeted ES cells into neural precursors on day 8. All cell lines gave rise to tubulin-positive cells. C1 +/+ 
gave rise to the fewest tubulin –positive neurons.
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5.2.3 The effect of insulin on the neural differentiation of Gab1β-targeted 
ES cells 
 
Insulin has been shown to be the main component of N2 which is required 
for the efficient proliferation and survival of dissociated postnatal mouse 
cerebellar neurons (Huck, 1983). IGF1 activation of PI3K has been shown to 
be responsible for this survival effect of cerebellar neurons, which is 
mediated by the activation of the serine-threonine kinase downstream of 
PI3K, Akt (Dudek et al., 1997). This is not surprising, as the IGFs and their 
receptors are widely expressed and distributed in the forebrain zones of 
neurogenesis (Baron-Van Evercooren et al., 1991; Hopkins and Williams, 
1997). In dorsal root ganglia, IGF1 has been shown to prevent apoptosis of 
neurons by regulating PI3K/Akt pathway effectors, such as CREB (cyclic 
AMP response element binding protein), GSK3β and FKHR (forkhead), as 
well as by blocking caspase activation (Leinninger et al., 2004). Insulin has 
also been shown to provide trophic support and aid survival for retinal 
neurons through a PI3K/Akt-dependent pathway (Barber et al., 2001). More 
recently, using oxygen deprivation as a cause of hypoxia, Zhao et al 
demonstrated that after 24 hours of hypoxia, 41% of neural stem cells are 
apoptotic and that insulin treatments reduces the frequency of hypoxia-
induced apoptosis by 33% (Zhao et al., 2007). The authors also showed that 
Akt phosphorylation increased upon this insulin treatment and that this 
increase was completely blocked with pharmacological inhibitors against 
PI3K. The use of the PI3K-specific inhibitor also reversed the effect of insulin-
induced Erk inhibition, which suggests that insulin inhibits Erk in a PI3K-
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dependent manner. This is contradicted, however, by the suggestion that 
insulin acts to sensitise cells to differentiation-inducing signals (Ying et al., 
2008). In this study, the authors demonstrated that by adding inhibitors to 
Erk, FGF and Gsk, ES cells could be maintained in culture without the 
addition of LIF or FBS. When insulin was omitted from the medium, cells 
were more sensitive to the Erk and FGF inhibitors, and although they 
remained undifferentiated over 4 weeks, their propagation rate decreased 
over time.   
 
In chapter 3, I showed that Gab1β represses both Akt and Erk activation in 
response to IGF. The biological effect of this repression is still not clear. As 
insulin has been shown to inhibit ERK and is also an important additive to 
N2B27 medium for the maintenance of neural stem cells and early neural 
precursors, it would be interesting to see whether Gab1β is involved in the 
process of ES cells differentiating to neural stem cells and in turn their 
differentiation into neural precursors. At what stage Gab1β may be involved 
in this pathway is still unclear. The fact, however, that Gab1β expression is 
detected in the dentate gyrus of the adult mouse brain (Burdon T., 
unpublished), suggests that it may be involved in the latter stages of neural 
differentiation, i.e. in the determination of neural precursors. In this section I 
aim to establish the role that Gab1β has in the generation of neural 




The same differentiation protocol as before was used. Briefly, Gab1β-targeted 
ES cells were plated in N2B27 plus 100 units/ml LIF, supplemented with 
varying levels of insulin: 0 µg/ml (zero), 0.25 µg/ml (low) and 25 µg/ml 
(high). The next day (day 1), LIF was removed and the cells were replenished 
with N2B27 medium supplemented with 2ng/ml FGF4 and 1µg/ml heparin. 
The medium was then replenished on days 3 and 5. Brightfield images were 
taken on days 1 (Figure 5.26), 3 (Figure 5.27) and 4 (Figure 5.28) and on day 5 
the cells were fixed and stained with aOct4 and aTUJI antibodies (Figures 
5.29-5.33). On day 1, all four cell lines plated equally well in the varying 
concentrations of insulin (Figure 5.26). Though the effect of insulin was 
subtle, it was clear that in the low and high concentrations, cells appeared 
flatter and more adherent than they did in the absence of insulin. By day 3 
there were more adherent cells at the high concentration of insulin (Figure 
5.27). This could be attributed to either the faster growth of the cells or more 
death of the cells at the lower concentrations of insulin. Interestingly on both 
days 1 and 3, there were no significant differences between Gab1β +/+ and -
/- cells. On day 4, the effect of insulin was clearer. There was a gradual 
increase in the size of the colonies of neural precursor-like cells as the 
concentration of insulin increased (Figure 5.28). Furthermore, both Gab1β -/- 
cells seemed to produce more neural precursor-like cells as distinguished by 
the long axons connecting the cells, compared to +/+ cells. Interestingly, in 
the absence of insulin, more Gab1β +/+ and Gab1β restored +/+ cells were 
seen compared to Gab1β -/- and Gab1α restored cells. it is not clear whether 




Figure 5.26: The effect of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors. Cells were differentiated in response to FGF4 




Figure 5.27: The effect of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors. Cells were differentiated in response to FGF4 




Figure 5.28: The effect of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors. Cells were differentiated in response to FGF4 
in varying amounts of insulin over 4 days. On day 4, cells in no insulin, though differentiating, were doing so at a much slower rate. As the 
concentration of insulin increased, so did the size of the neural precursor-like colonies. 
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When the cells were fixed and stained on day 5, it was clear that insulin 
provided a survival and growth advantage. In the absence of insulin, the 
colonies of neural precursors were very small and there were quite a few 
Oct4 positive cells (Figure 5.29). In low insulin, though there were still some 
Oct4-positive cells, the colonies of tubulin-positive cells were much larger 
(Figure 5.30). Furthermore, at both zero and low insulin, there seemed to be 
no significant differences in the levels of TUJI or Oct4 staining between 
Gab1β +/+ and -/- cells. At the higher insulin concentration (Figure 5.31), 
Gab1β -/- cells seemed to give rise to larger colonies of tubulin-positive cells, 
with less Oct4-positive cells, compared to +/+ cells. When a larger field was 
inspected, however, the differences were not as pronounced, with all cell 
lines having Oct4-positive cells (Figure 5.32). There were, however, more 
Gab1β -/- TUJI-positive cells. This suggests that in the absence of Gab1β, 
cells may be more sensitive to the potential inhibition of ERK in response to 
high levels of insulin concentration. These results suggest that Gab1β may 
have a slight effect on the generation of neural precursors at high levels of 
insulin. In the case of α -/- cells, the overexpression of Gab1α did not have a 
great effect on the emergence of neural precursors (Figure 5.33). The cells had 
a similar pattern to that of Gab1β 26 -/- cells. The addition of increasing 
amounts of insulin benefited the emergence of neural precursors.  
 
When comparing the levels of tubulin and Oct4 separately for the different 
cells line under the different insulin concentrations, a pattern seems to 
emerge. The mean grey values of TUJI and Oct4 were measured using 
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ImageJ software, and were then normalised to DAPI. When comparing the 
levels of TUJI intensity at different insulin concentrations, what is clear is 
that insulin has a negative effect on the expression of tubulin in neuronal 
precursors (Figure 5.34). The addition of insulin has a negative effect on the 
amount of TUJI expressed per cell, as values have been normalised to DAPI. 
Furthermore, Gab1β -/- cells exhibit more TUJI expression at all three insulin 
concentrations. This suggests that the presence of Gab1β somehow represses 
the expression of TUJI. When the levels of Oct4 were measured at the 
differing concentrations of insulin for the different cell lines, a similar pattern 
emerged (Figure 5.35). Apart from the Gab1β restored +/+ cell line, the 
increasing amounts of insulin had a negative effect on the intensity of Oct4 
staining. Interestingly, in accordance with was observed in Figures 5.8 & 5.9, 
Gab1β -/- cells exhibit more Oct4 expression compared to +/+ cells, 
irrespective of the insulin concentration. This suggests that Gab1β has a 
repressive effect on the neural differentiation of ES cells. Although these data 
stem from one experiment only, it would be interesting to find out the 










Figure 5.29: The effect of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors on day 5. In the absence of insulin, colonies 




Figure 5.30: The effect of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors on day 5. At low levels of insulin, there is an 




Figure 5.31: The effect of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors on day 5. Upon the addition of high levels of 




Figure 5.32: The effect of high levels of insulin on the differentiation of Gab1β-targeted ES cells into neural precursors on day 5.  In the larger field, all 




Figure 5.33: The effect of insulin on the neural differentiation of Gab1α-overexpressing Gab1β -/-  ES cells on day 5., The addition of insulin had a 




Figure 5.34: The effect insulin on the expression of TUJI in Gab1β-targeted ES cells on day 5 
of neuronal differentiation. Insulin seems to have a repressive effect on the expression of 
TUJI in all 4 cells lines. Gab1β also seems to inhibit the expression of TUJI in neuronal 
precursor-like cells. (n=3 different fields of view in 25µg/ml insulin). 
 
Figure 5.35: The effect insulin on the expression of Oct4 in Gab1β-targeted ES cells on day 5 
of neuronal differentiation. Insulin has a repressive effect on the expression of Oct4 in all 4 
cells lines. Gab1β also seems to inhibit the expression of Oct4 in neuronal precursors. (n=3 





The aim of this chapter was to establish the neural differentiation potential of 
Gab1β -/- cells. Before attempting to do this, a reproducible neural 
differentiation protocol was established using N2B27 and FGF4. After several 
pilot experiments, it was concluded that the number of cells to be plated for 
the maximum yield of neural progenitors was 0.7x105 cells/9.6cm2 well and 
that FGF4 required the addition of heparin to act as its carrier. Using these 
conditions, Gab1β-targeted ES cells were differentiated down the neural 
pathway and results showed that Gab1β -/- cells could indeed differentiate 
and give rise to neural precursors. In light of previous results, whereby 
Gab1β potentiated the activation of Erk in response to LIF (Figure 3.7), one 
might expect Gab1β +/+ cells to differentiate faster, as activation of Erk in 
response to LIF has been shown to act as a pro-differentiative signal, rather 
than contributing to self-renewal (Burdon et al., 1999a; Burdon et al., 1999b). 
The experiments performed here, however, indicate that this is not the case. 
Gab1β +/+ cells did not give rise to neural precursors at a faster rate 
compared to -/- cells. This suggests that the increased LIF-induced Erk 
activation observed in Gab1β +/+ cells may have a different effect unrelated 
to differentiation, such as growth during normal culture. Gab1α has been 
shown to enhance epidermal cell proliferation by promoting MAPK 
signalling (Cai et al., 2002), and Gab1β may also have a similar role in ES cells 




Surprisingly, on day 5 Gab1β restored +/+ cells exhibited fewer TUJI-
positive cells and fewer axons compared to Gab1β -/- cells. This indicates 
that the presence of Gab1β may inhibit the neural differentiation process of 
ES cells. Furthermore, Gab1α-overexpressing Gab1β -/- cells progressed 
through the differentiation process much faster and gave rise to more 
precursors compared to all other cell lines. When the intensity of TUJI 
expression was measured on day 9 neuronal precursors of this cell line, there 
was in fact no difference in the level of TUJI expression per cell, compared to 
Gab1β restored +/+ cells (Figure 5.21). In fact, it was merely the number of 
precursors that was much greater when Gab1α was overexpressed instead of 
Gab1β. This suggests that Gab1α promotes the differentiation of Gab1β -/- 
ES cells. Gab1α has been shown to be essential for EGF-dependent 
proliferation of Olig2(+) progenitor cells of the murine spinal cord, where 
glial cells originate (Hayakawa-Yano et al., 2007). Furthermore, Gab1α-
overexpressing Gab1β -/- cells consistently gave rise to neural precursors 
with long, thick axons. This indicates that Gab1α promotes the neural 
outgrowths of the TUJI-positive neural-like cells. Interestingly, Gab1α has 
been shown to promote Neural Growth Factor (NGF) – induced cell survival 
by binding to PI3K (Holgado-Madruga et al., 1997). Furthermore, 
adenovirus-expressed Gab1α has been demonstrated to promote neurite 
outgrowth of PC12 cells (Korhonen et al., 1999). Using MAPK and PI3K 
inhibitors, Korhonen et al showed that Gab1α-induced neurite outgrowth is 
suppressed. The recruitment of Shp2 by Frs2 and the catalytic activity of 
Shp2 have been demonstrated to be important for FGF-induced 
differentiation and neurite outgrowths of PC12 cells (Hadari et al., 1998). The 
 
 232 
downstream activation of the MAPK pathway in response to Shp2 
recruitment at the FGF receptor 1, was suggested to be crucial for the 
differentiation of the cells. The recruitment of Shp2 may indeed require the 
presence of Gab1α. In the case of the neural differentiation of ES cells, the 
presence of Gab1α promoted the outgrowth of neurites as well as the 
differentiation of the cells, a process dependent on FGF4 (Kunath et al., 2007). 
Therefore, one could hypothesise about the pathway: FGF4 induces the 
recruitment of Shp2 via Gab1α, which in turn promotes the neural 
differentiation, as well as the neurite outgrowths. Interestingly, Gab1β did 
not promote either of these processes. Gab1β may in fact inhibit this process. 
This suggests that in neurons, Gab1β may act as a dominant negative 
adaptor protein by somehow inhibiting the differentiation pathway. For 
example it may bind and mislocalise Shp2. Alternatively, due to the lack of a 
PH domain, it may just not have the ability to maintain the contact with the 
membrane for long enough, in order to induce the sustained activation of Erk 
which has been shown to be required for the efficient differentiation of PC12 
cells (Cowley et al., 1994; Traverse et al., 1994).   
 
Insulin has been shown to promote the survival of neurons by activating the 
PI3K signalling pathway and its downstream effector Akt (Dudek et al., 1997; 
Leinninger et al., 2004; Zhao et al., 2007). As insulin is one of the most 
abundant components of the differentiation medium N2B27, I was interested 
in seeing whether insulin had an effect on the differentiation of Gab1β -/- 
cells. What was clear from the results was that, regardless of their Gab1β 
 
 233 
genotype, cells survived better and differentiated much faster at higher levels 
of insulin. Data indicated that the number of neural precursors increased in 
response to higher levels of insulin, which suggests that insulin may 
potentiate the growth of differentiated cells. Although the same cells have 
been shown to repress Akt in response to IGF (Figure 3.20), they also repress 
Erk (Figure 3.24), which could give cells a survival advantage. This is 
supported by the fact that the suppression of Erk has been shown to promote 
the survival of neural stem cells (Zhao et al., 2007). The suppression of Erk 
and Akt by Gab1β in response to insulin, however, was demonstrated in ES 
cells. The effect of Gab1β on Akt and Erk in neural cells may be completely 
unrelated to that. Interestingly, both IGF1 and insulin have been shown to 
enhance cell survival and formation of neurites in sympathetic and sensory 
neurons (Recio-Pinto et al., 1986). Furthermore, this promotion of neurite 
outgrowth in response to insulin has been demonstrated to require the 
activation of MAPK (Kim et al., 1997). The data presented here, suggests that 
Gab1β suppresses the neural differentiation of ES cells at high levels of 
insulin. Interestingly, the overexpression of Gab1α in Gab1β -/- cells does 
not have the same effect. At higher levels of insulin, Gab1α restored cells 
exhibited similar levels of TUJI expression per cell, but had more TUJI-
positive cells compared to Gab1β restored cells. this suggests that Gab1α 
promotes the neural differentiation of ES cells in response to insulin. It 
further suggests that Gab1β may either act as a dominant negative effector, 
or it may indeed be unable to promote neural differentiation and neurite 
outgrowth in response to high levels of insulin as it cannot induce sustained 
Erk activation.  
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It would be interesting to see whether Gab1β had an effect on nestin and/or 
Ki-67 expression. Both these proteins have been shown to be expressed in the 
subventricular zone of mice (Tanaka et al., 2007), where Gab1β has been 
shown to be expressed (Burdon T. et al, unpublished). Nestin is a 
neuroepithelial stem cell marker (Lendahl et al., 1990), whilst Ki-67 is a 
marker of proliferating cells (Kim et al., 2002). Furthermore, it would be very 
interesting to determine the levels of Akt and Erk phosphorylation during 
the process of neural differentiation. These data would provide an important 
insight into the biochemical changes that take place in the presence of Gab1α 















CHAPTER  6: DISCUSSION 
 
Gab1 is a multifunctional adaptor protein that takes part in a myriad of 
signalling pathways. It has been shown to be involved in many biological 
processes ranging from cell survival (Holgado-Madruga et al., 1997; 
Holgado-Madruga and Wong, 2003) to cytoskeletal reorganisation and 
chemotaxis (Kallin et al., 2004) and glucose tolerance and hepatic insulin 
action (Bard-Chapeau et al., 2005). As they lack any enzymatic activity, their 
structure is what gives them this ability to multitask and to participate in the 
transmission of signals from various receptors ranging from the EGFR 
(Holgado-Madruga et al., 1996) to the gp130/LIFR (Takahashi-Tezuka et al., 
1998). The presence of tyrosine phosphorylation sites as well as specific 
binding sites for other adaptors and proteins are what give Gab1 this 
multifuncitonality. Therefore, its structure is pivotal to its function, and 
allows Gab1 to regulate signalling cascades in a dynamic manner. For 
example, whether an emanating signal is transient or sustained may depend 
on the affinity of Gab1 proteins to a specific receptor. The PH domain acts to 
bring Gab1 to points of cell-to-cell contact near the cellular membrane. It 
anchors Gab1 near the membrane and hence sustains the signalling cascade. 
It was therefore interesting to find that ES cells express a variant that lacks 
this critical structural component. In spite of this, I found that not only is 
Gab1β phosphorylated, it also forms active complexes with Shp2 and the p85 




Most importantly, I showed that Gab1β promotes Erk and potentially Akt 
activation in response to LIF. The biological effect of Erk activation in 
response to LIF is still unclear. This effect is likely to be unrelated to self-
renewal, as Gab1β -/- cells are still able to self-renew (Burdon T. 
unpublished). The kinetics of Erk activation, however, have been shown to 
influence the biological outcome. For example, transient phosphorylation of 
Erk has been shown to be associated with a proliferative response, whilst 
sustained Erk activation is thought to be associated with differentiation 
(Sharrocks, 2006). It would be interesting to see whether Gab1β promotes 
transient-proliferative or sustained-differentiating Erk. The lack of PH 
domain would potentially restrict Gab1β from anchoring to the membrane 
following receptor activation. Therefore, one might predict that Gab1β may 
favour transient bursts of Erk activation due to its inability to maintain  
sustained anchoring to the membrane. This would suggest that the 
potentiation of Erk in response to Gab1β recruitment to the LIFR/gp130 
receptor complex was associated with a proliferative effect. Although there 
are little differences between the growth rates of wildtype and Gab1β-
deficient cells, Gab1β -/- cells exhibit a deficit in their long-term growth, as 
observed in long-term growth competition assays (Burdon T., unpublished). 
As well as boosting Erk activity, Gab1β may also potentiate Akt activation in 
response to LIF. Although Akt activation has mainly been demonstrated to 
be associated with the maintenance of self-renewal, the PI3K pathway has 
also been implicated in the regulation of ES cell growth. ES cells with a 
mutation of PTEN, a lipid phosphatase that normally inhibits PI3K activity, 
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exhibit enhanced viability and increased rate of proliferation (Sun et al., 
1999).   
 
I also demonstrated that Gab1β inhibits Erk and Akt in response to IGF. The 
role of the IGF-insulin signalling pathway in ES cells is still unclear and of 
great interest. Published data on this point is, however, contradictory. For 
example, the activation of the PI3K signalling pathway in response to insulin 
has been suggested to be involved in the maintenance of ES cell proliferation, 
through the activation of Akt-dependent inactivation of Gsk3β (Paling et al., 
2004; Welham et al., 2007). More recently, the differentiation of ES cells has 
been suggested to be associated with a reduction in IRS1 expression, as well 
as a decrease in Akt and Gsk3 phosphorylation (Rubin et al., 2007). Recent 
data, however, suggests that insulin acts to sensitise cells to differentiation-
inducing signals, such as FGF4 (Ying et al., 2008).  
 
The data presented here demonstrates that Gab1β is an adaptor protein 
whose function is dependent on the environment the cells are surrounded 
by. For example, Erk ativation is potentiated by Gab1β in response to LIF, 
but it is also inhibited by Gab1β in response to insulin. Which outcome is 
achieved, is likely to depend on the instructions that a cell receives from its 
surroundings. This suggests that the function of Gab1β is context and 
receptor-dependent. Literature suggests that the context of a cell limits the 
possible responses to growth factor signalling and the magnitude and 
duration of RTK activation (Hopper, 2006). Its possible that the context of the 
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cell determines the specific response. As an adaptor protein, Gab1β may act 
to potentiate or inhibit a pathway, depending on the specific signals and the 
biological outcomes that a cell requires. For example, the data obtained here 
indicate that Gab1β may in fact inhibit the neural differentiation of ES cells, 
and that Gab1α actually promotes it. When insulin is present at high levels, 
the effect is more pronounced. Gab1β-deficient cells exhibit more neural-like 
precursor cells compared to Gab1β wild type cells. But I also demonstrated 
that Gab1β potentiates the activation of Akt in response to LIF, an effect that 
would be expected to promote the self-renewal of the cells. It would be very 
interesting to determine the signals that lie behind the differentiating effects, 
and to see whether Gab1 has an effect on Erk and/or Akt signalling during 
the neural differentiation process. The data surrounding the role of Gab1α 
and differentiation are varied and reflect the ability of this protein to convey 
signals from to the many receptors it binds to. Gab1α has been shown to 
oppose differentiation by activating the MAPK signalling pathway in 
epidermal cells (Cai et al., 2002). Recently, the Gab1α-Shp2 complex has been 
shown to negatively regulate myogenic differentiation by activating the 
MAPK pathway (Koyama et al., 2008). In contrast, the Gab1α-Shp2 complex 
has also been shown to promote colon cancer cell enterocytic differentiation 
in response to HGF (Kermorgant et al., 2001). Therefore, it may be that in ES 
cells, Gab1α can have a role in their differentiation into neural precursors, as 
long as its present at a high enough concentration, i.e. when it is artificially 
overexpressed. This is interesting and suggests that although Gab1β is able to 
activate signalling pathways in response to growth factors and cytokines, 
this does result in a biological effect, whilst introducing high levels of Gab1α 
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into ES cells does. It would be interesting to see whether deleting Gab1α 
from the Gab1β -/- cells will have a more profound effect on their ability to 
convey signals and to differentiate into neural precursors. 
 
The ability of Gab1β to potentiate and inhibit Erk in response to LIF or 
insulin respectively, suggests that it may take part in a regulatory 
mechanism. ES cells are cultured in an environment where self-renewal is 
aimed for, but they still have the ability to differentiate. ES cells are in a state 
of self-renewal and once they receive the appropriate signal, they ca for 
example differentiate into neural cells.  In vivo this is reflected by the process 
of delayed implantation, diapause. During this state of delayed implantation, 
embryos develop to the hatched blastocyst stage, but then cease development 
and remain unimplanted in the uterus (Holmes and Dickson, 1975). During 
diapause, proliferation and metabolism is arrested and the blastocyst cells 
are in a state of metabolic and proliferative quiescence (Holmes and Dickson, 
1975; Spindler et al., 1996). Once diapause is interrupted, the blastocyst 
regains an active metabolism, cell proliferation is initiated, the blastocyst 
implants in the uterus and development continues (Hondo and Stewart, 
2005). Diapause is therefore a reversible mechanism that can halt the 
proliferation of early embryonic cells, which in fact have the natural ability to 
proliferate very rapidly. Interestingly, LIF is required so that the uterus is 
induced to become receptive to the blastocyst but is dispensable for normal 
embryonic development (Stewart et al., 1992). If blastocysts undergo 
diapause, however, gp130 signalling is required to sustain ICM cells in 
conjunction with the arrest of ICM proliferation (Hondo and Stewart, 2005; 
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Nichols et al., 2001). In C. elegans, the process of dauer resembles in some 
respects the blastocyst dormancy state, diapause. The process of dauer is 
regulated by a gene called daf-2 (Kimura et al., 1997). Interestingly, daf-2 
encodes IRS1 in C. elegans, which acts to sense the nutritional status of the 
worm to repress dauer formation (Kimura et al., 1997; Morris et al., 1996), 
and Gab1 proteins were initially discovered as IRS1-like proteins (Holgado-
Madruga et al., 1996). Furthermore, Soc1, the C. elegans Gab1 homologue, has 
been shown to negatively regulate dauer formation. IRS1 has also been 
identified as a an upregulated gene in dormant blastocysts in mice, in a 
global gene expression microarray study (Hamatani et al., 2004). Therefore, 
IRS1 may take part in the regulation of diapause by initiating growth and 
metabolic activity when delayed implantation ceases. Gab1β could therefore, 
also be expressed in blastocysts during delayed implantation. It may have a 
similar role as IRS1 in promoting an increase in metabolic rate when 
diapause ceases, and proliferation and differentiation are initiated. The 
maintenance of this quiescent state of homeostasis may in fact be the reason 
it is so highly expressed in ES cells, which are the in vitro counterpart of ICM 
cells in the blastocyst. Interestingly, human ES cells express Gab1α, but do 
not express a Gab1β homologue which lacks the PH domain. Furthermore, 
human blastocysts are not known to undergo delayed implantation (Tarin 
and Cano, 1999). It may be that there is no requirement for the expression of 
a short form of Gab1α as blastocysts do not undergo diapause and therefore 
do not have the necessary signalling proteins in order to initiate the exit out 
of this inactive metabolic state during embryogenesis.            
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Most published data suggests that the lack of a PH domain in Gab1 inhibits 
its ability to act as an adaptor protein. PH domain mutants have been shown 
to either fail to form complexes downstream of receptor activation, or indeed 
fail to potentiate the appropriate effectors.  For example, the PH domain of 
Gab1α has been shown to be essential for the ability of Gab1α to support 
branching morphogenesis downstream from the Met receptor tyrosine 
kinase in epithelial cells, in concert with PI3K activity (Maroun et al., 1999a). 
Expression of a Gab1α mutant lacking the PH domain in fibroblasts, 
however, has been shown not to interfere with EGF-induced Erk activation. 
Furthermore, a “naturally occurring” Gab1β variant is tyrosine 
phosphorylated in response to EGF in transformed SHE (Syrian Hamster 
Embryo) cells. therefore, whether the PH domain would also affect the 
localisation of the protein and its ability to move to the plasma membrane is 
still unclear. Even if the short form of Gab1α is biochemically active, the 
localisation may be different due to the lack of a PH domain and a NLS.   I 
demonstrated that depending on which terminal Gab1β was tagged with 
EGFP, a different localisation pattern was obtained. When Gab1β was tagged 
at the C-terminal end, a localisation pattern similar to that of Gab1β wild 
type ES cells was obtained. However, when the protein was directly tagged 
at the N-terminal, where the PH domain would normally reside, this was not 
the case. The tagged protein did not localise to the perinuclear foci as the 
wild type protein did. Furthermore, when the N-terminal tag and the Gab1β 
protein were separated by a polyglycine linker, a more wild type pattern of 
localisation was exhibited. This suggests that another domain following the 
PH domain, which is present in both Gab1α and Gab1β, may be important 
 
 242 
for the localisation of the protein, as well its function potentially. It would be 
interesting to investigate whether the published PH domain mutants that 
have been demonstrated to interfere with the function of Gab1α, had a 
similar pattern of sequence deletion. It may be that in the cases where the 
loss of the PH domain interfered with the localisation of the protein, a extra 
domain following the PH domain was also deleted. Interestingly, the 
recruitment of Gab1α to the plasma membrane was recently shown to be 
regulated by a separate domain other than the PH domain (Eulenfeld and 
Schaper, 2008). The authors demonstrated that when the Gab1α PH domain 
alone was transiently expressed in HEK393T cells, it was located at the 
plasma membrane, unlike the full-length protein, which was found in the 
cytoplasm. The authors therefore speculated that the full length Gab1α 
protein has properties that prevent the protein’s translocation to the plasma 
membrane. It was then demonstrated that the membrane targeting of the full 
length Gab1 protein is in fact blocked by a protein region found after the PH 
domain. The data presented in this thesis suggest that Gab1β does not incude 
this novel domain, as Gab1β is membrane-targeted in Gab1β +/+ ES cells. 
The membrane-targeting of Gab1β was also demonstrated to be prevented by 
the fusion of EGFP to the N-terminal. The presence of the EGFP tag at the N-
terminal of Gab1β may in fact act in the same manner as this novel domain 
characterised by Eulenfeld & Schaper (Eulenfeld and Schaper, 2008), in that it 
also inhibits the membrane localisation of the tagged Gab1β. Progressively 
truncated constructs engineered to include different sequences post-PH 




The localisation data demonstrated here raise more questions as to the 
requirement for the high expression of Gab1β in ES cells. Gab1β was shown 
to be highly expressed in a distinct perinuclear body. An important event 
during the lifecycle of a receptor is the internalisation and recycling back to 
the surface in endosomes, in response to growth factor binding (Oksvold et 
al., 2001). Recycling endosomes are in charge of the recycling of receptors 
and ligands (Enrich et al., 1999). Grb2 in complex with the EGFR has been 
shown to be localised in endosomes (Oksvold et al., 2001) and therefore one 
could hypothesise that Gab1β may also be found in this complex in 
endosomes as well. In attempting to relate this observation with the fact that 
Gab1β may have a role in maintaining a state of homeostasis in ES cells, one 
could hypothesise that Gab1β is recycled in endosomes in complex with the 
receptors it conveys signals from.         
 
What controls the decision to transcribe Gab1β instead of Gab1α in ES cells is 
of great interest. Is this controlled by ES cell-specific transcription factors? Or 
is there a mechanism of silencing in place, whereby cues emanating from the 
surrounding environment control this process? It is likely that transcription 
factors that are important for ES cell biology may in fact instruct the 
transcription of Gab1β, rather than that of Gab1α. Deciphering the potential 
factors that regulate the maintenance of ES cells during diapause would be of 
great help in understanding the regulation of Gab1β protein expression. One 
of the most exciting advances in ES cell biology is the discovery of induced 
pluripotent stem cells, or iPS cells (Takahashi et al., 2007; Takahashi and 
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Yamanaka, 2006). These cells are pluripotent and are artificially derived from 
non-pluripotent fibroblasts by forcing the expression of four genes: Oct4, 
Sox2, cMyc and Klf4. It would be interesting to see whether Gab1β is 
expressed in iPS cells. This would indicate that one of these four factors may 
potentially be responsible for the decision to transcribe Gab1β in ES cells 
instead of Gab1α, which is normally expressed in differentiated cell types, 
such as fibroblasts.      
 
Although the exact role of Gab1β in ES cells is not clear, what is evident is 
that the exact biological identity of an ES cell is also of great interest. ES cells 
represent the in vitro counterpart of epiblast cells (Smith et al., 2001), but 
whether they truly reflect what happens in the epiblast is still unknown. One 
might expect that the signals that regulate ES cells, such as gp130 signalling, 
would also be important in vivo. During normal development, however, LIF 
is not required for the maintenance of the ICM in mouse epiblasts. The only 
time where the epiblast is dependent on gp130 signalling is during the 
process of delayed implantation, or diapause (Nichols et al., 2001). This is an 
example of the disparity that exists about what ES cells truly represent. 
Future work on identifying the signals  involved in the in vivo regulation of 
ES cells may indeed further our knowledge and more importantly the 
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